data_2epp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2epp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.931 0.396 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.0 mt -150.0 158.25 37.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.616 0.722 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 144.72 54.9 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.717 2.278 . . . . 0.0 112.335 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 26.7 t -52.01 116.33 2.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.28 39.46 2.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.469 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 75.5 mt -130.07 -42.36 1.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 110.906 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 18.8 p -113.25 -30.39 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.97 19.46 7.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.474 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -86.48 164.99 16.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.54 133.93 67.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -132.08 157.15 44.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 24.8 p -121.11 -33.23 3.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -93.99 120.79 34.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.828 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.63 -44.41 69.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.069 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.36 -37.86 88.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -66.98 -42.02 85.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 41.3 tp -71.63 -27.26 62.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -61.94 -35.39 78.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -75.88 -41.44 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -59.8 -39.75 86.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -55.36 -32.16 62.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.51 89.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.082 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -53.57 -40.79 65.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -79.38 -44.26 21.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.87 0.367 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.4 mt -150.09 158.15 36.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.603 0.716 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 140.78 43.67 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 36.5 t -52.02 109.64 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -90.8 47.97 3.01 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.538 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 73.0 mt -134.23 -44.41 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.88 0.371 . . . . 0.0 110.931 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 13.8 p -116.46 -27.08 6.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.13 19.56 7.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.546 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -89.05 169.38 11.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.8 t -129.88 133.77 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -131.11 164.94 24.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.9 t -127.51 -38.09 1.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.88 117.04 25.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.22 32.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -80.31 -30.1 38.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -73.05 -47.65 42.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -28.92 69.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 41.6 ttp85 -59.21 -47.69 84.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -66.35 -29.95 70.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -72.07 -48.65 42.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -59.54 -29.04 67.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.74 -38.31 60.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -69.5 -34.75 74.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -69.63 -35.47 75.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.878 0.371 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.1 mt -150.02 158.27 36.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.64 0.733 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 144.17 53.3 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 46.8 t -52.8 115.09 1.65 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.36 43.03 2.54 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 64.7 mt -131.68 -40.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.859 0.361 . . . . 0.0 110.92 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 12.6 p -115.74 -30.05 6.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.98 20.68 7.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.495 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -89.61 179.29 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 66.1 t -136.67 135.85 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -132.1 160.12 36.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 39.9 p -122.51 -35.06 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.136 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -91.44 116.48 28.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.81 -33.39 35.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -72.26 -37.94 68.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -67.3 -44.96 77.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 67.0 tp -67.37 -29.54 69.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -60.82 -40.92 94.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -76.91 -28.38 55.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.17 -40.31 82.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.39 -26.92 62.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.5 -30.44 60.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -77.89 -42.28 33.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -57.21 -37.01 71.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.9 mm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.8 mt -150.02 158.22 37.02 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.575 0.703 . . . . 0.0 110.958 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.28 47.53 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.38 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 30.0 t -52.52 114.44 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.84 32.97 5.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 32.0 mt -119.59 -41.02 2.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 12.6 p -116.13 -33.74 4.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.34 20.34 5.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.479 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -89.31 171.0 10.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 82.8 t -131.03 136.56 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.13 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -135.41 161.51 35.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 70.8 p -121.54 -37.99 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.21 124.78 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.02 -51.91 62.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.043 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -56.79 -43.09 80.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -57.27 -52.75 64.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 59.0 tp -65.15 -29.55 70.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -54.51 -53.37 55.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -61.88 -38.59 88.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.09 -43.0 95.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -56.56 -41.29 76.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.23 -29.29 45.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.07 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -63.94 -44.77 91.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -72.36 -35.37 68.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.48 -179.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.892 0.377 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.0 mt -149.99 158.23 37.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.661 0.743 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 146.65 60.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.711 2.274 . . . . 0.0 112.339 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 35.8 t -51.93 116.87 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.54 34.97 4.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 65.4 mt -123.48 -40.34 2.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 110.899 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 9.5 p -117.24 -28.36 6.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 109.72 20.32 7.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -86.63 169.07 13.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.7 t -127.48 134.71 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -131.38 173.6 10.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.822 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 43.4 p -134.42 -44.07 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.109 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.57 120.04 25.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.51 -44.97 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -65.71 -31.3 72.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -70.25 -49.9 45.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 35.1 tp -67.07 -29.15 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -57.05 -38.6 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -74.85 -34.96 62.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -65.03 -41.07 95.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -57.08 -29.91 63.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.27 -34.03 75.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -54.23 -51.9 63.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -70.5 -40.33 73.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.1 mt -150.05 158.12 37.04 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.624 0.726 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 139.62 40.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.64 2.227 . . . . 0.0 112.369 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 17.0 t -53.15 110.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.83 39.99 2.9 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 17.5 mt -126.02 -43.74 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.34 . . . . 0.0 110.921 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 23.8 p -115.44 -31.64 5.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.897 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.45 18.63 5.69 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.449 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -89.69 168.35 12.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.3 133.42 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -131.44 155.87 46.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.9 t -118.14 -28.92 5.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.119 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -100.03 123.06 43.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.76 71.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.105 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -55.41 -32.77 62.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -74.61 -45.13 47.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 63.5 tp -66.66 -26.42 67.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -57.54 -54.22 49.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -63.8 -31.39 72.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -69.94 -27.26 64.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -83.52 -26.43 30.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.88 -51.57 63.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.077 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -61.83 -32.3 72.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -67.89 -42.5 81.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.473 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.9 mm . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.07 158.19 36.94 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 0.0 110.916 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 149.14 66.54 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.69 2.26 . . . . 0.0 112.336 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 36.0 t -58.16 116.82 3.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.77 34.74 4.58 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.508 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.9 mt -122.56 -40.07 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.34 . . . . 0.0 110.923 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 14.9 p -116.36 -30.42 5.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.79 19.68 7.22 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -89.94 179.34 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.754 0.311 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.58 138.69 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -138.08 145.28 41.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 4.0 p -108.7 -33.93 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.12 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.2 109.8 20.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.79 -30.82 24.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -72.45 -37.45 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -67.52 -48.11 68.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 32.0 tp -57.22 -33.88 67.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -52.56 -41.44 63.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.849 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -74.75 -26.58 59.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -70.25 -41.76 73.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -59.69 -29.22 67.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.27 -37.04 64.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -62.4 -53.59 52.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -65.44 -32.1 73.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.958 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.6 mt -150.02 158.25 36.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.572 0.701 . . . . 0.0 110.927 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 141.42 45.12 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.702 2.268 . . . . 0.0 112.33 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 32.3 t -53.46 110.87 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.42 46.59 2.58 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.454 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.1 mt -132.3 -49.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.346 . . . . 0.0 110.925 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 20.4 p -111.18 -26.96 8.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.05 20.97 6.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.473 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -89.79 167.19 13.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.748 0.309 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.3 133.81 67.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.139 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -132.4 140.32 48.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 7.1 p -106.52 -26.29 11.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -103.23 131.77 50.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.842 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.55 -49.05 76.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.089 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -56.25 -43.26 78.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -62.87 -46.95 85.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 51.2 tp -64.23 -26.0 68.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -52.06 -61.57 2.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.944 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -51.82 -48.38 63.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -53.25 -64.93 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -53.55 -40.05 65.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.81 -25.04 66.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -86.71 -32.29 20.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.898 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -57.45 -29.13 63.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.511 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.832 0.349 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.6 mt -150.03 158.16 37.04 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.598 0.713 . . . . 0.0 110.936 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 140.72 43.46 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.674 2.249 . . . . 0.0 112.325 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 49.8 t -56.18 107.84 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -91.24 45.7 2.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 13.2 mt -132.67 -44.42 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 21.5 p -114.72 -27.1 7.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.83 19.49 7.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.466 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -88.98 166.37 13.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.9 t -130.5 135.16 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -130.85 158.01 41.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.91 -43.65 2.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -84.54 139.6 32.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.42 84.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -65.79 -41.49 91.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 37.3 tpt85 -58.7 -49.16 78.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.78 -26.03 64.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -55.93 -25.77 44.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -92.18 -34.32 14.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -71.37 -33.67 69.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -71.16 -26.5 63.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.881 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -72.18 -37.95 69.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -58.01 -40.69 81.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -70.28 -41.87 72.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.483 -179.943 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.854 0.359 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 28.0 mt -150.01 158.2 37.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.636 0.731 . . . . 0.0 110.934 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 147.33 62.27 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.635 2.223 . . . . 0.0 112.338 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 37.4 t -52.7 117.59 3.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -95.18 32.77 5.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.48 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 18.3 mt -119.83 -40.89 2.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 0.0 110.974 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.4 p -116.86 -31.17 5.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 113.21 22.87 5.41 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -89.82 168.81 11.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.42 142.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -141.61 160.97 39.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.1 p -127.86 -39.59 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.139 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.3 116.35 25.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.15 -45.43 65.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -65.68 -31.2 72.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -73.82 -45.31 52.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 34.6 tp -63.3 -26.61 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -55.13 -54.74 39.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -52.09 -49.76 62.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -56.77 -44.1 81.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -59.6 -31.81 69.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.93 70.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -61.93 -56.99 13.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -60.23 -44.52 95.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.848 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 -179.916 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.4 mm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.894 0.378 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.0 mt -150.05 158.18 36.99 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 145.54 57.64 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.666 2.244 . . . . 0.0 112.33 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 20.1 t -60.22 116.6 4.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -95.42 21.49 44.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 41.2 mt -105.01 -40.32 5.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.353 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.1 p -117.59 -29.14 5.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.67 20.48 7.28 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.51 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -89.79 178.75 6.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 80.4 t -135.22 135.07 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.118 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -132.05 159.99 37.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.75 -31.8 4.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.162 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -98.78 127.65 44.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.31 88.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -67.51 -34.55 77.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -70.8 -45.35 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 62.2 tp -67.75 -27.64 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -54.63 -50.45 68.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -67.52 -36.51 81.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -60.5 -35.61 76.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -74.35 -32.74 62.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.44 -31.87 47.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -76.01 -36.4 59.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.971 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -65.29 -28.27 69.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.431 -179.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.871 0.367 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.8 mt -150.04 158.22 36.98 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.602 0.715 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 154.37 67.89 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.388 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.4 t -63.55 117.2 6.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.71 34.43 4.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 93.7 mt -121.82 -39.53 2.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.36 . . . . 0.0 110.921 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 13.7 p -117.78 -29.94 5.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.14 21.54 6.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -89.17 178.89 6.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.902 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.0 t -135.2 135.08 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -131.74 159.28 38.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.2 -32.67 4.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -99.45 132.04 45.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.61 -45.35 93.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -59.6 -39.35 83.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -66.95 -45.98 76.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.35 -27.25 67.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 8.1 ttm-85 -61.22 -53.98 50.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -61.07 -31.74 71.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -67.09 -42.64 84.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.26 -30.92 71.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.74 73.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.26 -33.72 75.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -70.47 -32.96 70.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.498 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.3 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.864 0.364 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.05 158.18 36.98 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.718 . . . . 0.0 110.968 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 145.53 57.2 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.346 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 20.7 t -56.34 114.95 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.77 30.87 7.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.469 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 21.1 mt -117.98 -40.81 2.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.892 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 20.8 p -115.71 -35.07 4.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 117.81 19.05 4.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.481 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -88.29 166.69 14.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.7 t -125.47 134.58 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.086 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -134.09 151.13 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.1 p -116.81 -46.69 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.62 128.09 33.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.51 -48.75 78.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -58.56 -35.19 71.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -65.12 -51.39 61.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.818 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.59 -26.34 64.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -56.19 -26.0 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -93.69 -34.29 13.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -70.3 -33.59 71.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.816 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.21 -30.75 66.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.43 67.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -60.42 -60.34 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -53.72 -47.76 70.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.468 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.86 0.362 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.0 158.27 37.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 144.04 52.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.9 t -55.9 112.54 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.84 34.49 4.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 92.5 mt -119.07 -45.7 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.373 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 26.3 p -113.1 -28.39 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.44 20.99 6.33 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.501 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -89.96 177.32 6.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 65.3 t -136.41 136.2 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -135.47 150.28 49.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 23.3 p -116.62 -45.32 2.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.095 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -78.47 118.1 20.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.71 -37.95 53.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -67.39 -37.98 83.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -63.08 -50.8 69.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 54.8 tp -65.6 -27.42 68.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -57.27 -26.16 60.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -93.31 -36.54 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -70.23 -59.83 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -54.32 -29.76 48.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.21 -34.13 77.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -67.0 -47.26 72.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -55.53 -27.26 47.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.956 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.857 0.361 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.6 mt -150.09 158.13 36.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 145.53 57.36 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.637 2.225 . . . . 0.0 112.344 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 39.3 t -52.04 115.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.89 22.2 35.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.494 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 63.0 mt -105.32 -41.63 5.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.821 0.343 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 26.7 p -118.96 -31.34 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 115.0 27.02 3.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.518 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -90.01 179.32 5.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.865 0.364 . . . . 0.0 110.884 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.7 t -136.05 139.82 45.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -138.72 167.22 22.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.0 p -118.71 -56.19 2.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.78 141.59 40.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.14 -60.45 3.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -53.51 -43.05 67.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -55.45 -48.99 73.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 29.3 tp -58.35 -38.28 76.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -38.12 81.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.31 -55.43 21.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.2 -50.84 72.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -52.46 -30.45 29.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.819 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.9 -27.44 42.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.092 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -82.64 -44.17 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.956 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -52.91 -29.17 26.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.95 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 49.4 mm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.863 0.364 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.2 mt -150.05 158.26 36.93 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.599 0.714 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 161.23 46.74 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.715 2.276 . . . . 0.0 112.35 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.3 115.27 9.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.43 41.32 2.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.454 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 60.0 mt -127.94 -43.33 1.52 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 22.2 p -115.93 -27.55 6.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.7 19.59 7.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -89.85 177.64 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 63.8 t -136.82 138.65 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -135.0 145.47 48.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 17.4 p -106.62 -49.12 3.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -77.99 115.97 18.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.23 -29.62 23.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.058 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.9 -39.37 61.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -62.31 -39.56 93.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 59.8 tp -74.6 -25.92 59.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -56.15 -25.89 48.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -92.69 -34.49 13.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -69.17 -47.7 64.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -58.31 -26.36 62.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.16 -49.43 44.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -52.34 -36.28 53.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -67.6 -40.68 84.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.44 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.848 0.356 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.2 mt -150.09 158.21 36.88 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.619 0.723 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 138.64 38.22 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.245 . . . . 0.0 112.348 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 11.8 t -53.08 113.27 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.42 29.45 8.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 81.7 mt -115.93 -38.51 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 14.6 p -117.34 -33.37 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 114.7 18.88 6.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.421 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -90.08 170.53 10.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.809 0.337 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.23 138.34 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.128 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -139.7 156.5 46.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.66 -44.4 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.144 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -80.02 131.22 35.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.71 91.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -65.65 -42.18 91.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -60.31 -50.51 73.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 56.2 tp -67.18 -26.33 66.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -56.66 -43.12 80.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -78.25 -32.3 49.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -67.97 -31.92 71.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.7 -36.76 57.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.57 -30.2 60.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.07 -51.81 49.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -56.44 -26.67 54.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 -179.943 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.876 0.369 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.7 mt -150.04 158.15 37.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.616 0.722 . . . . 0.0 110.94 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 146.99 61.76 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.654 2.236 . . . . 0.0 112.367 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 52.6 t -52.09 107.69 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -90.8 46.51 2.93 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.521 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 69.0 mt -131.39 -42.23 1.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.921 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 29.8 p -117.43 -28.49 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.47 23.66 4.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -90.04 178.49 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 63.0 t -141.86 142.63 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -140.52 174.11 10.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.2 p -129.74 -39.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -88.34 127.67 35.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.77 84.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -73.07 -37.18 66.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -68.89 -46.25 68.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 26.0 tp -52.04 -38.44 57.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -58.33 -33.73 69.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -57.43 9.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -62.87 -48.9 76.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -54.89 -26.85 38.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.8 -25.37 41.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -87.89 -43.87 11.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -52.02 -31.22 28.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.49 -179.955 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.9 mm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.906 0.384 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 28.0 mt -150.03 158.22 37.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.571 0.7 . . . . 0.0 110.941 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 148.3 64.93 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.702 2.268 . . . . 0.0 112.325 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 25.8 t -58.87 113.98 2.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.75 29.26 8.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.52 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.24 -42.77 3.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.89 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.0 p -114.8 -29.91 6.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.08 19.71 7.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.466 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -89.98 179.09 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 71.9 t -134.89 136.08 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.09 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -136.85 143.66 43.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.8 p -107.11 -43.17 4.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.44 116.02 19.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.39 -41.35 69.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -65.15 -31.73 73.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -69.76 -49.95 47.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.07 -26.24 68.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -56.01 -40.21 73.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -79.15 -37.73 37.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -55.62 -39.72 71.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -67.9 -30.79 70.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.01 -27.52 44.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.86 -53.01 7.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -53.47 -33.15 53.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.868 0.366 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 31.0 mt -150.01 158.21 37.05 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.649 0.738 . . . . 0.0 110.937 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 148.55 65.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.654 2.236 . . . . 0.0 112.348 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.17 114.34 2.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.39 37.68 3.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.2 mt -124.32 -42.76 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 19.6 p -115.66 -26.49 7.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.12 20.28 7.61 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -89.67 179.11 6.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 68.3 t -135.59 135.41 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -134.06 124.85 26.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 26.7 p -90.67 -34.57 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -89.82 128.07 36.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.92 -58.59 7.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -52.91 -33.85 52.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 18.7 tpt85 -63.85 -44.01 94.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 53.8 tp -71.79 -27.17 62.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.13 -25.56 63.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -90.76 -35.05 15.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -71.04 -41.85 70.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.04 -26.24 68.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.23 -34.0 72.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -62.33 -52.1 64.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -55.38 -31.1 61.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 -179.916 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 46.8 p -165.06 151.65 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 0.0 110.891 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 39.8 m -76.29 174.38 10.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -161.05 -106.89 0.21 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.469 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 27.6 p -134.74 58.4 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.819 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.9 m -110.87 109.72 20.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.873 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 158.71 -140.15 6.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.07 172.1 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.868 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -77.2 82.88 3.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -105.33 91.93 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -86.41 -73.97 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 129.16 108.18 1.34 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.452 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm -84.32 135.05 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 0.0 111.088 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.0 mt -150.0 158.25 37.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.616 0.722 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 144.72 54.9 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.717 2.278 . . . . 0.0 112.335 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 26.7 t -52.01 116.33 2.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.28 39.46 2.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.469 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 75.5 mt -130.07 -42.36 1.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 110.906 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 18.8 p -113.25 -30.39 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.97 19.46 7.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.474 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -86.48 164.99 16.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.54 133.93 67.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -132.08 157.15 44.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 24.8 p -121.11 -33.23 3.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -93.99 120.79 34.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.828 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.63 -44.41 69.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.069 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.36 -37.86 88.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -66.98 -42.02 85.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 41.3 tp -71.63 -27.26 62.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -61.94 -35.39 78.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -75.88 -41.44 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -59.8 -39.75 86.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -55.36 -32.16 62.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.51 89.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.082 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -53.57 -40.79 65.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -79.38 -44.26 21.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 110.1 38.96 1.6 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 81.9 t -62.61 100.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.958 0.409 . . . . 0.0 111.094 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.4 m 53.43 29.84 9.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 27.9 t -154.29 161.19 41.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.4 tt -119.79 90.14 3.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.964 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -82.28 114.65 20.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -123.33 -176.75 3.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.93 -20.75 21.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -73.52 168.64 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.891 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 5.4 mp -95.28 132.06 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.116 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -148.01 134.95 20.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.827 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.68 70.97 17.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.633 0.73 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 167.73 23.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.247 . . . . 0.0 112.304 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 167.77 23.53 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.685 2.257 . . . . 0.0 112.341 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 152.61 69.07 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.664 2.243 . . . . 0.0 112.303 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.52 165.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 81.5 mt -108.11 95.85 5.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -156.7 168.23 33.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.526 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -150.91 172.39 15.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.883 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -159.52 159.45 33.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 111.63 59.39 0.46 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.14 159.62 71.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.622 0.725 . . . . 0.0 110.894 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -173.12 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.645 2.23 . . . . 0.0 112.367 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 45.2 mm -110.96 -28.39 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.147 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 73.8 m -96.94 -30.0 13.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 80.67 -176.47 54.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.478 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 143.98 52.83 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.67 2.247 . . . . 0.0 112.381 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 4.2 m -107.45 64.78 0.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.04 148.23 47.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.873 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 CA-C-O 119.168 -0.796 . . . . 0.0 112.483 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 82.6 p -146.78 155.47 42.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.854 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 5.6 p -115.66 -39.82 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 148.35 -157.23 27.23 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.478 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.7 m -142.88 152.54 42.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 80.8 p -121.69 63.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.897 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -109.88 164.54 12.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.27 168.61 15.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.24 155.3 15.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.839 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.64 119.34 9.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -117.36 65.49 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -135.16 -109.54 1.03 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.455 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.92 133.24 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 111.143 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.4 mt -150.09 158.15 36.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.603 0.716 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 140.78 43.67 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 36.5 t -52.02 109.64 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -90.8 47.97 3.01 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.538 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 73.0 mt -134.23 -44.41 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.88 0.371 . . . . 0.0 110.931 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 13.8 p -116.46 -27.08 6.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.13 19.56 7.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.546 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -89.05 169.38 11.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.8 t -129.88 133.77 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -131.11 164.94 24.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.9 t -127.51 -38.09 1.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.88 117.04 25.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.22 32.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -80.31 -30.1 38.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -73.05 -47.65 42.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -28.92 69.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 41.6 ttp85 -59.21 -47.69 84.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -66.35 -29.95 70.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -72.07 -48.65 42.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -59.54 -29.04 67.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.74 -38.31 60.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -69.5 -34.75 74.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -69.63 -35.47 75.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.25 45.1 0.88 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 90.5 t -104.32 -52.23 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.934 0.397 . . . . 0.0 111.106 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.62 148.6 15.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.097 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 6.5 m -95.94 -34.15 11.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.0 mp -61.2 -49.44 77.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -82.11 160.18 23.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.04 130.82 48.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.934 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 179.71 -72.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.527 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -103.68 169.7 8.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.923 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 2.0 pp -61.92 178.01 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -134.29 154.41 51.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 65.6 mt 55.54 73.31 0.87 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.624 0.726 . . . . 0.0 110.923 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 167.75 23.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 167.74 23.6 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 103.62 1.18 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.735 2.29 . . . . 0.0 112.341 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -96.59 93.44 6.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.844 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.79 156.49 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 142.4 -118.34 1.26 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.473 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -135.51 132.16 36.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 0.0 110.922 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -163.33 116.57 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -155.54 143.93 10.41 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.23 159.18 32.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.909 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 99.54 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 0.0 112.355 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 74.3 mt -113.99 91.36 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.4 m -164.03 169.2 18.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -174.93 68.86 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.458 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 108.47 2.09 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.681 2.254 . . . . 0.0 112.301 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 t -136.85 134.25 36.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 70.1 m -100.82 -44.26 5.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.159 -0.8 . . . . 0.0 112.469 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.2 p -157.39 122.6 4.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 110.854 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 37.1 t -110.8 131.49 55.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -74.79 96.54 0.95 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.5 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 72.7 p -76.36 164.46 25.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.856 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 18.1 t -111.1 105.03 13.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.27 40.3 2.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 11.5 mt -125.64 158.0 35.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.828 0.347 . . . . 0.0 110.899 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -167.25 152.27 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -119.92 90.32 3.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.47 144.72 25.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 96.37 -97.04 1.99 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.468 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.28 141.87 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 111.151 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.1 mt -150.02 158.27 36.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.64 0.733 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 144.17 53.3 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 46.8 t -52.8 115.09 1.65 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.36 43.03 2.54 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 64.7 mt -131.68 -40.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.859 0.361 . . . . 0.0 110.92 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 12.6 p -115.74 -30.05 6.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.98 20.68 7.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.495 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -89.61 179.29 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 66.1 t -136.67 135.85 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -132.1 160.12 36.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 39.9 p -122.51 -35.06 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.136 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -91.44 116.48 28.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.81 -33.39 35.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -72.26 -37.94 68.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -67.3 -44.96 77.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 67.0 tp -67.37 -29.54 69.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -60.82 -40.92 94.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -76.91 -28.38 55.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.17 -40.31 82.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.39 -26.92 62.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.5 -30.44 60.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -77.89 -42.28 33.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -57.21 -37.01 71.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.83 20.71 6.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.26 143.37 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.928 0.394 . . . . 0.0 111.154 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.8 m -55.05 109.65 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 6.0 m -154.88 172.19 18.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.42 49.38 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -97.17 162.29 13.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -119.09 169.63 9.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.959 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 156.8 -81.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.47 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -103.87 165.2 11.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.85 0.357 . . . . 0.0 110.902 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.85 144.87 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -124.3 164.18 20.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.56 159.65 51.96 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.64 0.733 . . . . 0.0 110.884 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.76 23.52 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.684 2.256 . . . . 0.0 112.325 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.74 23.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 107.52 1.87 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.1 160.82 32.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.72 138.83 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 161.15 -56.18 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.477 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -112.02 113.9 26.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.85 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -144.07 178.83 7.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -74.64 -70.76 1.21 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.57 159.68 62.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.628 0.727 . . . . 0.0 110.887 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 174.84 8.93 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.65 2.233 . . . . 0.0 112.365 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 67.1 mt -88.38 135.11 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.13 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.6 t -73.95 137.96 43.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.832 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -88.92 -172.25 46.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 110.38 2.54 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 44.8 m -85.43 177.74 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 18.4 t -57.92 114.87 2.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.832 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 CA-C-O 119.148 -0.807 . . . . 0.0 112.45 -179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 11.0 t -169.04 110.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.883 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.5 p -147.18 174.07 11.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -148.58 -139.62 3.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.519 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 17.5 m -142.92 167.38 22.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.871 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.9 t -127.83 177.46 6.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.92 -115.32 4.43 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 53.61 49.12 20.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 0.0 110.942 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -111.0 28.85 8.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -98.79 117.32 33.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.22 67.95 3.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -166.1 -145.14 4.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.432 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.9 mm -64.07 138.21 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.85 0.357 . . . . 0.0 111.166 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.8 mt -150.02 158.22 37.02 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.575 0.703 . . . . 0.0 110.958 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.28 47.53 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.38 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 30.0 t -52.52 114.44 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.84 32.97 5.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 32.0 mt -119.59 -41.02 2.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 12.6 p -116.13 -33.74 4.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.34 20.34 5.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.479 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -89.31 171.0 10.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 82.8 t -131.03 136.56 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.13 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -135.41 161.51 35.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 70.8 p -121.54 -37.99 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.21 124.78 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.02 -51.91 62.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.043 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -56.79 -43.09 80.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -57.27 -52.75 64.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 59.0 tp -65.15 -29.55 70.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -54.51 -53.37 55.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -61.88 -38.59 88.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.09 -43.0 95.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -56.56 -41.29 76.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.23 -29.29 45.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.07 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -63.94 -44.77 91.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -72.36 -35.37 68.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 109.09 31.44 3.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 67.9 t -57.4 135.94 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 111.174 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 2.7 p -59.99 103.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.6 m -159.57 165.57 32.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.85 -38.46 78.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -53.31 109.78 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 39.4 mt -95.29 113.49 25.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.921 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -81.02 -100.81 0.34 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.478 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -128.19 -46.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 0.0 110.912 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 56.3 mt -146.75 130.06 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -82.11 102.91 11.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt -80.7 159.25 69.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.631 0.729 . . . . 0.0 110.919 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.69 23.73 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.713 2.275 . . . . 0.0 112.348 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 167.71 23.69 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.654 2.236 . . . . 0.0 112.332 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 171.77 13.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -97.8 137.26 36.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.9 mt -129.18 172.81 11.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -163.83 -60.36 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.48 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -123.23 98.05 5.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -174.11 144.6 0.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.901 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -86.13 127.77 8.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.514 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -98.34 159.24 31.09 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.62 0.724 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 136.74 33.66 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.641 2.227 . . . . 0.0 112.338 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 62.5 mt -71.77 -68.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 6.1 m -75.99 170.62 15.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -132.26 -176.65 14.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.521 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 125.81 12.6 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.745 2.297 . . . . 0.0 112.325 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 7.0 t -67.73 116.45 8.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 4.5 m -97.58 -34.7 10.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.486 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 92.6 p -62.09 -27.25 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 110.889 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 28.5 t -127.01 148.76 50.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.845 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 150.21 68.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 30.5 t -99.88 149.19 23.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 0.0 110.874 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.0 p -130.7 131.92 45.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.856 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -136.2 104.03 0.47 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.517 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.7 mp -78.41 158.04 28.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -131.18 136.57 48.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -56.36 162.17 2.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -137.55 139.83 40.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -170.54 -126.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.522 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm -93.88 138.1 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.079 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.0 mt -149.99 158.23 37.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.661 0.743 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 146.65 60.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.711 2.274 . . . . 0.0 112.339 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 35.8 t -51.93 116.87 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.54 34.97 4.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 65.4 mt -123.48 -40.34 2.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 110.899 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 9.5 p -117.24 -28.36 6.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 109.72 20.32 7.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -86.63 169.07 13.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.7 t -127.48 134.71 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -131.38 173.6 10.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.822 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 43.4 p -134.42 -44.07 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.109 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.57 120.04 25.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.51 -44.97 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -65.71 -31.3 72.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -70.25 -49.9 45.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 35.1 tp -67.07 -29.15 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -57.05 -38.6 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -74.85 -34.96 62.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -65.03 -41.07 95.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -57.08 -29.91 63.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.27 -34.03 75.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -54.23 -51.9 63.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -70.5 -40.33 73.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 109.37 65.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 91.4 t -97.05 84.11 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.3 m 54.53 42.82 31.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 8.5 p -154.97 129.37 9.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 14.1 tp -94.85 91.43 6.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -61.47 158.64 14.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.979 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -112.43 88.63 2.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.954 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 135.08 47.9 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.512 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -100.84 -57.31 2.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.948 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 56.5 mt -127.36 130.01 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.128 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -126.94 39.98 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 4.2 tt -154.01 73.3 6.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.632 0.729 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 167.77 23.48 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.666 2.244 . . . . 0.0 112.352 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.71 23.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.695 2.264 . . . . 0.0 112.337 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 175.04 8.66 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.647 2.232 . . . . 0.0 112.357 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.61 25.33 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 7.3 mt -73.55 106.38 5.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 98.55 64.94 0.86 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.516 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -133.31 138.71 46.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.904 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -108.29 -33.01 7.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -104.76 130.53 10.27 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.84 160.24 34.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.695 0.759 . . . . 0.0 110.871 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 145.01 56.05 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.723 2.282 . . . . 0.0 112.32 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 2.7 pp -60.55 165.11 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.101 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 8.2 t -107.13 -32.49 7.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.855 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 108.21 68.38 0.64 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.495 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 151.46 69.1 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.632 2.221 . . . . 0.0 112.361 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.5 t -101.03 146.33 27.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 12.2 p -62.91 -50.78 69.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.461 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.4 t -120.14 107.27 12.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 110.84 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 22.5 t -98.37 146.62 25.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 157.59 152.49 6.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.499 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 59.3 m -93.29 160.96 14.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.87 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.7 t -156.24 150.93 25.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.864 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 138.75 68.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.19 68.17 1.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.778 0.323 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 66.9 mmt-85 -116.29 -177.57 3.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -119.06 87.35 2.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.13 113.04 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.14 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -108.49 -30.53 3.78 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.495 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.1 mm -96.98 129.71 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.1 mt -150.05 158.12 37.04 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.624 0.726 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 139.62 40.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.64 2.227 . . . . 0.0 112.369 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 17.0 t -53.15 110.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.83 39.99 2.9 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 17.5 mt -126.02 -43.74 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.34 . . . . 0.0 110.921 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 23.8 p -115.44 -31.64 5.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.897 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.45 18.63 5.69 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.449 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -89.69 168.35 12.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.3 133.42 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -131.44 155.87 46.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.9 t -118.14 -28.92 5.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.119 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -100.03 123.06 43.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.76 71.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.105 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -55.41 -32.77 62.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -74.61 -45.13 47.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 63.5 tp -66.66 -26.42 67.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -57.54 -54.22 49.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -63.8 -31.39 72.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -69.94 -27.26 64.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -83.52 -26.43 30.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.88 -51.57 63.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.077 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -61.83 -32.3 72.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -67.89 -42.5 81.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.75 50.35 0.96 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.473 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 71.6 t -98.53 87.35 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.925 0.393 . . . . 0.0 111.143 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.1 p 46.15 36.14 3.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.13 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 15.8 m -118.64 146.4 44.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 13.6 mt -123.05 57.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.83 115.19 10.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.85 104.32 16.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -152.61 -84.03 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -91.3 164.51 13.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.839 0.352 . . . . 0.0 110.938 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 2.0 pp -56.31 151.33 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.161 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -164.72 127.66 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.77 159.67 64.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.69 23.67 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.694 2.263 . . . . 0.0 112.35 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 167.7 23.6 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.743 2.295 . . . . 0.0 112.367 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 127.01 13.98 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.7 2.267 . . . . 0.0 112.342 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -74.03 178.69 4.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.815 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 5.4 mp -75.29 176.99 6.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -99.39 150.67 19.23 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.73 142.2 28.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.348 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -91.05 -176.25 4.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -93.74 -91.38 1.6 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.482 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.2 160.65 72.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.665 0.745 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 98.59 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 0.0 112.33 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 72.3 mt -70.57 131.01 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.148 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 40.2 t -125.01 108.81 12.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -106.16 -173.46 23.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 98.85 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.699 2.266 . . . . 0.0 112.326 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.7 p -64.46 159.45 21.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.3 m -89.19 102.8 15.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.453 -179.974 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.8 m -118.4 174.89 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 110.837 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.5 m -83.15 141.64 31.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.45 171.63 38.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 34.4 p -175.03 114.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 8.3 t -56.76 141.3 44.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 148.06 -21.91 1.42 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.57 76.02 1.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -96.93 36.7 1.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -148.73 174.5 12.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -81.88 159.35 23.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.97 -113.75 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.482 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.76 138.06 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 0.0 111.101 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.07 158.19 36.94 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 0.0 110.916 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 149.14 66.54 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.69 2.26 . . . . 0.0 112.336 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 36.0 t -58.16 116.82 3.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.77 34.74 4.58 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.508 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.9 mt -122.56 -40.07 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.34 . . . . 0.0 110.923 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 14.9 p -116.36 -30.42 5.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.79 19.68 7.22 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -89.94 179.34 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.754 0.311 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 67.2 t -136.58 138.69 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -138.08 145.28 41.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 4.0 p -108.7 -33.93 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.12 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.2 109.8 20.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.79 -30.82 24.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -72.45 -37.45 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -67.52 -48.11 68.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 32.0 tp -57.22 -33.88 67.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -52.56 -41.44 63.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.849 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -74.75 -26.58 59.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -70.25 -41.76 73.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -59.69 -29.22 67.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.27 -37.04 64.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -62.4 -53.59 52.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -65.44 -32.1 73.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 119.42 -83.86 0.36 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 63.8 t 59.1 79.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.7 m 51.84 35.64 16.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 2.6 p -130.71 145.0 51.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.848 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.34 63.89 3.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.945 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -122.34 165.88 15.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 28.3 mt -102.47 131.22 49.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -166.97 70.97 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.494 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -76.62 150.74 36.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.839 0.352 . . . . 0.0 110.937 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.07 126.5 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -128.72 149.26 50.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 3.0 mt 64.24 154.62 0.12 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.643 0.735 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.76 23.55 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.643 2.229 . . . . 0.0 112.323 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 167.76 23.55 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.642 2.228 . . . . 0.0 112.34 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 170.99 15.32 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.665 2.243 . . . . 0.0 112.329 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -81.44 106.23 13.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 51.3 tp -167.29 150.33 6.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 166.55 84.82 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.522 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -122.79 30.26 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.932 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -87.15 133.44 33.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -112.45 -106.63 2.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.78 159.68 33.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.701 . . . . 0.0 110.95 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 133.34 25.3 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.723 2.282 . . . . 0.0 112.323 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 31.0 mm -82.11 104.8 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.9 t -105.31 153.18 21.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -60.64 178.62 3.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 111.91 2.93 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.663 2.242 . . . . 0.0 112.38 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.8 p -71.85 117.22 13.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.9 p -91.57 -39.48 11.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.493 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.79 159.57 15.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.841 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 8.8 m -84.13 137.16 33.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.833 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -72.37 -65.39 2.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.454 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.8 p -165.19 177.94 7.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 0.0 110.883 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.8 p -150.0 133.86 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -153.54 131.76 3.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.446 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -71.35 -31.56 67.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.32 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -122.84 145.0 48.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.819 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -120.83 133.18 55.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -119.87 -69.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.095 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 150.12 -19.84 1.09 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.475 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm -82.9 140.26 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.6 mt -150.02 158.25 36.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.572 0.701 . . . . 0.0 110.927 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 141.42 45.12 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.702 2.268 . . . . 0.0 112.33 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 32.3 t -53.46 110.87 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.42 46.59 2.58 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.454 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.1 mt -132.3 -49.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.346 . . . . 0.0 110.925 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 20.4 p -111.18 -26.96 8.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.05 20.97 6.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.473 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -89.79 167.19 13.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.748 0.309 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.3 133.81 67.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.139 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -132.4 140.32 48.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 7.1 p -106.52 -26.29 11.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -103.23 131.77 50.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.842 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.55 -49.05 76.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.089 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -56.25 -43.26 78.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -62.87 -46.95 85.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 51.2 tp -64.23 -26.0 68.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -52.06 -61.57 2.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.944 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -51.82 -48.38 63.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -53.25 -64.93 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -53.55 -40.05 65.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.566 ' N ' HE22 ' A' ' 320' ' ' GLN . . . -60.81 -25.04 66.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -86.71 -32.29 20.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.898 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -57.45 -29.13 63.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.74 20.76 6.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.511 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.51 144.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.141 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.77 165.43 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 5.8 t -66.03 91.67 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.35 -41.8 0.56 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . 0.566 HE22 ' N ' ' A' ' 312' ' ' ALA . 27.3 mt-30 -55.33 163.0 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 12.5 mt -74.59 154.63 38.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 151.82 -158.61 27.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -128.45 28.06 5.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 110.95 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.13 45.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.082 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.35 38.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.862 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 4.0 tt -137.35 71.63 52.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.63 0.729 . . . . 0.0 110.902 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 167.77 23.46 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 167.73 23.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.677 2.252 . . . . 0.0 112.371 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 141.05 44.32 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.707 2.271 . . . . 0.0 112.328 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -161.14 140.92 10.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.92 111.92 9.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -92.79 -128.98 4.89 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -130.41 -176.77 4.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 110.891 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -103.97 41.99 1.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -92.82 -139.49 9.22 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.66 159.56 40.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.604 0.716 . . . . 0.0 110.942 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 114.7 3.78 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.0 112.38 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 1.2 pp -88.32 162.48 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 19.5 m -115.94 174.13 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -147.84 170.37 28.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.496 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 91.16 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.661 2.241 . . . . 0.0 112.343 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 52.2 p -152.8 150.04 28.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.809 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 57.7 m -84.81 121.17 27.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.177 -0.791 . . . . 0.0 112.473 179.996 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.3 m 54.58 30.59 13.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.919 0.39 . . . . 0.0 110.883 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 54.4 p -107.21 96.96 6.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.92 169.42 45.92 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.489 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 33.2 p -161.75 166.01 27.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 0.0 110.848 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 17.7 p -153.85 172.55 17.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 147.83 80.53 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.43 125.63 28.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -156.98 168.42 27.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -81.54 150.41 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -58.7 132.85 55.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.059 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 155.74 -90.41 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm -72.26 135.41 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 0.0 111.148 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.6 mt -150.03 158.16 37.04 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.598 0.713 . . . . 0.0 110.936 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 140.72 43.46 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.674 2.249 . . . . 0.0 112.325 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 49.8 t -56.18 107.84 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -91.24 45.7 2.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 13.2 mt -132.67 -44.42 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 21.5 p -114.72 -27.1 7.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.83 19.49 7.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.466 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -88.98 166.37 13.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.9 t -130.5 135.16 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -130.85 158.01 41.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.91 -43.65 2.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -84.54 139.6 32.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.42 84.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -65.79 -41.49 91.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 37.3 tpt85 -58.7 -49.16 78.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 59.8 tp -69.78 -26.03 64.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -55.93 -25.77 44.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -92.18 -34.32 14.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -71.37 -33.67 69.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -71.16 -26.5 63.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.881 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -72.18 -37.95 69.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -58.01 -40.69 81.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -70.28 -41.87 72.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 108.73 38.22 1.93 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.483 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.55 -45.76 96.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 111.126 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 15.0 t -131.98 170.55 14.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 61.6 p -79.57 60.97 3.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 53.7 mt -146.83 117.42 7.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.73 31.23 17.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.34 165.8 2.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -101.73 -102.31 2.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.478 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -109.65 27.21 9.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 110.936 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 4.9 mp -92.78 136.2 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 2.8 t0 63.34 43.02 6.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.38 73.41 2.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.61 0.719 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 167.69 23.7 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.712 2.275 . . . . 0.0 112.344 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 167.77 23.47 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.688 2.259 . . . . 0.0 112.318 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 164.7 33.6 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.256 . . . . 0.0 112.355 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -75.64 123.57 25.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 59.7 tp -77.58 115.02 17.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -100.19 -101.42 2.4 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -139.35 148.72 43.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.889 0.376 . . . . 0.0 110.897 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -88.22 151.42 22.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.856 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -82.1 -76.06 1.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.513 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.92 159.66 35.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.614 0.721 . . . . 0.0 110.881 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 148.01 63.96 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.71 2.273 . . . . 0.0 112.357 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 63.3 mt -84.98 128.0 39.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.4 t -95.74 -41.63 8.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -152.75 177.58 30.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.516 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 159.52 53.08 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.4 p -137.25 176.16 8.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.871 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 4.9 p -84.48 128.92 34.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 119.091 -0.838 . . . . 0.0 112.526 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 13.7 m -67.38 142.93 56.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 110.87 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.4 m -141.3 153.8 45.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.06 71.26 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.462 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 50.6 m -85.61 76.58 9.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.923 0.392 . . . . 0.0 110.825 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 18.6 p -79.44 114.95 18.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -108.34 79.2 0.25 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.511 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.95 81.29 2.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.344 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 8.2 tpt85 -116.31 34.1 5.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -56.96 148.75 20.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -90.07 149.58 22.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -170.66 -149.29 6.36 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.485 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm -76.69 134.88 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 0.0 111.105 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 28.0 mt -150.01 158.2 37.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.636 0.731 . . . . 0.0 110.934 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 147.33 62.27 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.635 2.223 . . . . 0.0 112.338 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 37.4 t -52.7 117.59 3.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -95.18 32.77 5.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.48 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 18.3 mt -119.83 -40.89 2.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 0.0 110.974 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.4 p -116.86 -31.17 5.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 113.21 22.87 5.41 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -89.82 168.81 11.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.42 142.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -141.61 160.97 39.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.1 p -127.86 -39.59 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.139 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.3 116.35 25.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.15 -45.43 65.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -65.68 -31.2 72.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -73.82 -45.31 52.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 34.6 tp -63.3 -26.61 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -55.13 -54.74 39.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -52.09 -49.76 62.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -56.77 -44.1 81.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -59.6 -31.81 69.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.93 70.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -61.93 -56.99 13.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -60.23 -44.52 95.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.848 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 109.06 64.06 0.55 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 84.8 t -93.37 -57.89 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 0.0 111.151 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 33.2 p -114.84 31.35 6.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.158 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 35.2 t -173.47 155.72 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.77 66.45 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -87.26 163.71 16.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 5.3 tp -110.98 89.32 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -128.82 -72.15 0.14 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.488 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.87 160.25 3.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 2.0 pp -61.12 174.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -129.96 114.87 16.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.27 73.17 9.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.661 0.743 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 167.76 23.53 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 0.0 112.343 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 167.75 23.54 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.654 2.236 . . . . 0.0 112.365 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 133.29 25.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.711 2.274 . . . . 0.0 112.339 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.02 162.72 23.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 31.8 tp -153.62 145.68 23.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -66.25 143.02 43.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.84 137.0 38.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.932 0.396 . . . . 0.0 110.872 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -70.95 128.0 34.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -54.46 155.36 8.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -113.05 159.21 35.53 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.615 0.722 . . . . 0.0 110.942 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -174.19 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.706 2.271 . . . . 0.0 112.359 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 1.2 pp -126.64 174.15 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 30.8 t -114.34 163.47 15.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -142.71 -179.26 19.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 146.19 59.44 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.1 t -117.66 178.31 4.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 12.1 m -120.58 164.65 16.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 CA-C-O 119.187 -0.785 . . . . 0.0 112.52 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.6 t -122.56 -41.0 2.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 110.822 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 4.9 p -126.24 88.61 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.85 141.45 4.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 5.5 t -166.62 143.38 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.871 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -102.21 104.61 15.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -150.1 -75.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 5.9 mp -118.49 98.9 6.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.69 -34.96 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -97.43 -16.8 20.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . 60.07 28.51 18.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -153.97 -96.77 0.13 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.477 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.4 mm -56.57 141.91 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 111.141 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.0 mt -150.05 158.18 36.99 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 145.54 57.64 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.666 2.244 . . . . 0.0 112.33 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 20.1 t -60.22 116.6 4.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -95.42 21.49 44.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 41.2 mt -105.01 -40.32 5.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.353 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.1 p -117.59 -29.14 5.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.67 20.48 7.28 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.51 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -89.79 178.75 6.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 80.4 t -135.22 135.07 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.118 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -132.05 159.99 37.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.75 -31.8 4.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.162 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -98.78 127.65 44.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.31 88.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -67.51 -34.55 77.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -70.8 -45.35 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 62.2 tp -67.75 -27.64 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -54.63 -50.45 68.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -67.52 -36.51 81.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -60.5 -35.61 76.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -74.35 -32.74 62.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.44 -31.87 47.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -76.01 -36.4 59.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.971 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -65.29 -28.27 69.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 107.75 27.38 5.2 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.431 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 82.5 t -81.62 138.23 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 111.119 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 2.2 t -56.39 110.51 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 24.0 p -159.59 163.36 35.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.88 61.43 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.952 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -39.06 40.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 5.5 tp -87.38 128.38 35.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -80.64 79.24 1.78 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.51 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -86.1 -28.91 23.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.956 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 45.2 mm -94.01 146.01 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -99.4 135.64 40.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.4 tp -158.53 71.42 3.81 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 167.75 23.47 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.263 . . . . 0.0 112.342 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 167.77 23.49 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 0.0 112.335 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 174.3 9.76 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.624 2.216 . . . . 0.0 112.349 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -56.31 158.45 4.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.836 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 18.4 tp -52.23 113.69 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 169.51 40.67 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.494 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -146.43 150.97 36.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.911 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -106.79 157.55 17.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 155.15 -108.44 0.36 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.25 159.65 71.06 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.646 0.736 . . . . 0.0 110.928 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 176.21 7.07 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.698 2.265 . . . . 0.0 112.356 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 1.2 pp -126.61 162.72 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.14 172.82 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 134.41 71.62 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.455 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 172.15 13.23 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.355 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 94.3 p -117.96 -178.5 3.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.4 m -110.98 81.03 1.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 CA-C-O 119.122 -0.821 . . . . 0.0 112.466 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.1 t -141.97 118.24 10.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.828 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.1 t -146.5 147.69 31.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.78 158.88 9.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.484 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.6 p -150.58 111.46 4.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.875 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.9 p -68.55 87.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 169.41 46.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.515 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 19.7 mt -102.21 31.73 3.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.65 129.35 19.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -167.49 145.36 4.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.15 91.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -173.8 -112.67 0.29 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm -66.49 137.8 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.113 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.8 mt -150.04 158.22 36.98 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.602 0.715 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 154.37 67.89 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.388 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.4 t -63.55 117.2 6.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.71 34.43 4.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 93.7 mt -121.82 -39.53 2.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.36 . . . . 0.0 110.921 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 13.7 p -117.78 -29.94 5.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.14 21.54 6.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -89.17 178.89 6.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.902 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.0 t -135.2 135.08 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -131.74 159.28 38.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.2 -32.67 4.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -99.45 132.04 45.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.61 -45.35 93.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -59.6 -39.35 83.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -66.95 -45.98 76.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.35 -27.25 67.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 8.1 ttm-85 -61.22 -53.98 50.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -61.07 -31.74 71.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -67.09 -42.64 84.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.26 -30.92 71.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.74 73.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.26 -33.72 75.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -70.47 -32.96 70.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.5 27.92 3.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.498 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 63.6 t -74.33 -42.19 50.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.123 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.4 t -126.02 137.74 53.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 51.0 m -103.43 -35.45 8.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.0 pp -54.93 -30.67 59.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -56.45 125.47 22.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.34 149.33 16.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -90.37 -163.7 39.25 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.11 130.7 14.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.854 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 8.9 mt 51.34 45.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.103 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -59.51 143.06 51.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 3.7 tt -119.93 70.2 14.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.57 0.7 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 167.75 23.61 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.63 2.22 . . . . 0.0 112.353 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 167.75 23.56 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.644 2.229 . . . . 0.0 112.346 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 99.62 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.662 2.241 . . . . 0.0 112.385 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 45.3 mmm-85 -93.2 -18.08 22.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 11.6 tp -95.19 70.79 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -111.44 65.73 0.25 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.48 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -132.36 108.92 9.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.933 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 30.6 t30 57.42 27.96 14.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -146.82 132.93 4.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -86.56 159.2 53.22 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.627 0.727 . . . . 0.0 110.929 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 148.71 66.05 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.732 2.288 . . . . 0.0 112.328 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.09 100.47 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.118 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 20.1 m -67.42 157.98 32.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -157.84 71.53 0.25 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.447 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 175.86 7.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.701 2.267 . . . . 0.0 112.32 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 33.0 t -108.47 118.05 35.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 2.5 t -109.27 177.17 4.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.855 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.48 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 55.5 m -149.46 143.66 25.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.8 t -159.72 172.47 17.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 147.62 56.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.463 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 14.6 m -115.27 145.39 42.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.867 0.365 . . . . 0.0 110.887 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 35.9 m -105.74 99.12 8.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.9 -115.71 3.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.51 125.33 54.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 110.889 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -64.66 -66.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -91.66 113.97 26.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -86.28 105.42 16.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -93.5 -100.93 1.55 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.496 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.3 mm -57.23 135.35 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 111.106 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.05 158.18 36.98 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.718 . . . . 0.0 110.968 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 145.53 57.2 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.346 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 20.7 t -56.34 114.95 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.77 30.87 7.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.469 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 21.1 mt -117.98 -40.81 2.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.892 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 20.8 p -115.71 -35.07 4.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 117.81 19.05 4.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.481 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -88.29 166.69 14.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.7 t -125.47 134.58 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.086 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -134.09 151.13 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.1 p -116.81 -46.69 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.62 128.09 33.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.51 -48.75 78.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -58.56 -35.19 71.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -65.12 -51.39 61.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.818 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 51.3 tp -69.59 -26.34 64.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -56.19 -26.0 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -93.69 -34.29 13.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -70.3 -33.59 71.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.816 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.21 -30.75 66.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.43 67.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -60.42 -60.34 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -53.72 -47.76 70.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 129.66 35.61 0.44 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.468 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 67.5 t -74.89 144.39 12.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 0.0 111.136 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.0 t -52.55 124.26 13.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 9.9 p -173.84 166.99 4.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.3 pp -75.85 -27.6 57.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.95 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -55.1 101.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -53.37 155.53 2.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -139.81 135.62 7.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.515 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -98.9 -28.36 13.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 0.0 110.926 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 3.6 mp -59.62 138.51 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.165 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -55.99 160.6 2.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.78 154.96 78.3 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.722 . . . . 0.0 110.944 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 167.71 23.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.721 2.281 . . . . 0.0 112.302 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.74 23.57 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.704 2.269 . . . . 0.0 112.351 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 175.53 7.98 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.704 2.269 . . . . 0.0 112.308 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -111.66 94.72 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 15.6 mt -93.9 57.13 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -67.11 167.21 39.72 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.474 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -96.45 96.59 8.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.379 . . . . 0.0 110.893 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -66.76 112.34 4.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -56.52 123.2 30.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.504 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -98.46 159.24 31.03 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.661 0.744 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 178.15 4.89 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.666 2.244 . . . . 0.0 112.353 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 72.7 mt -73.63 97.77 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 10.2 p -69.15 179.06 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 107.4 174.37 22.47 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -175.01 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.645 2.23 . . . . 0.0 112.374 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 10.7 t -156.86 150.82 24.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.3 t -100.07 99.63 10.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.834 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 119.155 -0.803 . . . . 0.0 112.493 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.0 m -53.93 138.9 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.8 t -65.38 -57.4 8.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.5 53.95 3.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.2 p -67.81 179.22 1.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 0.0 110.842 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.7 m -107.35 -31.58 8.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.839 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.98 -68.54 2.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.452 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.55 149.87 30.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.775 0.322 . . . . 0.0 110.926 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -121.62 -55.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -91.08 77.22 6.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -142.09 125.53 16.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.051 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -88.02 -26.07 29.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.529 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.0 mm -84.12 137.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.0 158.27 37.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 144.04 52.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.9 t -55.9 112.54 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.84 34.49 4.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 92.5 mt -119.07 -45.7 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.373 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 26.3 p -113.1 -28.39 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.44 20.99 6.33 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.501 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -89.96 177.32 6.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 65.3 t -136.41 136.2 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -135.47 150.28 49.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 23.3 p -116.62 -45.32 2.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.095 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -78.47 118.1 20.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.71 -37.95 53.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -67.39 -37.98 83.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -63.08 -50.8 69.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 54.8 tp -65.6 -27.42 68.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -57.27 -26.16 60.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -93.31 -36.54 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -70.23 -59.83 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -54.32 -29.76 48.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.21 -34.13 77.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -67.0 -47.26 72.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -55.53 -27.26 47.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 112.28 24.77 4.96 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 66.6 t -78.06 144.21 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.956 0.408 . . . . 0.0 111.106 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 44.1 m -52.58 116.27 2.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.076 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 14.7 t -160.98 171.96 17.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 12.3 mt -62.87 -36.85 84.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -64.44 133.67 52.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.11 166.11 18.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -177.49 59.3 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.502 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -50.22 -36.73 32.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 110.961 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 54.6 mt -150.66 133.92 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -132.82 147.83 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 6.6 tp -165.66 72.33 1.32 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.607 0.718 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 167.75 23.5 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.348 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 167.76 23.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.661 2.24 . . . . 0.0 112.3 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 136.39 32.83 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.647 2.231 . . . . 0.0 112.34 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.62 147.99 29.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 7.7 tp -133.11 118.0 18.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.966 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 170.55 76.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -107.21 89.18 2.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -159.53 -179.6 8.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -78.86 -149.33 4.61 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.468 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.17 159.63 30.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.552 0.691 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 165.35 31.2 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.691 2.261 . . . . 0.0 112.374 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 68.4 mt -95.49 99.66 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.5 p -96.63 134.48 39.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.869 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -171.44 73.59 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.52 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -43.66 2.56 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.692 2.261 . . . . 0.0 112.392 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 55.56 35.63 25.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 7.4 p -147.16 119.94 8.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-O 119.148 -0.807 . . . . 0.0 112.485 -179.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.1 m -58.74 113.23 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.347 . . . . 0.0 110.902 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 8.1 t -161.56 133.95 5.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -71.57 -118.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.462 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 28.7 t -153.95 153.42 31.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 110.833 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 74.7 p -112.24 104.86 13.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.841 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -106.14 103.17 2.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.53 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.7 mp -107.28 131.37 54.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -117.26 -41.14 3.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.03 139.84 58.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -97.26 -177.3 3.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 110.03 -87.45 0.47 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.46 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.7 mm -67.29 129.85 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.361 . . . . 0.0 111.148 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.6 mt -150.09 158.13 36.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 145.53 57.36 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.637 2.225 . . . . 0.0 112.344 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 39.3 t -52.04 115.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.89 22.2 35.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.494 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 63.0 mt -105.32 -41.63 5.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.821 0.343 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 26.7 p -118.96 -31.34 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 115.0 27.02 3.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.518 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -90.01 179.32 5.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.865 0.364 . . . . 0.0 110.884 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.7 t -136.05 139.82 45.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -138.72 167.22 22.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.0 p -118.71 -56.19 2.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.78 141.59 40.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.14 -60.45 3.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -53.51 -43.05 67.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -55.45 -48.99 73.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 29.3 tp -58.35 -38.28 76.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -38.12 81.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.31 -55.43 21.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.2 -50.84 72.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -52.46 -30.45 29.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.819 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.9 -27.44 42.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.092 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -82.64 -44.17 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.956 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -52.91 -29.17 26.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 119.03 19.9 4.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 91.2 t -84.75 134.85 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 111.116 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 2.2 p -60.17 127.07 30.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 7.1 p -162.27 163.28 28.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 6.0 mp -81.39 57.98 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.67 123.11 29.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.53 113.71 8.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.19 98.71 1.35 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.501 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -58.59 162.0 4.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.899 0.38 . . . . 0.0 110.872 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.68 128.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.122 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -116.0 143.37 45.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 4.0 tt 58.23 71.52 1.01 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.569 0.699 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 167.73 23.56 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.685 2.257 . . . . 0.0 112.352 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.76 23.51 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.654 2.236 . . . . 0.0 112.368 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 178.47 4.56 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.28 151.69 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 88.0 mt -115.44 -33.93 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 93.42 -80.93 1.04 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.519 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -139.37 105.41 5.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -124.04 101.81 7.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 140.49 159.76 8.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.473 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.85 82.54 43.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.614 0.721 . . . . 0.0 110.913 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 91.97 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.666 2.244 . . . . 0.0 112.371 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 68.8 mt -122.09 97.35 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.69 157.51 34.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 174.74 -71.74 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 100.71 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.716 2.278 . . . . 0.0 112.328 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.8 m -123.83 153.57 40.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 48.4 t 52.87 55.2 9.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.849 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 CA-C-O 119.123 -0.821 . . . . 0.0 112.454 -179.974 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.8 p -64.39 144.74 56.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 0.0 110.839 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 7.9 t 60.84 54.22 3.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.87 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -137.19 46.07 1.03 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.51 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 3.8 m -131.99 -50.19 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.88 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 43.6 t -56.74 110.82 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.95 45.21 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.55 59.74 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.785 0.326 . . . . 0.0 110.919 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -116.08 85.21 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -111.13 28.63 8.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . 56.55 25.04 9.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 65.69 -92.5 0.16 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.51 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 49.4 mm -93.81 140.81 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.364 . . . . 0.0 111.09 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.2 mt -150.05 158.26 36.93 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.599 0.714 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 161.23 46.74 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.715 2.276 . . . . 0.0 112.35 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.3 115.27 9.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.43 41.32 2.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.454 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 60.0 mt -127.94 -43.33 1.52 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 22.2 p -115.93 -27.55 6.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.7 19.59 7.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -89.85 177.64 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 63.8 t -136.82 138.65 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -135.0 145.47 48.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 17.4 p -106.62 -49.12 3.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -77.99 115.97 18.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.23 -29.62 23.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.058 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.9 -39.37 61.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -62.31 -39.56 93.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 59.8 tp -74.6 -25.92 59.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -56.15 -25.89 48.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -92.69 -34.49 13.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -69.17 -47.7 64.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -58.31 -26.36 62.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.16 -49.43 44.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -52.34 -36.28 53.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -67.6 -40.68 84.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.92 42.68 1.0 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.44 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 82.5 t -78.32 -71.8 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 111.13 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 50.6 p -113.2 35.11 4.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.154 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 78.7 p -165.48 176.26 8.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.32 32.68 5.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -53.37 151.93 5.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -105.65 170.46 7.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 164.67 -80.91 0.12 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.504 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -131.04 31.68 4.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 110.929 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 41.3 mm -94.09 140.72 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 18.3 p30 -67.96 156.18 37.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.76 159.28 84.75 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.613 0.721 . . . . 0.0 110.888 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 167.72 23.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.746 2.297 . . . . 0.0 112.301 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 167.7 23.65 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.717 2.278 . . . . 0.0 112.319 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 95.63 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.267 . . . . 0.0 112.317 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -136.57 137.89 40.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.53 125.77 25.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 172.95 129.18 1.12 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.521 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -77.47 96.94 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -80.95 -38.16 28.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 146.85 70.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 2.8 mt 64.2 154.66 0.12 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.636 0.731 . . . . 0.0 110.928 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 104.4 1.32 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.665 2.243 . . . . 0.0 112.324 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 2.5 pp -78.81 151.97 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 87.6 p -159.29 145.9 16.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -134.81 179.23 17.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 176.88 6.16 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.731 2.287 . . . . 0.0 112.318 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 27.6 m -103.31 124.3 48.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 46.3 t -148.68 158.21 43.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 CA-C-O 119.185 -0.786 . . . . 0.0 112.518 -179.956 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 12.0 p -150.73 156.16 40.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 0.0 110.859 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 45.8 t -105.42 123.48 47.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.69 47.43 1.55 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.486 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 18.8 p -95.8 144.24 26.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.867 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 87.1 p -141.74 145.21 34.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -151.32 -164.52 12.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -151.33 168.9 23.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.912 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -100.22 166.16 11.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -107.29 -16.81 14.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -79.05 -66.12 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 100.44 19.89 16.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.5 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.6 mm -97.77 134.58 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.156 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.2 mt -150.09 158.21 36.88 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.619 0.723 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 138.64 38.22 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.245 . . . . 0.0 112.348 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 11.8 t -53.08 113.27 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.42 29.45 8.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 81.7 mt -115.93 -38.51 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 14.6 p -117.34 -33.37 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 114.7 18.88 6.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.421 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -90.08 170.53 10.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.809 0.337 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.23 138.34 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.128 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -139.7 156.5 46.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.66 -44.4 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.144 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -80.02 131.22 35.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.71 91.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -65.65 -42.18 91.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -60.31 -50.51 73.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 56.2 tp -67.18 -26.33 66.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -56.66 -43.12 80.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -78.25 -32.3 49.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -67.97 -31.92 71.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.7 -36.76 57.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.57 -30.2 60.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.07 -51.81 49.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -56.44 -26.67 54.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 110.79 29.1 3.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 74.2 t -79.83 137.36 21.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.125 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.8 p -73.49 77.49 1.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.105 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 53.1 p -112.97 34.97 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.07 46.15 4.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.909 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -136.79 136.55 38.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 4.5 pp -105.1 172.54 6.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -169.46 -68.23 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.496 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -109.45 169.54 8.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.862 0.363 . . . . 0.0 110.936 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 5.4 mp -87.28 134.07 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -74.65 150.38 39.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -155.82 154.8 28.53 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.591 0.71 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 167.75 23.51 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.355 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 167.71 23.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 175.07 8.57 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.264 . . . . 0.0 112.331 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -77.39 132.92 38.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.35 -27.76 27.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 163.47 -148.96 15.88 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.464 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.83 127.43 52.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.825 0.345 . . . . 0.0 110.909 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -105.15 139.37 39.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.936 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -169.31 -179.3 41.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.21 81.39 67.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.615 0.721 . . . . 0.0 110.907 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.43 49.72 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.723 2.282 . . . . 0.0 112.33 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 73.9 mt -116.0 95.86 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 10.3 p -98.29 -59.58 1.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 140.45 72.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.474 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 147.0 61.62 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.724 2.282 . . . . 0.0 112.313 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.8 m -58.36 160.14 5.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 67.4 m -141.18 164.01 31.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 CA-C-O 119.121 -0.822 . . . . 0.0 112.452 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.1 m -128.83 72.76 1.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.897 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 9.4 p -99.8 147.22 25.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -148.48 -168.92 14.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.543 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 63.9 p -112.36 161.83 16.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 110.828 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 32.9 p -136.42 105.28 5.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.817 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 138.66 109.88 0.9 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.5 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 76.7 mt -113.64 130.55 56.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.05 110.37 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -145.89 150.61 36.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -116.76 106.36 13.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.073 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -149.56 129.36 2.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.47 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm -61.12 131.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.876 0.369 . . . . 0.0 111.18 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.7 mt -150.04 158.15 37.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.616 0.722 . . . . 0.0 110.94 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 146.99 61.76 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.654 2.236 . . . . 0.0 112.367 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 52.6 t -52.09 107.69 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -90.8 46.51 2.93 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.521 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 69.0 mt -131.39 -42.23 1.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.921 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 29.8 p -117.43 -28.49 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.47 23.66 4.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -90.04 178.49 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 63.0 t -141.86 142.63 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -140.52 174.11 10.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.2 p -129.74 -39.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -88.34 127.67 35.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.77 84.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -73.07 -37.18 66.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -68.89 -46.25 68.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 26.0 tp -52.04 -38.44 57.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -58.33 -33.73 69.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -57.43 9.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -62.87 -48.9 76.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -54.89 -26.85 38.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.8 -25.37 41.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -87.89 -43.87 11.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -52.02 -31.22 28.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 110.24 19.37 8.05 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.49 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 91.6 t -73.81 -52.4 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 111.172 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.0 p -65.7 139.36 58.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 71.0 m -113.33 -30.64 6.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 19.2 mt -97.63 26.48 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -113.55 73.55 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.943 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.08 106.26 13.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 167.95 52.11 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -86.64 -42.74 13.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.846 0.355 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 57.4 mt -133.26 139.47 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.134 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.14 120.8 37.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.9 tt 61.01 73.36 0.61 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.648 0.737 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.74 23.56 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.72 2.28 . . . . 0.0 112.349 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 167.75 23.57 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.683 2.255 . . . . 0.0 112.371 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 154.93 67.14 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.72 2.28 . . . . 0.0 112.329 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -142.64 118.63 10.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.845 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -52.82 143.12 17.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 97.17 -24.07 32.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.494 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -68.58 101.2 1.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 0.0 110.873 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -110.42 174.48 5.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -177.53 -143.74 5.1 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.2 82.93 61.49 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.615 0.722 . . . . 0.0 110.872 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 141.63 45.33 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.639 2.226 . . . . 0.0 112.325 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 1.2 pp -126.83 169.74 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 5.0 t -76.5 156.93 32.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -163.6 177.72 39.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.479 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 108.17 2.03 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.665 2.243 . . . . 0.0 112.348 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 4.0 m -63.63 129.89 42.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 14.5 m -110.42 -46.01 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.519 -179.976 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.8 t 56.38 42.15 28.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 110.873 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 10.5 p -102.01 135.23 43.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.866 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.15 20.08 59.72 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.459 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 55.3 p -102.91 105.99 16.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 0.0 110.847 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.1 p -171.96 110.47 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.866 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -97.09 138.3 13.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.473 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.73 111.36 6.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 110.91 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 19.4 ptt85 -106.05 43.42 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -111.34 31.6 5.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -99.33 163.44 12.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.104 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -81.96 -30.92 33.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.484 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.9 mm -98.0 139.87 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 111.107 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 28.0 mt -150.03 158.22 37.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.571 0.7 . . . . 0.0 110.941 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 148.3 64.93 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.702 2.268 . . . . 0.0 112.325 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 25.8 t -58.87 113.98 2.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.75 29.26 8.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.52 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.24 -42.77 3.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.89 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.0 p -114.8 -29.91 6.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.08 19.71 7.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.466 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -89.98 179.09 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 71.9 t -134.89 136.08 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.09 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -136.85 143.66 43.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.8 p -107.11 -43.17 4.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.44 116.02 19.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.39 -41.35 69.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -65.15 -31.73 73.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -69.76 -49.95 47.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.07 -26.24 68.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -56.01 -40.21 73.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -79.15 -37.73 37.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -55.62 -39.72 71.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -67.9 -30.79 70.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.01 -27.52 44.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.86 -53.01 7.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -53.47 -33.15 53.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.8 45.18 1.43 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 65.0 t -94.34 -34.43 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 111.079 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.6 t -78.2 166.46 22.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 2.2 p -96.66 25.05 5.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.857 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 2.3 mp -145.88 -167.03 2.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 61.04 40.66 14.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 43.4 mt 52.62 49.09 21.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -75.25 -86.29 0.3 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -139.83 162.05 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.337 . . . . 0.0 110.957 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 9.0 mt 51.36 45.71 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.123 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -85.08 157.2 20.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 13.8 mt -119.48 69.07 11.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.604 0.716 . . . . 0.0 110.9 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 167.75 23.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.665 2.243 . . . . 0.0 112.3 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 167.74 23.53 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.695 2.263 . . . . 0.0 112.334 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 114.58 3.75 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.688 2.258 . . . . 0.0 112.363 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -98.61 94.15 6.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.2 tp 57.11 27.51 13.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.35 163.46 35.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.451 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -77.78 -32.18 52.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.828 0.346 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -80.78 153.3 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -76.55 -106.37 0.14 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.494 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.09 159.64 40.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.566 0.698 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 173.0 11.58 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.67 2.247 . . . . 0.0 112.361 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 49.5 mt -63.19 106.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.136 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.8 t -153.88 112.64 3.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -150.53 171.1 30.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 108.33 2.05 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.728 2.285 . . . . 0.0 112.32 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 79.1 p -101.34 84.12 2.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 27.1 m -161.55 155.87 22.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.526 179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.0 t -133.14 150.93 52.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 0.0 110.86 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.3 m -74.1 86.24 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 156.04 -54.09 0.41 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.46 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.3 m -114.8 143.61 44.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.914 0.388 . . . . 0.0 110.829 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 48.5 t -67.25 154.02 42.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.837 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -135.61 115.32 1.34 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.5 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 19.5 mt -124.99 166.35 16.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.841 0.353 . . . . 0.0 110.912 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.79 153.87 42.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -157.03 121.8 4.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -154.87 171.96 18.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -77.3 -113.84 0.16 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.473 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.84 136.72 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 111.105 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 31.0 mt -150.01 158.21 37.05 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.649 0.738 . . . . 0.0 110.937 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 148.55 65.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.654 2.236 . . . . 0.0 112.348 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.17 114.34 2.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.39 37.68 3.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 24.2 mt -124.32 -42.76 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.896 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 19.6 p -115.66 -26.49 7.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.12 20.28 7.61 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -89.67 179.11 6.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 68.3 t -135.59 135.41 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -134.06 124.85 26.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 26.7 p -90.67 -34.57 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -89.82 128.07 36.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.92 -58.59 7.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -52.91 -33.85 52.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 18.7 tpt85 -63.85 -44.01 94.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 53.8 tp -71.79 -27.17 62.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.13 -25.56 63.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -90.76 -35.05 15.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -71.04 -41.85 70.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.04 -26.24 68.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.23 -34.0 72.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -62.33 -52.1 64.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -55.38 -31.1 61.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 107.35 40.62 1.75 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 78.0 t -80.44 -59.16 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 111.17 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.7 p -122.07 150.4 42.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 16.1 p -106.32 31.94 4.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.839 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.2 pp -87.31 -29.47 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -59.73 120.93 10.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.91 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -58.14 156.26 9.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 100.39 162.33 28.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -76.35 153.13 36.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.371 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.99 170.13 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.111 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -144.69 150.71 37.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 26.5 tp 54.77 70.87 1.47 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.62 0.724 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 167.73 23.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.741 2.294 . . . . 0.0 112.329 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 167.81 23.45 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.657 2.238 . . . . 0.0 112.323 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 133.92 26.62 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.65 2.234 . . . . 0.0 112.319 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.67 64.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 13.0 tp -105.66 59.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -72.37 155.49 51.44 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.9 168.18 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.908 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -75.63 -33.98 60.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -53.1 152.9 7.68 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.502 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.22 154.13 0.12 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.574 0.702 . . . . 0.0 110.899 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 173.88 10.31 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.719 2.279 . . . . 0.0 112.372 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.35 103.14 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 m -81.66 96.83 7.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.834 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -94.58 -74.77 1.26 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -22.62 31.63 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.68 2.253 . . . . 0.0 112.358 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 8.5 t -98.56 75.71 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 14.1 t -53.07 135.57 37.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.474 179.988 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.7 mm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.931 0.396 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.0 mt -150.0 158.25 37.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.616 0.722 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 144.72 54.9 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.717 2.278 . . . . 0.0 112.335 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 26.7 t -52.01 116.33 2.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.28 39.46 2.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.469 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 75.5 mt -130.07 -42.36 1.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 110.906 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 18.8 p -113.25 -30.39 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.97 19.46 7.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.474 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -86.48 164.99 16.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.54 133.93 67.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.415 ' CD1' HD13 ' A' ' 307' ' ' LEU . 61.9 m-85 -132.08 157.15 44.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 24.8 p -121.11 -33.23 3.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -93.99 120.79 34.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.828 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -53.63 -44.41 69.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.069 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.36 -37.86 88.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -66.98 -42.02 85.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.415 HD13 ' CD1' ' A' ' 301' ' ' PHE . 41.3 tp -71.63 -27.26 62.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -61.94 -35.39 78.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -75.88 -41.44 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -59.8 -39.75 86.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -55.36 -32.16 62.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.51 89.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.082 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -53.57 -40.79 65.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -79.38 -44.26 21.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.87 0.367 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.4 mt -150.09 158.15 36.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.603 0.716 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 140.78 43.67 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 36.5 t -52.02 109.64 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -90.8 47.97 3.01 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.538 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 73.0 mt -134.23 -44.41 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.88 0.371 . . . . 0.0 110.931 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 13.8 p -116.46 -27.08 6.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.13 19.56 7.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.546 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -89.05 169.38 11.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.8 t -129.88 133.77 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -131.11 164.94 24.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.9 t -127.51 -38.09 1.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.88 117.04 25.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.22 32.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -80.31 -30.1 38.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -73.05 -47.65 42.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -28.92 69.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 41.6 ttp85 -59.21 -47.69 84.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -66.35 -29.95 70.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -72.07 -48.65 42.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -59.54 -29.04 67.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.74 -38.31 60.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -69.5 -34.75 74.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -69.63 -35.47 75.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.878 0.371 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.1 mt -150.02 158.27 36.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.64 0.733 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.445 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.74 144.17 53.3 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 46.8 t -52.8 115.09 1.65 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.36 43.03 2.54 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 64.7 mt -131.68 -40.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.859 0.361 . . . . 0.0 110.92 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 12.6 p -115.74 -30.05 6.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.98 20.68 7.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.495 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -89.61 179.29 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 293' ' ' PRO . 66.1 t -136.67 135.85 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -132.1 160.12 36.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 39.9 p -122.51 -35.06 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.136 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -91.44 116.48 28.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.81 -33.39 35.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -72.26 -37.94 68.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -67.3 -44.96 77.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 67.0 tp -67.37 -29.54 69.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -60.82 -40.92 94.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -76.91 -28.38 55.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.17 -40.31 82.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.39 -26.92 62.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.5 -30.44 60.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -77.89 -42.28 33.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -57.21 -37.01 71.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.9 mm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.8 mt -150.02 158.22 37.02 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.575 0.703 . . . . 0.0 110.958 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.28 47.53 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.38 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 30.0 t -52.52 114.44 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.84 32.97 5.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.444 HD12 ' CD2' ' A' ' 314' ' ' HIS . 32.0 mt -119.59 -41.02 2.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 12.6 p -116.13 -33.74 4.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.34 20.34 5.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.479 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -89.31 171.0 10.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 82.8 t -131.03 136.56 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.13 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.409 ' CD1' HD13 ' A' ' 307' ' ' LEU . 70.3 m-85 -135.41 161.51 35.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 70.8 p -121.54 -37.99 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.21 124.78 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.02 -51.91 62.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.043 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -56.79 -43.09 80.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -57.27 -52.75 64.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.409 HD13 ' CD1' ' A' ' 301' ' ' PHE . 59.0 tp -65.15 -29.55 70.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -54.51 -53.37 55.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -61.88 -38.59 88.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.09 -43.0 95.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -56.56 -41.29 76.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.23 -29.29 45.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.07 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -63.94 -44.77 91.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' HIS . . . . . 0.444 ' CD2' HD12 ' A' ' 296' ' ' LEU . 99.0 m-70 -72.36 -35.37 68.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.48 -179.976 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.892 0.377 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.0 mt -149.99 158.23 37.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.661 0.743 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.44 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.9 Cg_endo -69.8 146.65 60.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.711 2.274 . . . . 0.0 112.339 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 35.8 t -51.93 116.87 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.54 34.97 4.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 65.4 mt -123.48 -40.34 2.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 110.899 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 9.5 p -117.24 -28.36 6.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 109.72 20.32 7.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -86.63 169.07 13.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 293' ' ' PRO . 64.7 t -127.48 134.71 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.16 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.534 ' CD1' HD13 ' A' ' 307' ' ' LEU . 56.3 m-85 -131.38 173.6 10.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.822 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 43.4 p -134.42 -44.07 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.109 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.57 120.04 25.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.51 -44.97 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -65.71 -31.3 72.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -70.25 -49.9 45.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.534 HD13 ' CD1' ' A' ' 301' ' ' PHE . 35.1 tp -67.07 -29.15 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -57.05 -38.6 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -74.85 -34.96 62.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -65.03 -41.07 95.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -57.08 -29.91 63.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.27 -34.03 75.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -54.23 -51.9 63.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -70.5 -40.33 73.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.1 mt -150.05 158.12 37.04 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.624 0.726 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 139.62 40.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.64 2.227 . . . . 0.0 112.369 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 17.0 t -53.15 110.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.83 39.99 2.9 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 17.5 mt -126.02 -43.74 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.34 . . . . 0.0 110.921 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 23.8 p -115.44 -31.64 5.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.897 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.45 18.63 5.69 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.449 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -89.69 168.35 12.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.3 133.42 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -131.44 155.87 46.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.9 t -118.14 -28.92 5.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.119 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -100.03 123.06 43.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.76 71.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.105 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -55.41 -32.77 62.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -74.61 -45.13 47.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 63.5 tp -66.66 -26.42 67.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -57.54 -54.22 49.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -63.8 -31.39 72.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -69.94 -27.26 64.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -83.52 -26.43 30.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.88 -51.57 63.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.077 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -61.83 -32.3 72.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -67.89 -42.5 81.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.473 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.417 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.9 mm . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.07 158.19 36.94 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 0.0 110.916 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.539 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.75 149.14 66.54 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.69 2.26 . . . . 0.0 112.336 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 36.0 t -58.16 116.82 3.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.77 34.74 4.58 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.508 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.9 mt -122.56 -40.07 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.34 . . . . 0.0 110.923 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 14.9 p -116.36 -30.42 5.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.79 19.68 7.22 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -89.94 179.34 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.754 0.311 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 293' ' ' PRO . 67.2 t -136.58 138.69 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -138.08 145.28 41.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 4.0 p -108.7 -33.93 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.12 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.2 109.8 20.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.417 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -51.79 -30.82 24.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -72.45 -37.45 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -67.52 -48.11 68.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 32.0 tp -57.22 -33.88 67.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -52.56 -41.44 63.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.849 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -74.75 -26.58 59.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -70.25 -41.76 73.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -59.69 -29.22 67.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.27 -37.04 64.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -62.4 -53.59 52.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -65.44 -32.1 73.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.958 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.6 mt -150.02 158.25 36.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.572 0.701 . . . . 0.0 110.927 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 141.42 45.12 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.702 2.268 . . . . 0.0 112.33 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 32.3 t -53.46 110.87 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.42 46.59 2.58 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.454 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.1 mt -132.3 -49.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.346 . . . . 0.0 110.925 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 20.4 p -111.18 -26.96 8.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.05 20.97 6.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.473 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -89.79 167.19 13.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.748 0.309 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.3 133.81 67.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.139 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -132.4 140.32 48.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 7.1 p -106.52 -26.29 11.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -103.23 131.77 50.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.842 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.55 -49.05 76.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.089 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -56.25 -43.26 78.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -62.87 -46.95 85.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 51.2 tp -64.23 -26.0 68.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -52.06 -61.57 2.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.944 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -51.82 -48.38 63.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -53.25 -64.93 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -53.55 -40.05 65.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.81 -25.04 66.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -86.71 -32.29 20.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.898 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -57.45 -29.13 63.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.511 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.832 0.349 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.6 mt -150.03 158.16 37.04 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.598 0.713 . . . . 0.0 110.936 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 140.72 43.46 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.674 2.249 . . . . 0.0 112.325 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 49.8 t -56.18 107.84 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -91.24 45.7 2.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.456 HD12 ' CD2' ' A' ' 314' ' ' HIS . 13.2 mt -132.67 -44.42 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 21.5 p -114.72 -27.1 7.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.83 19.49 7.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.466 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -88.98 166.37 13.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.9 t -130.5 135.16 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -130.85 158.01 41.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.91 -43.65 2.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -84.54 139.6 32.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.42 84.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -65.79 -41.49 91.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 37.3 tpt85 -58.7 -49.16 78.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.531 HD12 ' HB3' ' A' ' 310' ' ' HIS . 59.8 tp -69.78 -26.03 64.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -55.93 -25.77 44.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -92.18 -34.32 14.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' HIS . . . . . 0.531 ' HB3' HD12 ' A' ' 307' ' ' LEU . 46.6 t60 -71.37 -33.67 69.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -71.16 -26.5 63.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.881 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -72.18 -37.95 69.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -58.01 -40.69 81.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' HIS . . . . . 0.456 ' CD2' HD12 ' A' ' 296' ' ' LEU . 68.1 m-70 -70.28 -41.87 72.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.483 -179.943 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.854 0.359 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 28.0 mt -150.01 158.2 37.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.636 0.731 . . . . 0.0 110.934 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 147.33 62.27 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.635 2.223 . . . . 0.0 112.338 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 37.4 t -52.7 117.59 3.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -95.18 32.77 5.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.48 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.571 HD12 ' CD2' ' A' ' 314' ' ' HIS . 18.3 mt -119.83 -40.89 2.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 0.0 110.974 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.4 p -116.86 -31.17 5.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 113.21 22.87 5.41 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -89.82 168.81 11.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.42 142.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.493 ' CD1' HD13 ' A' ' 307' ' ' LEU . 48.9 m-85 -141.61 160.97 39.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.1 p -127.86 -39.59 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.139 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.3 116.35 25.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.15 -45.43 65.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -65.68 -31.2 72.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -73.82 -45.31 52.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.493 HD13 ' CD1' ' A' ' 301' ' ' PHE . 34.6 tp -63.3 -26.61 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -55.13 -54.74 39.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -52.09 -49.76 62.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -56.77 -44.1 81.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -59.6 -31.81 69.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.93 70.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -61.93 -56.99 13.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' HIS . . . . . 0.571 ' CD2' HD12 ' A' ' 296' ' ' LEU . 95.5 m-70 -60.23 -44.52 95.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 -179.916 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.4 mm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.894 0.378 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.0 mt -150.05 158.18 36.99 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 145.54 57.64 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.666 2.244 . . . . 0.0 112.33 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 20.1 t -60.22 116.6 4.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -95.42 21.49 44.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 314' ' ' HIS . 41.2 mt -105.01 -40.32 5.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.353 . . . . 0.0 110.908 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.1 p -117.59 -29.14 5.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.67 20.48 7.28 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.51 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -89.79 178.75 6.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 80.4 t -135.22 135.07 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.118 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.553 ' CD1' HD13 ' A' ' 307' ' ' LEU . 41.6 m-85 -132.05 159.99 37.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.75 -31.8 4.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.162 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -98.78 127.65 44.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.31 88.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -67.51 -34.55 77.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -70.8 -45.35 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.553 HD13 ' CD1' ' A' ' 301' ' ' PHE . 62.2 tp -67.75 -27.64 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -54.63 -50.45 68.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -67.52 -36.51 81.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -60.5 -35.61 76.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -74.35 -32.74 62.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.44 -31.87 47.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -76.01 -36.4 59.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.971 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' HIS . . . . . 0.497 ' CD2' HD12 ' A' ' 296' ' ' LEU . 23.4 m-70 -65.29 -28.27 69.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.839 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.431 -179.977 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.871 0.367 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.8 mt -150.04 158.22 36.98 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.602 0.715 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 154.37 67.89 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.388 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.4 t -63.55 117.2 6.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.71 34.43 4.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 93.7 mt -121.82 -39.53 2.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.36 . . . . 0.0 110.921 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 13.7 p -117.78 -29.94 5.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.14 21.54 6.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -89.17 178.89 6.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.902 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.0 t -135.2 135.08 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -131.74 159.28 38.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.2 -32.67 4.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -99.45 132.04 45.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.61 -45.35 93.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -59.6 -39.35 83.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -66.95 -45.98 76.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.35 -27.25 67.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 8.1 ttm-85 -61.22 -53.98 50.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -61.07 -31.74 71.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -67.09 -42.64 84.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.26 -30.92 71.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.74 73.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.26 -33.72 75.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -70.47 -32.96 70.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.498 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.3 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.864 0.364 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.05 158.18 36.98 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.718 . . . . 0.0 110.968 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 145.53 57.2 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.346 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 20.7 t -56.34 114.95 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.77 30.87 7.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.469 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 21.1 mt -117.98 -40.81 2.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.892 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 20.8 p -115.71 -35.07 4.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 117.81 19.05 4.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.481 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -88.29 166.69 14.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.7 t -125.47 134.58 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.086 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -134.09 151.13 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.1 p -116.81 -46.69 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.62 128.09 33.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.51 -48.75 78.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -58.56 -35.19 71.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -65.12 -51.39 61.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.818 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 310' ' ' HIS . 51.3 tp -69.59 -26.34 64.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -56.19 -26.0 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -93.69 -34.29 13.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' HIS . . . . . 0.513 ' HB3' HD12 ' A' ' 307' ' ' LEU . 24.8 t60 -70.3 -33.59 71.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.816 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.21 -30.75 66.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.43 67.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -60.42 -60.34 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -53.72 -47.76 70.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.468 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.86 0.362 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.0 158.27 37.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 144.04 52.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.9 t -55.9 112.54 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.84 34.49 4.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 314' ' ' HIS . 92.5 mt -119.07 -45.7 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.373 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 26.3 p -113.1 -28.39 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.44 20.99 6.33 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.501 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -89.96 177.32 6.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 65.3 t -136.41 136.2 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -135.47 150.28 49.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 23.3 p -116.62 -45.32 2.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.095 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -78.47 118.1 20.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.71 -37.95 53.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -67.39 -37.98 83.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -63.08 -50.8 69.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.57 HD11 ' HG2' ' A' ' 311' ' ' GLU . 54.8 tp -65.6 -27.42 68.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -57.27 -26.16 60.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -93.31 -36.54 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -70.23 -59.83 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' GLU . . . . . 0.57 ' HG2' HD11 ' A' ' 307' ' ' LEU . 4.2 mm-40 -54.32 -29.76 48.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.21 -34.13 77.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -67.0 -47.26 72.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' HIS . . . . . 0.429 ' HB3' HD13 ' A' ' 296' ' ' LEU . 74.2 m-70 -55.53 -27.26 47.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.956 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.857 0.361 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.6 mt -150.09 158.13 36.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 145.53 57.36 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.637 2.225 . . . . 0.0 112.344 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 39.3 t -52.04 115.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.89 22.2 35.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.494 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.509 HD12 ' CD2' ' A' ' 314' ' ' HIS . 63.0 mt -105.32 -41.63 5.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.821 0.343 . . . . 0.0 110.902 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 26.7 p -118.96 -31.34 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 115.0 27.02 3.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.518 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -90.01 179.32 5.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.865 0.364 . . . . 0.0 110.884 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.7 t -136.05 139.82 45.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -138.72 167.22 22.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.0 p -118.71 -56.19 2.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.78 141.59 40.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.14 -60.45 3.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -53.51 -43.05 67.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -55.45 -48.99 73.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 29.3 tp -58.35 -38.28 76.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -38.12 81.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -52.31 -55.43 21.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.2 -50.84 72.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -52.46 -30.45 29.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.819 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 309' ' ' GLN . . . -54.9 -27.44 42.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.092 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -82.64 -44.17 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.956 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' HIS . . . . . 0.509 ' CD2' HD12 ' A' ' 296' ' ' LEU . 12.7 m-70 -52.91 -29.17 26.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.95 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 49.4 mm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.863 0.364 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.2 mt -150.05 158.26 36.93 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.599 0.714 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.576 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.79 161.23 46.74 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.715 2.276 . . . . 0.0 112.35 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.3 115.27 9.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.43 41.32 2.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.454 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 60.0 mt -127.94 -43.33 1.52 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 22.2 p -115.93 -27.55 6.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.7 19.59 7.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -89.85 177.64 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.576 HG22 ' HB3' ' A' ' 293' ' ' PRO . 63.8 t -136.82 138.65 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -135.0 145.47 48.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 17.4 p -106.62 -49.12 3.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -77.99 115.97 18.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.23 -29.62 23.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.058 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.9 -39.37 61.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -62.31 -39.56 93.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 310' ' ' HIS . 59.8 tp -74.6 -25.92 59.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -56.15 -25.89 48.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -92.69 -34.49 13.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' HIS . . . . . 0.495 ' HB3' HD12 ' A' ' 307' ' ' LEU . 83.1 t60 -69.17 -47.7 64.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -58.31 -26.36 62.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.16 -49.43 44.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -52.34 -36.28 53.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -67.6 -40.68 84.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.44 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.573 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.6 mm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.848 0.356 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.2 mt -150.09 158.21 36.88 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.619 0.723 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 138.64 38.22 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.245 . . . . 0.0 112.348 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 11.8 t -53.08 113.27 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.42 29.45 8.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 81.7 mt -115.93 -38.51 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 14.6 p -117.34 -33.37 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 114.7 18.88 6.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.421 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -90.08 170.53 10.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.809 0.337 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.23 138.34 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.128 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -139.7 156.5 46.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.66 -44.4 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.144 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -80.02 131.22 35.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -64.42 -38.71 91.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -65.65 -42.18 91.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -60.31 -50.51 73.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 56.2 tp -67.18 -26.33 66.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -56.66 -43.12 80.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -78.25 -32.3 49.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -67.97 -31.92 71.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.7 -36.76 57.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.57 -30.2 60.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.07 -51.81 49.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -56.44 -26.67 54.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 -179.943 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.876 0.369 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.7 mt -150.04 158.15 37.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.616 0.722 . . . . 0.0 110.94 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.543 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.78 146.99 61.76 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.654 2.236 . . . . 0.0 112.367 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 52.6 t -52.09 107.69 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -90.8 46.51 2.93 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.521 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 69.0 mt -131.39 -42.23 1.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.921 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 29.8 p -117.43 -28.49 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.47 23.66 4.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -90.04 178.49 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 293' ' ' PRO . 63.0 t -141.86 142.63 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -140.52 174.11 10.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.2 p -129.74 -39.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -88.34 127.67 35.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.77 84.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -73.07 -37.18 66.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -68.89 -46.25 68.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 26.0 tp -52.04 -38.44 57.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -58.33 -33.73 69.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' GLN . . . . . 0.44 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -51.86 -57.43 9.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -62.87 -48.9 76.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -54.89 -26.85 38.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 309' ' ' GLN . . . -55.8 -25.37 41.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -87.89 -43.87 11.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -52.02 -31.22 28.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.49 -179.955 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.9 mm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.906 0.384 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 28.0 mt -150.03 158.22 37.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.571 0.7 . . . . 0.0 110.941 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 148.3 64.93 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.702 2.268 . . . . 0.0 112.325 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 25.8 t -58.87 113.98 2.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.75 29.26 8.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.52 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.24 -42.77 3.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.89 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.0 p -114.8 -29.91 6.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.08 19.71 7.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.466 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -89.98 179.09 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 71.9 t -134.89 136.08 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.09 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -136.85 143.66 43.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.8 p -107.11 -43.17 4.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.44 116.02 19.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.474 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -54.39 -41.35 69.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -65.15 -31.73 73.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -69.76 -49.95 47.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 310' ' ' HIS . 51.4 tp -65.07 -26.24 68.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -56.01 -40.21 73.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -79.15 -37.73 37.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' HIS . . . . . 0.471 ' HB3' HD12 ' A' ' 307' ' ' LEU . 86.4 t60 -55.62 -39.72 71.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -67.9 -30.79 70.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.01 -27.52 44.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.86 -53.01 7.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -53.47 -33.15 53.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.4 mm . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.868 0.366 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 31.0 mt -150.01 158.21 37.05 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.649 0.738 . . . . 0.0 110.937 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 148.55 65.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.654 2.236 . . . . 0.0 112.348 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.17 114.34 2.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.39 37.68 3.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.443 HD12 ' CD2' ' A' ' 314' ' ' HIS . 24.2 mt -124.32 -42.76 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.896 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 19.6 p -115.66 -26.49 7.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.12 20.28 7.61 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -89.67 179.11 6.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 68.3 t -135.59 135.41 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -134.06 124.85 26.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 26.7 p -90.67 -34.57 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -89.82 128.07 36.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -58.92 -58.59 7.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -52.91 -33.85 52.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 18.7 tpt85 -63.85 -44.01 94.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 53.8 tp -71.79 -27.17 62.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.13 -25.56 63.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -90.76 -35.05 15.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -71.04 -41.85 70.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.04 -26.24 68.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.23 -34.0 72.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -62.33 -52.1 64.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' HIS . . . . . 0.443 ' CD2' HD12 ' A' ' 296' ' ' LEU . 61.3 m-70 -55.38 -31.1 61.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 -179.916 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 46.8 p -165.06 151.65 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 0.0 110.891 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 39.8 m -76.29 174.38 10.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -161.05 -106.89 0.21 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.469 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 27.6 p -134.74 58.4 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.819 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.9 m -110.87 109.72 20.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.873 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 158.71 -140.15 6.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.07 172.1 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.868 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -77.2 82.88 3.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -105.33 91.93 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -86.41 -73.97 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 129.16 108.18 1.34 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.452 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.7 mm -84.32 135.05 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 0.0 111.088 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.0 mt -150.0 158.25 37.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.616 0.722 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 144.72 54.9 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.717 2.278 . . . . 0.0 112.335 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 26.7 t -52.01 116.33 2.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.28 39.46 2.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.469 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 75.5 mt -130.07 -42.36 1.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 110.906 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 18.8 p -113.25 -30.39 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.97 19.46 7.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.474 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -86.48 164.99 16.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.54 133.93 67.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.415 ' CD1' HD13 ' A' ' 307' ' ' LEU . 61.9 m-85 -132.08 157.15 44.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 24.8 p -121.11 -33.23 3.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -93.99 120.79 34.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.828 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -53.63 -44.41 69.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.069 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.36 -37.86 88.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -66.98 -42.02 85.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.415 HD13 ' CD1' ' A' ' 301' ' ' PHE . 41.3 tp -71.63 -27.26 62.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -61.94 -35.39 78.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -75.88 -41.44 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -59.8 -39.75 86.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -55.36 -32.16 62.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.51 89.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.082 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -53.57 -40.79 65.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -79.38 -44.26 21.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 110.1 38.96 1.6 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 81.9 t -62.61 100.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.958 0.409 . . . . 0.0 111.094 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.4 m 53.43 29.84 9.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 27.9 t -154.29 161.19 41.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.4 tt -119.79 90.14 3.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.964 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 46.2 tp60 -82.28 114.65 20.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 321' ' ' LEU . 1.6 pt? -123.33 -176.75 3.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.93 -20.75 21.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -73.52 168.64 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.891 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 5.4 mp -95.28 132.06 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.116 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -148.01 134.95 20.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.827 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.68 70.97 17.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.633 0.73 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 167.73 23.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.247 . . . . 0.0 112.304 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 167.77 23.53 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.685 2.257 . . . . 0.0 112.341 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 152.61 69.07 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.664 2.243 . . . . 0.0 112.303 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.52 165.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 81.5 mt -108.11 95.85 5.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -156.7 168.23 33.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.526 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -150.91 172.39 15.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.883 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -159.52 159.45 33.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 111.63 59.39 0.46 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.14 159.62 71.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.622 0.725 . . . . 0.0 110.894 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -173.12 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.645 2.23 . . . . 0.0 112.367 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 45.2 mm -110.96 -28.39 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.147 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 73.8 m -96.94 -30.0 13.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 80.67 -176.47 54.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.478 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 143.98 52.83 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.67 2.247 . . . . 0.0 112.381 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 4.2 m -107.45 64.78 0.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.04 148.23 47.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.873 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 CA-C-O 119.168 -0.796 . . . . 0.0 112.483 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 82.6 p -146.78 155.47 42.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.854 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 5.6 p -115.66 -39.82 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 148.35 -157.23 27.23 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.478 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.7 m -142.88 152.54 42.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 80.8 p -121.69 63.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.897 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -109.88 164.54 12.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.27 168.61 15.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.24 155.3 15.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.839 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.64 119.34 9.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -117.36 65.49 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -135.16 -109.54 1.03 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.455 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.92 133.24 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 111.143 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.4 mt -150.09 158.15 36.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.603 0.716 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 140.78 43.67 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 36.5 t -52.02 109.64 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -90.8 47.97 3.01 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.538 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 73.0 mt -134.23 -44.41 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.88 0.371 . . . . 0.0 110.931 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 13.8 p -116.46 -27.08 6.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.13 19.56 7.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.546 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -89.05 169.38 11.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.8 t -129.88 133.77 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -131.11 164.94 24.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.9 t -127.51 -38.09 1.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.88 117.04 25.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.22 32.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -80.31 -30.1 38.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -73.05 -47.65 42.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -28.92 69.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 41.6 ttp85 -59.21 -47.69 84.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -66.35 -29.95 70.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -72.07 -48.65 42.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.607 ' OE1' HG21 ' A' ' 316' ' ' VAL . 30.9 mm-40 -59.54 -29.04 67.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.74 -38.31 60.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -69.5 -34.75 74.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -69.63 -35.47 75.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.25 45.1 0.88 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.607 HG21 ' OE1' ' A' ' 311' ' ' GLU . 90.5 t -104.32 -52.23 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.934 0.397 . . . . 0.0 111.106 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.62 148.6 15.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.097 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 6.5 m -95.94 -34.15 11.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.0 mp -61.2 -49.44 77.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -82.11 160.18 23.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 321' ' ' LEU . 4.0 pp -59.04 130.82 48.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 179.71 -72.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.527 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -103.68 169.7 8.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.923 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 2.0 pp -61.92 178.01 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -134.29 154.41 51.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 65.6 mt 55.54 73.31 0.87 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.624 0.726 . . . . 0.0 110.923 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 167.75 23.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 167.74 23.6 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 103.62 1.18 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.735 2.29 . . . . 0.0 112.341 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -96.59 93.44 6.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.844 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.79 156.49 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 142.4 -118.34 1.26 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.473 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -135.51 132.16 36.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 0.0 110.922 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -163.33 116.57 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -155.54 143.93 10.41 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.23 159.18 32.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.909 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 99.54 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 0.0 112.355 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 74.3 mt -113.99 91.36 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.4 m -164.03 169.2 18.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -174.93 68.86 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.458 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 108.47 2.09 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.681 2.254 . . . . 0.0 112.301 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 t -136.85 134.25 36.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 70.1 m -100.82 -44.26 5.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.159 -0.8 . . . . 0.0 112.469 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.2 p -157.39 122.6 4.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 110.854 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 37.1 t -110.8 131.49 55.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -74.79 96.54 0.95 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.5 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 72.7 p -76.36 164.46 25.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.856 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 18.1 t -111.1 105.03 13.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.27 40.3 2.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 11.5 mt -125.64 158.0 35.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.828 0.347 . . . . 0.0 110.899 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -167.25 152.27 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -119.92 90.32 3.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.47 144.72 25.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 96.37 -97.04 1.99 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.468 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.28 141.87 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 111.151 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.1 mt -150.02 158.27 36.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.64 0.733 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.445 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.74 144.17 53.3 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 46.8 t -52.8 115.09 1.65 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.36 43.03 2.54 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 64.7 mt -131.68 -40.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.859 0.361 . . . . 0.0 110.92 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 12.6 p -115.74 -30.05 6.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.98 20.68 7.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.495 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -89.61 179.29 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 293' ' ' PRO . 66.1 t -136.67 135.85 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -132.1 160.12 36.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 39.9 p -122.51 -35.06 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.136 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -91.44 116.48 28.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.81 -33.39 35.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -72.26 -37.94 68.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -67.3 -44.96 77.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 67.0 tp -67.37 -29.54 69.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -60.82 -40.92 94.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -76.91 -28.38 55.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.17 -40.31 82.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.39 -26.92 62.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.5 -30.44 60.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -77.89 -42.28 33.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -57.21 -37.01 71.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.83 20.71 6.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.26 143.37 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.928 0.394 . . . . 0.0 111.154 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.8 m -55.05 109.65 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 6.0 m -154.88 172.19 18.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.42 49.38 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -97.17 162.29 13.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 321' ' ' LEU . 2.3 pt? -119.09 169.63 9.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.959 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 156.8 -81.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.47 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -103.87 165.2 11.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.85 0.357 . . . . 0.0 110.902 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.85 144.87 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -124.3 164.18 20.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.56 159.65 51.96 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.64 0.733 . . . . 0.0 110.884 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.76 23.52 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.684 2.256 . . . . 0.0 112.325 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.74 23.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 107.52 1.87 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.1 160.82 32.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.72 138.83 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 161.15 -56.18 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.477 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -112.02 113.9 26.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.85 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -144.07 178.83 7.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -74.64 -70.76 1.21 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.57 159.68 62.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.628 0.727 . . . . 0.0 110.887 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 174.84 8.93 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.65 2.233 . . . . 0.0 112.365 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 67.1 mt -88.38 135.11 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.13 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.6 t -73.95 137.96 43.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.832 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -88.92 -172.25 46.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 110.38 2.54 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 44.8 m -85.43 177.74 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 18.4 t -57.92 114.87 2.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.832 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 CA-C-O 119.148 -0.807 . . . . 0.0 112.45 -179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 11.0 t -169.04 110.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.883 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.5 p -147.18 174.07 11.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -148.58 -139.62 3.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.519 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 17.5 m -142.92 167.38 22.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.871 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.9 t -127.83 177.46 6.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.92 -115.32 4.43 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 53.61 49.12 20.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 0.0 110.942 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -111.0 28.85 8.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -98.79 117.32 33.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.22 67.95 3.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -166.1 -145.14 4.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.432 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.9 mm -64.07 138.21 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.85 0.357 . . . . 0.0 111.166 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.8 mt -150.02 158.22 37.02 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.575 0.703 . . . . 0.0 110.958 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.28 47.53 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.38 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 30.0 t -52.52 114.44 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.84 32.97 5.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.444 HD12 ' CD2' ' A' ' 314' ' ' HIS . 32.0 mt -119.59 -41.02 2.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 12.6 p -116.13 -33.74 4.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.34 20.34 5.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.479 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -89.31 171.0 10.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 82.8 t -131.03 136.56 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.13 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.409 ' CD1' HD13 ' A' ' 307' ' ' LEU . 70.3 m-85 -135.41 161.51 35.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 70.8 p -121.54 -37.99 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.21 124.78 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.02 -51.91 62.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.043 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -56.79 -43.09 80.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -57.27 -52.75 64.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.409 HD13 ' CD1' ' A' ' 301' ' ' PHE . 59.0 tp -65.15 -29.55 70.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -54.51 -53.37 55.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -61.88 -38.59 88.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.09 -43.0 95.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -56.56 -41.29 76.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.23 -29.29 45.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.07 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -63.94 -44.77 91.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' HIS . . . . . 0.444 ' CD2' HD12 ' A' ' 296' ' ' LEU . 99.0 m-70 -72.36 -35.37 68.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 109.09 31.44 3.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 67.9 t -57.4 135.94 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 111.174 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 2.7 p -59.99 103.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.6 m -159.57 165.57 32.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.85 -38.46 78.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -53.31 109.78 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 39.4 mt -95.29 113.49 25.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.921 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -81.02 -100.81 0.34 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.478 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -128.19 -46.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 0.0 110.912 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 56.3 mt -146.75 130.06 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -82.11 102.91 11.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt -80.7 159.25 69.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.631 0.729 . . . . 0.0 110.919 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.69 23.73 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.713 2.275 . . . . 0.0 112.348 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 167.71 23.69 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.654 2.236 . . . . 0.0 112.332 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 171.77 13.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -97.8 137.26 36.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.9 mt -129.18 172.81 11.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -163.83 -60.36 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.48 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -123.23 98.05 5.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -174.11 144.6 0.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.901 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -86.13 127.77 8.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.514 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -98.34 159.24 31.09 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.62 0.724 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 136.74 33.66 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.641 2.227 . . . . 0.0 112.338 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 62.5 mt -71.77 -68.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 6.1 m -75.99 170.62 15.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -132.26 -176.65 14.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.521 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 125.81 12.6 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.745 2.297 . . . . 0.0 112.325 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 7.0 t -67.73 116.45 8.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 4.5 m -97.58 -34.7 10.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.486 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 92.6 p -62.09 -27.25 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 110.889 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 28.5 t -127.01 148.76 50.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.845 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 150.21 68.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 30.5 t -99.88 149.19 23.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 0.0 110.874 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.0 p -130.7 131.92 45.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.856 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -136.2 104.03 0.47 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.517 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.7 mp -78.41 158.04 28.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -131.18 136.57 48.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -56.36 162.17 2.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -137.55 139.83 40.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -170.54 -126.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.522 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm -93.88 138.1 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.079 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.0 mt -149.99 158.23 37.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.661 0.743 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.44 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.9 Cg_endo -69.8 146.65 60.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.711 2.274 . . . . 0.0 112.339 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 35.8 t -51.93 116.87 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.54 34.97 4.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 65.4 mt -123.48 -40.34 2.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 110.899 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 9.5 p -117.24 -28.36 6.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 109.72 20.32 7.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -86.63 169.07 13.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 293' ' ' PRO . 64.7 t -127.48 134.71 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.16 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.534 ' CD1' HD13 ' A' ' 307' ' ' LEU . 56.3 m-85 -131.38 173.6 10.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.822 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 43.4 p -134.42 -44.07 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.109 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.57 120.04 25.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.51 -44.97 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -65.71 -31.3 72.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -70.25 -49.9 45.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.534 HD13 ' CD1' ' A' ' 301' ' ' PHE . 35.1 tp -67.07 -29.15 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -57.05 -38.6 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -74.85 -34.96 62.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -65.03 -41.07 95.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -57.08 -29.91 63.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.27 -34.03 75.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -54.23 -51.9 63.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -70.5 -40.33 73.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 109.37 65.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 91.4 t -97.05 84.11 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.3 m 54.53 42.82 31.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 8.5 p -154.97 129.37 9.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 14.1 tp -94.85 91.43 6.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -61.47 158.64 14.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.979 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -112.43 88.63 2.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.954 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 135.08 47.9 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.512 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -100.84 -57.31 2.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.948 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.402 HG22 ' H ' ' A' ' 326' ' ' LEU . 56.5 mt -127.36 130.01 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -126.94 39.98 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LEU . . . . . 0.402 ' H ' HG22 ' A' ' 324' ' ' ILE . 4.2 tt -154.01 73.3 6.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.632 0.729 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 167.77 23.48 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.666 2.244 . . . . 0.0 112.352 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.71 23.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.695 2.264 . . . . 0.0 112.337 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 175.04 8.66 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.647 2.232 . . . . 0.0 112.357 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.61 25.33 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 7.3 mt -73.55 106.38 5.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 98.55 64.94 0.86 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.516 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -133.31 138.71 46.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.904 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -108.29 -33.01 7.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -104.76 130.53 10.27 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.508 HD23 ' HD2' ' A' ' 337' ' ' PRO . 0.5 OUTLIER -92.84 160.24 34.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.695 0.759 . . . . 0.0 110.871 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.508 ' HD2' HD23 ' A' ' 336' ' ' LEU . 53.8 Cg_endo -69.73 145.01 56.05 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.723 2.282 . . . . 0.0 112.32 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 2.7 pp -60.55 165.11 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.101 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 8.2 t -107.13 -32.49 7.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.855 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 108.21 68.38 0.64 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.495 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 151.46 69.1 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.632 2.221 . . . . 0.0 112.361 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.5 t -101.03 146.33 27.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 12.2 p -62.91 -50.78 69.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.461 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.4 t -120.14 107.27 12.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 110.84 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 22.5 t -98.37 146.62 25.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 157.59 152.49 6.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.499 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 59.3 m -93.29 160.96 14.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.87 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.7 t -156.24 150.93 25.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.864 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 138.75 68.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.19 68.17 1.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.778 0.323 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 66.9 mmt-85 -116.29 -177.57 3.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -119.06 87.35 2.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.13 113.04 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.14 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -108.49 -30.53 3.78 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.495 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.1 mm -96.98 129.71 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.1 mt -150.05 158.12 37.04 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.624 0.726 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 139.62 40.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.64 2.227 . . . . 0.0 112.369 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 17.0 t -53.15 110.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.83 39.99 2.9 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 17.5 mt -126.02 -43.74 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.34 . . . . 0.0 110.921 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 23.8 p -115.44 -31.64 5.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.897 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.45 18.63 5.69 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.449 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -89.69 168.35 12.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.3 133.42 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -131.44 155.87 46.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.9 t -118.14 -28.92 5.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.119 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -100.03 123.06 43.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.76 71.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.105 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -55.41 -32.77 62.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -74.61 -45.13 47.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 63.5 tp -66.66 -26.42 67.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -57.54 -54.22 49.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -63.8 -31.39 72.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -69.94 -27.26 64.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -83.52 -26.43 30.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.88 -51.57 63.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.077 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -61.83 -32.3 72.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -67.89 -42.5 81.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.75 50.35 0.96 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.473 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 71.6 t -98.53 87.35 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.925 0.393 . . . . 0.0 111.143 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.1 p 46.15 36.14 3.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.13 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 15.8 m -118.64 146.4 44.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 13.6 mt -123.05 57.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.83 115.19 10.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.85 104.32 16.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -152.61 -84.03 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -91.3 164.51 13.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.839 0.352 . . . . 0.0 110.938 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 2.0 pp -56.31 151.33 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.161 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -164.72 127.66 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.77 159.67 64.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.69 23.67 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.694 2.263 . . . . 0.0 112.35 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 167.7 23.6 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.743 2.295 . . . . 0.0 112.367 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 127.01 13.98 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.7 2.267 . . . . 0.0 112.342 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -74.03 178.69 4.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.815 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 5.4 mp -75.29 176.99 6.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -99.39 150.67 19.23 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.73 142.2 28.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.348 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -91.05 -176.25 4.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -93.74 -91.38 1.6 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.482 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 337' ' ' PRO . 0.3 OUTLIER -78.2 160.65 72.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.665 0.745 . . . . 0.0 110.924 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.545 ' HD2' HD23 ' A' ' 336' ' ' LEU . 53.2 Cg_endo -69.79 98.59 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 0.0 112.33 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 72.3 mt -70.57 131.01 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.148 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 40.2 t -125.01 108.81 12.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -106.16 -173.46 23.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 98.85 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.699 2.266 . . . . 0.0 112.326 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.7 p -64.46 159.45 21.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.3 m -89.19 102.8 15.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.453 -179.974 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.8 m -118.4 174.89 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 110.837 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.5 m -83.15 141.64 31.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.45 171.63 38.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 34.4 p -175.03 114.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 8.3 t -56.76 141.3 44.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 148.06 -21.91 1.42 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.57 76.02 1.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -96.93 36.7 1.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -148.73 174.5 12.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -81.88 159.35 23.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.97 -113.75 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.482 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.417 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.9 mm -72.76 138.06 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 0.0 111.101 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.07 158.19 36.94 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 0.0 110.916 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.539 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.75 149.14 66.54 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.69 2.26 . . . . 0.0 112.336 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 36.0 t -58.16 116.82 3.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.77 34.74 4.58 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.508 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.9 mt -122.56 -40.07 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.34 . . . . 0.0 110.923 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 14.9 p -116.36 -30.42 5.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.79 19.68 7.22 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -89.94 179.34 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.754 0.311 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 293' ' ' PRO . 67.2 t -136.58 138.69 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -138.08 145.28 41.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 4.0 p -108.7 -33.93 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.12 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.2 109.8 20.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.417 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -51.79 -30.82 24.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -72.45 -37.45 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -67.52 -48.11 68.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 32.0 tp -57.22 -33.88 67.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -52.56 -41.44 63.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.849 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -74.75 -26.58 59.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -70.25 -41.76 73.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -59.69 -29.22 67.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.27 -37.04 64.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -62.4 -53.59 52.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -65.44 -32.1 73.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 119.42 -83.86 0.36 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 63.8 t 59.1 79.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.7 m 51.84 35.64 16.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 2.6 p -130.71 145.0 51.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.848 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.34 63.89 3.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.945 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -122.34 165.88 15.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 28.3 mt -102.47 131.22 49.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -166.97 70.97 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.494 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -76.62 150.74 36.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.839 0.352 . . . . 0.0 110.937 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.07 126.5 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -128.72 149.26 50.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 3.0 mt 64.24 154.62 0.12 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.643 0.735 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.76 23.55 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.643 2.229 . . . . 0.0 112.323 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 167.76 23.55 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.642 2.228 . . . . 0.0 112.34 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 170.99 15.32 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.665 2.243 . . . . 0.0 112.329 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -81.44 106.23 13.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 51.3 tp -167.29 150.33 6.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 166.55 84.82 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.522 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -122.79 30.26 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.932 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -87.15 133.44 33.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -112.45 -106.63 2.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.78 159.68 33.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.701 . . . . 0.0 110.95 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 133.34 25.3 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.723 2.282 . . . . 0.0 112.323 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 31.0 mm -82.11 104.8 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.9 t -105.31 153.18 21.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -60.64 178.62 3.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 111.91 2.93 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.663 2.242 . . . . 0.0 112.38 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.8 p -71.85 117.22 13.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.9 p -91.57 -39.48 11.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.493 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.79 159.57 15.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.841 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 8.8 m -84.13 137.16 33.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.833 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -72.37 -65.39 2.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.454 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.8 p -165.19 177.94 7.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 0.0 110.883 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.8 p -150.0 133.86 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -153.54 131.76 3.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.446 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -71.35 -31.56 67.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.32 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -122.84 145.0 48.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.819 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -120.83 133.18 55.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -119.87 -69.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.095 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 150.12 -19.84 1.09 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.475 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm -82.9 140.26 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.6 mt -150.02 158.25 36.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.572 0.701 . . . . 0.0 110.927 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 141.42 45.12 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.702 2.268 . . . . 0.0 112.33 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 32.3 t -53.46 110.87 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.42 46.59 2.58 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.454 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.1 mt -132.3 -49.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.346 . . . . 0.0 110.925 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 20.4 p -111.18 -26.96 8.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.05 20.97 6.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.473 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -89.79 167.19 13.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.748 0.309 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.3 133.81 67.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.139 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -132.4 140.32 48.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 7.1 p -106.52 -26.29 11.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -103.23 131.77 50.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.842 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.55 -49.05 76.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.089 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -56.25 -43.26 78.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -62.87 -46.95 85.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 51.2 tp -64.23 -26.0 68.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -52.06 -61.57 2.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.944 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -51.82 -48.38 63.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -53.25 -64.93 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 316' ' ' VAL . 10.0 mt-10 -53.55 -40.05 65.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.608 ' N ' HE22 ' A' ' 320' ' ' GLN . . . -60.81 -25.04 66.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -86.71 -32.29 20.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.898 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -57.45 -29.13 63.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.74 20.76 6.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.511 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 311' ' ' GLU . 66.7 t -54.51 144.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.141 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.77 165.43 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 5.8 t -66.03 91.67 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.41 ' O ' HD13 ' A' ' 319' ' ' LEU . 0.3 OUTLIER -137.35 -41.8 0.56 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.951 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 320' ' ' GLN . . . . . 0.608 HE22 ' N ' ' A' ' 312' ' ' ALA . 27.3 mt-30 -55.33 163.0 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 12.5 mt -74.59 154.63 38.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 151.82 -158.61 27.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -128.45 28.06 5.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 110.95 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.13 45.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.082 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.35 38.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.862 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 4.0 tt -137.35 71.63 52.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.63 0.729 . . . . 0.0 110.902 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 167.77 23.46 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 167.73 23.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.677 2.252 . . . . 0.0 112.371 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 141.05 44.32 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.707 2.271 . . . . 0.0 112.328 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -161.14 140.92 10.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.92 111.92 9.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -92.79 -128.98 4.89 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -130.41 -176.77 4.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 110.891 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -103.97 41.99 1.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -92.82 -139.49 9.22 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.66 159.56 40.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.604 0.716 . . . . 0.0 110.942 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 114.7 3.78 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.0 112.38 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 1.2 pp -88.32 162.48 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 19.5 m -115.94 174.13 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -147.84 170.37 28.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.496 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 91.16 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.661 2.241 . . . . 0.0 112.343 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 52.2 p -152.8 150.04 28.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.809 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 57.7 m -84.81 121.17 27.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.177 -0.791 . . . . 0.0 112.473 179.996 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.3 m 54.58 30.59 13.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.919 0.39 . . . . 0.0 110.883 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 54.4 p -107.21 96.96 6.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.92 169.42 45.92 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.489 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 33.2 p -161.75 166.01 27.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 0.0 110.848 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 17.7 p -153.85 172.55 17.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 147.83 80.53 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.43 125.63 28.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -156.98 168.42 27.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -81.54 150.41 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -58.7 132.85 55.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.059 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 155.74 -90.41 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm -72.26 135.41 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 0.0 111.148 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.6 mt -150.03 158.16 37.04 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.598 0.713 . . . . 0.0 110.936 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 140.72 43.46 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.674 2.249 . . . . 0.0 112.325 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 49.8 t -56.18 107.84 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -91.24 45.7 2.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.456 HD12 ' CD2' ' A' ' 314' ' ' HIS . 13.2 mt -132.67 -44.42 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 21.5 p -114.72 -27.1 7.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.83 19.49 7.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.466 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -88.98 166.37 13.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.9 t -130.5 135.16 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -130.85 158.01 41.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.91 -43.65 2.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -84.54 139.6 32.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.42 84.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -65.79 -41.49 91.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 37.3 tpt85 -58.7 -49.16 78.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.531 HD12 ' HB3' ' A' ' 310' ' ' HIS . 59.8 tp -69.78 -26.03 64.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -55.93 -25.77 44.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -92.18 -34.32 14.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' HIS . . . . . 0.531 ' HB3' HD12 ' A' ' 307' ' ' LEU . 46.6 t60 -71.37 -33.67 69.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -71.16 -26.5 63.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.881 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -72.18 -37.95 69.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -58.01 -40.69 81.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' HIS . . . . . 0.456 ' CD2' HD12 ' A' ' 296' ' ' LEU . 68.1 m-70 -70.28 -41.87 72.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 108.73 38.22 1.93 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.483 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.55 -45.76 96.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 111.126 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 15.0 t -131.98 170.55 14.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 61.6 p -79.57 60.97 3.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 53.7 mt -146.83 117.42 7.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.73 31.23 17.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.34 165.8 2.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -101.73 -102.31 2.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.478 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -109.65 27.21 9.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 110.936 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 4.9 mp -92.78 136.2 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 2.8 t0 63.34 43.02 6.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.38 73.41 2.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.61 0.719 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 167.69 23.7 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.712 2.275 . . . . 0.0 112.344 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 167.77 23.47 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.688 2.259 . . . . 0.0 112.318 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 164.7 33.6 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.256 . . . . 0.0 112.355 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -75.64 123.57 25.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 59.7 tp -77.58 115.02 17.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -100.19 -101.42 2.4 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -139.35 148.72 43.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.889 0.376 . . . . 0.0 110.897 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -88.22 151.42 22.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.856 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -82.1 -76.06 1.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.513 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.92 159.66 35.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.614 0.721 . . . . 0.0 110.881 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 148.01 63.96 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.71 2.273 . . . . 0.0 112.357 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 63.3 mt -84.98 128.0 39.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.4 t -95.74 -41.63 8.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -152.75 177.58 30.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.516 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 159.52 53.08 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.4 p -137.25 176.16 8.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.871 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 4.9 p -84.48 128.92 34.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 119.091 -0.838 . . . . 0.0 112.526 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 13.7 m -67.38 142.93 56.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 110.87 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.4 m -141.3 153.8 45.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.06 71.26 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.462 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 50.6 m -85.61 76.58 9.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.923 0.392 . . . . 0.0 110.825 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 18.6 p -79.44 114.95 18.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -108.34 79.2 0.25 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.511 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.95 81.29 2.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.344 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 8.2 tpt85 -116.31 34.1 5.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -56.96 148.75 20.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -90.07 149.58 22.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -170.66 -149.29 6.36 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.485 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm -76.69 134.88 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 0.0 111.105 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 28.0 mt -150.01 158.2 37.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.636 0.731 . . . . 0.0 110.934 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 147.33 62.27 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.635 2.223 . . . . 0.0 112.338 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 37.4 t -52.7 117.59 3.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -95.18 32.77 5.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.48 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.571 HD12 ' CD2' ' A' ' 314' ' ' HIS . 18.3 mt -119.83 -40.89 2.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 0.0 110.974 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.4 p -116.86 -31.17 5.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 113.21 22.87 5.41 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -89.82 168.81 11.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.42 142.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.493 ' CD1' HD13 ' A' ' 307' ' ' LEU . 48.9 m-85 -141.61 160.97 39.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.1 p -127.86 -39.59 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.139 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.3 116.35 25.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.15 -45.43 65.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -65.68 -31.2 72.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -73.82 -45.31 52.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.493 HD13 ' CD1' ' A' ' 301' ' ' PHE . 34.6 tp -63.3 -26.61 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -55.13 -54.74 39.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -52.09 -49.76 62.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -56.77 -44.1 81.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -59.6 -31.81 69.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.93 70.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -61.93 -56.99 13.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' HIS . . . . . 0.571 ' CD2' HD12 ' A' ' 296' ' ' LEU . 95.5 m-70 -60.23 -44.52 95.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 109.06 64.06 0.55 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 84.8 t -93.37 -57.89 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 0.0 111.151 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 33.2 p -114.84 31.35 6.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.158 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 35.2 t -173.47 155.72 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.77 66.45 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -87.26 163.71 16.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 5.3 tp -110.98 89.32 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -128.82 -72.15 0.14 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.488 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.87 160.25 3.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 2.0 pp -61.12 174.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -129.96 114.87 16.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.27 73.17 9.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.661 0.743 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 167.76 23.53 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 0.0 112.343 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 167.75 23.54 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.654 2.236 . . . . 0.0 112.365 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 133.29 25.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.711 2.274 . . . . 0.0 112.339 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.02 162.72 23.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 31.8 tp -153.62 145.68 23.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -66.25 143.02 43.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.84 137.0 38.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.932 0.396 . . . . 0.0 110.872 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -70.95 128.0 34.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -54.46 155.36 8.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -113.05 159.21 35.53 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.615 0.722 . . . . 0.0 110.942 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -174.19 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.706 2.271 . . . . 0.0 112.359 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 1.2 pp -126.64 174.15 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 30.8 t -114.34 163.47 15.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -142.71 -179.26 19.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 146.19 59.44 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.1 t -117.66 178.31 4.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 12.1 m -120.58 164.65 16.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 CA-C-O 119.187 -0.785 . . . . 0.0 112.52 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.6 t -122.56 -41.0 2.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 110.822 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 4.9 p -126.24 88.61 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.85 141.45 4.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 5.5 t -166.62 143.38 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.871 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -102.21 104.61 15.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -150.1 -75.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 5.9 mp -118.49 98.9 6.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.69 -34.96 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -97.43 -16.8 20.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . 60.07 28.51 18.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -153.97 -96.77 0.13 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.477 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.4 mm -56.57 141.91 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 111.141 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.0 mt -150.05 158.18 36.99 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 145.54 57.64 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.666 2.244 . . . . 0.0 112.33 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 20.1 t -60.22 116.6 4.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -95.42 21.49 44.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 314' ' ' HIS . 41.2 mt -105.01 -40.32 5.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.353 . . . . 0.0 110.908 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.1 p -117.59 -29.14 5.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.67 20.48 7.28 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.51 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -89.79 178.75 6.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 80.4 t -135.22 135.07 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.118 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.553 ' CD1' HD13 ' A' ' 307' ' ' LEU . 41.6 m-85 -132.05 159.99 37.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.75 -31.8 4.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.162 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -98.78 127.65 44.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.31 88.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -67.51 -34.55 77.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -70.8 -45.35 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.553 HD13 ' CD1' ' A' ' 301' ' ' PHE . 62.2 tp -67.75 -27.64 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -54.63 -50.45 68.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -67.52 -36.51 81.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -60.5 -35.61 76.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -74.35 -32.74 62.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.44 -31.87 47.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -76.01 -36.4 59.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.971 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' HIS . . . . . 0.497 ' CD2' HD12 ' A' ' 296' ' ' LEU . 23.4 m-70 -65.29 -28.27 69.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.839 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 107.75 27.38 5.2 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.431 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 82.5 t -81.62 138.23 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 111.119 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 2.2 t -56.39 110.51 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 24.0 p -159.59 163.36 35.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.88 61.43 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.952 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -39.06 40.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 5.5 tp -87.38 128.38 35.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -80.64 79.24 1.78 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.51 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -86.1 -28.91 23.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.956 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 45.2 mm -94.01 146.01 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -99.4 135.64 40.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.4 tp -158.53 71.42 3.81 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 167.75 23.47 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.263 . . . . 0.0 112.342 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 167.77 23.49 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 0.0 112.335 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 174.3 9.76 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.624 2.216 . . . . 0.0 112.349 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -56.31 158.45 4.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.836 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 18.4 tp -52.23 113.69 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 169.51 40.67 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.494 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -146.43 150.97 36.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.911 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -106.79 157.55 17.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 155.15 -108.44 0.36 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.25 159.65 71.06 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.646 0.736 . . . . 0.0 110.928 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 176.21 7.07 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.698 2.265 . . . . 0.0 112.356 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 338' ' ' ILE . 1.2 pp -126.61 162.72 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.14 172.82 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 134.41 71.62 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.455 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 172.15 13.23 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.355 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 94.3 p -117.96 -178.5 3.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.4 m -110.98 81.03 1.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 CA-C-O 119.122 -0.821 . . . . 0.0 112.466 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.1 t -141.97 118.24 10.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.828 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.1 t -146.5 147.69 31.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.78 158.88 9.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.484 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.6 p -150.58 111.46 4.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.875 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.9 p -68.55 87.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 169.41 46.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.515 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 19.7 mt -102.21 31.73 3.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.65 129.35 19.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -167.49 145.36 4.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.15 91.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -173.8 -112.67 0.29 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm -66.49 137.8 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.113 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.8 mt -150.04 158.22 36.98 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.602 0.715 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 154.37 67.89 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.388 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.4 t -63.55 117.2 6.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.71 34.43 4.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 93.7 mt -121.82 -39.53 2.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.36 . . . . 0.0 110.921 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 13.7 p -117.78 -29.94 5.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.14 21.54 6.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -89.17 178.89 6.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.902 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.0 t -135.2 135.08 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -131.74 159.28 38.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.2 -32.67 4.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -99.45 132.04 45.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.61 -45.35 93.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -59.6 -39.35 83.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -66.95 -45.98 76.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.35 -27.25 67.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 8.1 ttm-85 -61.22 -53.98 50.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -61.07 -31.74 71.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -67.09 -42.64 84.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.26 -30.92 71.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.74 73.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.26 -33.72 75.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -70.47 -32.96 70.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.5 27.92 3.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.498 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 63.6 t -74.33 -42.19 50.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.123 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.4 t -126.02 137.74 53.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 51.0 m -103.43 -35.45 8.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.0 pp -54.93 -30.67 59.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -56.45 125.47 22.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.34 149.33 16.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -90.37 -163.7 39.25 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.11 130.7 14.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.854 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 324' ' ' ILE . 8.9 mt 51.34 45.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -59.51 143.06 51.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 3.7 tt -119.93 70.2 14.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.57 0.7 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 167.75 23.61 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.63 2.22 . . . . 0.0 112.353 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 167.75 23.56 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.644 2.229 . . . . 0.0 112.346 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 99.62 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.662 2.241 . . . . 0.0 112.385 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 45.3 mmm-85 -93.2 -18.08 22.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 11.6 tp -95.19 70.79 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -111.44 65.73 0.25 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.48 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -132.36 108.92 9.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.933 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 30.6 t30 57.42 27.96 14.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -146.82 132.93 4.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -86.56 159.2 53.22 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.627 0.727 . . . . 0.0 110.929 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 148.71 66.05 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.732 2.288 . . . . 0.0 112.328 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.09 100.47 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.118 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 20.1 m -67.42 157.98 32.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -157.84 71.53 0.25 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.447 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 175.86 7.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.701 2.267 . . . . 0.0 112.32 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 33.0 t -108.47 118.05 35.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 2.5 t -109.27 177.17 4.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.855 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.48 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 55.5 m -149.46 143.66 25.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.8 t -159.72 172.47 17.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 147.62 56.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.463 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 14.6 m -115.27 145.39 42.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.867 0.365 . . . . 0.0 110.887 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 35.9 m -105.74 99.12 8.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.9 -115.71 3.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.51 125.33 54.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 110.889 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -64.66 -66.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -91.66 113.97 26.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -86.28 105.42 16.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -93.5 -100.93 1.55 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.496 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.3 mm -57.23 135.35 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 111.106 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.05 158.18 36.98 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.718 . . . . 0.0 110.968 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 145.53 57.2 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.346 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 20.7 t -56.34 114.95 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.77 30.87 7.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.469 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 21.1 mt -117.98 -40.81 2.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.892 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 20.8 p -115.71 -35.07 4.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 117.81 19.05 4.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.481 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -88.29 166.69 14.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.7 t -125.47 134.58 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.086 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -134.09 151.13 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.1 p -116.81 -46.69 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.62 128.09 33.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.51 -48.75 78.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -58.56 -35.19 71.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -65.12 -51.39 61.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.818 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 310' ' ' HIS . 51.3 tp -69.59 -26.34 64.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -56.19 -26.0 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -93.69 -34.29 13.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' HIS . . . . . 0.513 ' HB3' HD12 ' A' ' 307' ' ' LEU . 24.8 t60 -70.3 -33.59 71.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.816 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.21 -30.75 66.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.43 67.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -60.42 -60.34 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -53.72 -47.76 70.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 129.66 35.61 0.44 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.468 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 67.5 t -74.89 144.39 12.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 0.0 111.136 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.0 t -52.55 124.26 13.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 9.9 p -173.84 166.99 4.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.411 ' C ' HD12 ' A' ' 319' ' ' LEU . 4.3 pp -75.85 -27.6 57.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -55.1 101.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -53.37 155.53 2.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -139.81 135.62 7.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.515 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -98.9 -28.36 13.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 0.0 110.926 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 3.6 mp -59.62 138.51 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.165 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -55.99 160.6 2.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.78 154.96 78.3 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.722 . . . . 0.0 110.944 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 167.71 23.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.721 2.281 . . . . 0.0 112.302 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.74 23.57 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.704 2.269 . . . . 0.0 112.351 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 175.53 7.98 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.704 2.269 . . . . 0.0 112.308 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -111.66 94.72 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 15.6 mt -93.9 57.13 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -67.11 167.21 39.72 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.474 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -96.45 96.59 8.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.379 . . . . 0.0 110.893 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -66.76 112.34 4.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -56.52 123.2 30.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.504 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -98.46 159.24 31.03 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.661 0.744 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 178.15 4.89 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.666 2.244 . . . . 0.0 112.353 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 72.7 mt -73.63 97.77 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 10.2 p -69.15 179.06 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 107.4 174.37 22.47 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -175.01 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.645 2.23 . . . . 0.0 112.374 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 10.7 t -156.86 150.82 24.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.3 t -100.07 99.63 10.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.834 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 119.155 -0.803 . . . . 0.0 112.493 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.0 m -53.93 138.9 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.8 t -65.38 -57.4 8.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.5 53.95 3.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.2 p -67.81 179.22 1.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 0.0 110.842 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.7 m -107.35 -31.58 8.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.839 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.98 -68.54 2.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.452 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.68 HD12 ' HB3' ' A' ' 289' ' ' ALA . 0.4 OUTLIER -150.55 149.87 30.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.775 0.322 . . . . 0.0 110.926 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -121.62 -55.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -91.08 77.22 6.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.68 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -142.09 125.53 16.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.051 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -88.02 -26.07 29.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.529 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.0 mm -84.12 137.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.0 158.27 37.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 144.04 52.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.9 t -55.9 112.54 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.84 34.49 4.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 314' ' ' HIS . 92.5 mt -119.07 -45.7 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.373 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 26.3 p -113.1 -28.39 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.44 20.99 6.33 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.501 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -89.96 177.32 6.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 65.3 t -136.41 136.2 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -135.47 150.28 49.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 23.3 p -116.62 -45.32 2.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.095 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -78.47 118.1 20.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.71 -37.95 53.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -67.39 -37.98 83.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -63.08 -50.8 69.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.57 HD11 ' HG2' ' A' ' 311' ' ' GLU . 54.8 tp -65.6 -27.42 68.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -57.27 -26.16 60.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -93.31 -36.54 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -70.23 -59.83 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.57 ' HG2' HD11 ' A' ' 307' ' ' LEU . 4.2 mm-40 -54.32 -29.76 48.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.21 -34.13 77.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -67.0 -47.26 72.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' HIS . . . . . 0.429 ' HB3' HD13 ' A' ' 296' ' ' LEU . 74.2 m-70 -55.53 -27.26 47.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 112.28 24.77 4.96 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.54 HG21 ' CD ' ' A' ' 311' ' ' GLU . 66.6 t -78.06 144.21 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.956 0.408 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 44.1 m -52.58 116.27 2.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.076 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 14.7 t -160.98 171.96 17.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 12.3 mt -62.87 -36.85 84.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -64.44 133.67 52.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.11 166.11 18.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -177.49 59.3 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.502 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -50.22 -36.73 32.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 110.961 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 54.6 mt -150.66 133.92 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -132.82 147.83 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 6.6 tp -165.66 72.33 1.32 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.607 0.718 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 167.75 23.5 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.348 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 167.76 23.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.661 2.24 . . . . 0.0 112.3 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 136.39 32.83 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.647 2.231 . . . . 0.0 112.34 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.62 147.99 29.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 7.7 tp -133.11 118.0 18.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.966 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 170.55 76.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -107.21 89.18 2.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -159.53 -179.6 8.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.606 ' C ' HD23 ' A' ' 336' ' ' LEU . . . -78.86 -149.33 4.61 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.468 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.606 HD23 ' C ' ' A' ' 335' ' ' GLY . 0.1 OUTLIER -157.17 159.63 30.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.552 0.691 . . . . 0.0 110.889 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 165.35 31.2 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.691 2.261 . . . . 0.0 112.374 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 68.4 mt -95.49 99.66 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.5 p -96.63 134.48 39.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.869 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -171.44 73.59 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.52 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -43.66 2.56 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.692 2.261 . . . . 0.0 112.392 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 55.56 35.63 25.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 7.4 p -147.16 119.94 8.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-O 119.148 -0.807 . . . . 0.0 112.485 -179.993 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.1 m -58.74 113.23 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.347 . . . . 0.0 110.902 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 8.1 t -161.56 133.95 5.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -71.57 -118.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.462 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 28.7 t -153.95 153.42 31.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 110.833 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 74.7 p -112.24 104.86 13.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.841 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -106.14 103.17 2.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.53 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.7 mp -107.28 131.37 54.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -117.26 -41.14 3.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.03 139.84 58.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -97.26 -177.3 3.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 110.03 -87.45 0.47 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.46 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.7 mm -67.29 129.85 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.361 . . . . 0.0 111.148 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.6 mt -150.09 158.13 36.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 145.53 57.36 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.637 2.225 . . . . 0.0 112.344 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 39.3 t -52.04 115.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.89 22.2 35.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.494 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.509 HD12 ' CD2' ' A' ' 314' ' ' HIS . 63.0 mt -105.32 -41.63 5.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.821 0.343 . . . . 0.0 110.902 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 26.7 p -118.96 -31.34 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 115.0 27.02 3.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.518 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -90.01 179.32 5.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.865 0.364 . . . . 0.0 110.884 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.7 t -136.05 139.82 45.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -138.72 167.22 22.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.0 p -118.71 -56.19 2.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.78 141.59 40.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.14 -60.45 3.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -53.51 -43.05 67.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -55.45 -48.99 73.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 29.3 tp -58.35 -38.28 76.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -38.12 81.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -52.31 -55.43 21.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.2 -50.84 72.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.722 ' OE1' HG21 ' A' ' 316' ' ' VAL . 12.0 mm-40 -52.46 -30.45 29.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.819 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 309' ' ' GLN . . . -54.9 -27.44 42.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.092 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -82.64 -44.17 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.956 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' HIS . . . . . 0.509 ' CD2' HD12 ' A' ' 296' ' ' LEU . 12.7 m-70 -52.91 -29.17 26.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 119.03 19.9 4.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.722 HG21 ' OE1' ' A' ' 311' ' ' GLU . 91.2 t -84.75 134.85 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 111.116 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 2.2 p -60.17 127.07 30.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 7.1 p -162.27 163.28 28.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 6.0 mp -81.39 57.98 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.67 123.11 29.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.53 113.71 8.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.19 98.71 1.35 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.501 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -58.59 162.0 4.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.899 0.38 . . . . 0.0 110.872 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 324' ' ' ILE . 4.7 mp -88.68 128.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.122 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -116.0 143.37 45.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 4.0 tt 58.23 71.52 1.01 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.569 0.699 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 167.73 23.56 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.685 2.257 . . . . 0.0 112.352 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.76 23.51 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.654 2.236 . . . . 0.0 112.368 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 178.47 4.56 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.28 151.69 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 88.0 mt -115.44 -33.93 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 93.42 -80.93 1.04 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.519 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -139.37 105.41 5.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -124.04 101.81 7.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 140.49 159.76 8.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.473 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.85 82.54 43.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.614 0.721 . . . . 0.0 110.913 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 91.97 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.666 2.244 . . . . 0.0 112.371 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 68.8 mt -122.09 97.35 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.69 157.51 34.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 174.74 -71.74 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 100.71 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.716 2.278 . . . . 0.0 112.328 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.8 m -123.83 153.57 40.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 48.4 t 52.87 55.2 9.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.849 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 CA-C-O 119.123 -0.821 . . . . 0.0 112.454 -179.974 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.8 p -64.39 144.74 56.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 0.0 110.839 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 7.9 t 60.84 54.22 3.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.87 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -137.19 46.07 1.03 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.51 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 3.8 m -131.99 -50.19 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.88 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 43.6 t -56.74 110.82 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.95 45.21 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.55 59.74 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.785 0.326 . . . . 0.0 110.919 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -116.08 85.21 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -111.13 28.63 8.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . 56.55 25.04 9.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 65.69 -92.5 0.16 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.51 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 49.4 mm -93.81 140.81 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.364 . . . . 0.0 111.09 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.2 mt -150.05 158.26 36.93 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.599 0.714 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.576 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.79 161.23 46.74 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.715 2.276 . . . . 0.0 112.35 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.3 115.27 9.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.43 41.32 2.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.454 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 60.0 mt -127.94 -43.33 1.52 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 22.2 p -115.93 -27.55 6.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.7 19.59 7.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -89.85 177.64 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.576 HG22 ' HB3' ' A' ' 293' ' ' PRO . 63.8 t -136.82 138.65 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -135.0 145.47 48.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 17.4 p -106.62 -49.12 3.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -77.99 115.97 18.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.23 -29.62 23.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.058 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.9 -39.37 61.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -62.31 -39.56 93.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 310' ' ' HIS . 59.8 tp -74.6 -25.92 59.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -56.15 -25.89 48.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -92.69 -34.49 13.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' HIS . . . . . 0.495 ' HB3' HD12 ' A' ' 307' ' ' LEU . 83.1 t60 -69.17 -47.7 64.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 316' ' ' VAL . 20.3 mt-10 -58.31 -26.36 62.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.16 -49.43 44.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -52.34 -36.28 53.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -67.6 -40.68 84.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.92 42.68 1.0 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.44 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.577 HG12 HG23 ' A' ' 317' ' ' THR . 82.5 t -78.32 -71.8 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 111.13 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.577 HG23 HG12 ' A' ' 316' ' ' VAL . 50.6 p -113.2 35.11 4.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.154 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 78.7 p -165.48 176.26 8.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.32 32.68 5.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -53.37 151.93 5.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -105.65 170.46 7.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 164.67 -80.91 0.12 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.504 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -131.04 31.68 4.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 110.929 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 41.3 mm -94.09 140.72 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 18.3 p30 -67.96 156.18 37.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.76 159.28 84.75 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.613 0.721 . . . . 0.0 110.888 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 167.72 23.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.746 2.297 . . . . 0.0 112.301 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 167.7 23.65 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.717 2.278 . . . . 0.0 112.319 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 95.63 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.267 . . . . 0.0 112.317 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -136.57 137.89 40.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.53 125.77 25.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 172.95 129.18 1.12 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.521 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -77.47 96.94 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -80.95 -38.16 28.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 146.85 70.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 2.8 mt 64.2 154.66 0.12 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.636 0.731 . . . . 0.0 110.928 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 104.4 1.32 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.665 2.243 . . . . 0.0 112.324 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 2.5 pp -78.81 151.97 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 87.6 p -159.29 145.9 16.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -134.81 179.23 17.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 176.88 6.16 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.731 2.287 . . . . 0.0 112.318 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 27.6 m -103.31 124.3 48.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 46.3 t -148.68 158.21 43.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 CA-C-O 119.185 -0.786 . . . . 0.0 112.518 -179.956 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 12.0 p -150.73 156.16 40.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 0.0 110.859 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 45.8 t -105.42 123.48 47.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.69 47.43 1.55 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.486 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 18.8 p -95.8 144.24 26.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.867 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 87.1 p -141.74 145.21 34.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -151.32 -164.52 12.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -151.33 168.9 23.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.912 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -100.22 166.16 11.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -107.29 -16.81 14.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -79.05 -66.12 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 100.44 19.89 16.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.5 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.573 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.6 mm -97.77 134.58 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.156 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.2 mt -150.09 158.21 36.88 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.619 0.723 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 138.64 38.22 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.245 . . . . 0.0 112.348 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 11.8 t -53.08 113.27 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.42 29.45 8.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 81.7 mt -115.93 -38.51 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 14.6 p -117.34 -33.37 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 114.7 18.88 6.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.421 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -90.08 170.53 10.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.809 0.337 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.23 138.34 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.128 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -139.7 156.5 46.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.66 -44.4 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.144 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -80.02 131.22 35.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -64.42 -38.71 91.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -65.65 -42.18 91.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -60.31 -50.51 73.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 56.2 tp -67.18 -26.33 66.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -56.66 -43.12 80.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -78.25 -32.3 49.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -67.97 -31.92 71.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.7 -36.76 57.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.4 ' HB2' ' OE1' ' A' ' 320' ' ' GLN . . . -55.57 -30.2 60.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.07 -51.81 49.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -56.44 -26.67 54.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 110.79 29.1 3.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 74.2 t -79.83 137.36 21.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.125 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.8 p -73.49 77.49 1.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.105 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 53.1 p -112.97 34.97 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.07 46.15 4.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.909 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' GLN . . . . . 0.4 ' OE1' ' HB2' ' A' ' 312' ' ' ALA . 20.9 mt-30 -136.79 136.55 38.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.944 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 4.5 pp -105.1 172.54 6.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -169.46 -68.23 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.496 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -109.45 169.54 8.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.862 0.363 . . . . 0.0 110.936 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 5.4 mp -87.28 134.07 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -74.65 150.38 39.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -155.82 154.8 28.53 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.591 0.71 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 167.75 23.51 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.355 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 167.71 23.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 175.07 8.57 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.264 . . . . 0.0 112.331 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -77.39 132.92 38.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.35 -27.76 27.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 163.47 -148.96 15.88 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.464 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.83 127.43 52.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.825 0.345 . . . . 0.0 110.909 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -105.15 139.37 39.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.936 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -169.31 -179.3 41.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.21 81.39 67.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.615 0.721 . . . . 0.0 110.907 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.43 49.72 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.723 2.282 . . . . 0.0 112.33 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 73.9 mt -116.0 95.86 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 10.3 p -98.29 -59.58 1.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 140.45 72.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.474 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 147.0 61.62 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.724 2.282 . . . . 0.0 112.313 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.8 m -58.36 160.14 5.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 67.4 m -141.18 164.01 31.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 CA-C-O 119.121 -0.822 . . . . 0.0 112.452 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.1 m -128.83 72.76 1.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.897 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 9.4 p -99.8 147.22 25.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -148.48 -168.92 14.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.543 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 63.9 p -112.36 161.83 16.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 110.828 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 32.9 p -136.42 105.28 5.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.817 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 138.66 109.88 0.9 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.5 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 76.7 mt -113.64 130.55 56.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.05 110.37 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -145.89 150.61 36.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -116.76 106.36 13.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.073 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -149.56 129.36 2.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.47 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm -61.12 131.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.876 0.369 . . . . 0.0 111.18 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.7 mt -150.04 158.15 37.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.616 0.722 . . . . 0.0 110.94 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.543 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.78 146.99 61.76 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.654 2.236 . . . . 0.0 112.367 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 52.6 t -52.09 107.69 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -90.8 46.51 2.93 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.521 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 69.0 mt -131.39 -42.23 1.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.921 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 29.8 p -117.43 -28.49 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.47 23.66 4.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -90.04 178.49 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 293' ' ' PRO . 63.0 t -141.86 142.63 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -140.52 174.11 10.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.2 p -129.74 -39.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -88.34 127.67 35.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.77 84.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -73.07 -37.18 66.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -68.89 -46.25 68.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 26.0 tp -52.04 -38.44 57.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -58.33 -33.73 69.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' GLN . . . . . 0.44 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -51.86 -57.43 9.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -62.87 -48.9 76.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.743 ' OE1' HG21 ' A' ' 316' ' ' VAL . 6.6 mm-40 -54.89 -26.85 38.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 309' ' ' GLN . . . -55.8 -25.37 41.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -87.89 -43.87 11.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -52.02 -31.22 28.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 110.24 19.37 8.05 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.49 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.743 HG21 ' OE1' ' A' ' 311' ' ' GLU . 91.6 t -73.81 -52.4 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 111.172 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.0 p -65.7 139.36 58.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 71.0 m -113.33 -30.64 6.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 19.2 mt -97.63 26.48 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -113.55 73.55 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.943 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.08 106.26 13.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 167.95 52.11 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -86.64 -42.74 13.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.846 0.355 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 57.4 mt -133.26 139.47 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.134 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.14 120.8 37.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.9 tt 61.01 73.36 0.61 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.648 0.737 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.74 23.56 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.72 2.28 . . . . 0.0 112.349 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 167.75 23.57 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.683 2.255 . . . . 0.0 112.371 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 154.93 67.14 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.72 2.28 . . . . 0.0 112.329 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -142.64 118.63 10.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.845 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -52.82 143.12 17.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 97.17 -24.07 32.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.494 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -68.58 101.2 1.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 0.0 110.873 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -110.42 174.48 5.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -177.53 -143.74 5.1 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.2 82.93 61.49 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.615 0.722 . . . . 0.0 110.872 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 141.63 45.33 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.639 2.226 . . . . 0.0 112.325 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 338' ' ' ILE . 1.2 pp -126.83 169.74 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 5.0 t -76.5 156.93 32.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -163.6 177.72 39.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.479 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 108.17 2.03 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.665 2.243 . . . . 0.0 112.348 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 4.0 m -63.63 129.89 42.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 14.5 m -110.42 -46.01 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.519 -179.976 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.8 t 56.38 42.15 28.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 110.873 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 10.5 p -102.01 135.23 43.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.866 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.15 20.08 59.72 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.459 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 55.3 p -102.91 105.99 16.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 0.0 110.847 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.1 p -171.96 110.47 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.866 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -97.09 138.3 13.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.473 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.73 111.36 6.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 110.91 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 19.4 ptt85 -106.05 43.42 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -111.34 31.6 5.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -99.33 163.44 12.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.104 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -81.96 -30.92 33.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.484 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.9 mm -98.0 139.87 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 111.107 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 28.0 mt -150.03 158.22 37.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.571 0.7 . . . . 0.0 110.941 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 148.3 64.93 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.702 2.268 . . . . 0.0 112.325 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 25.8 t -58.87 113.98 2.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.75 29.26 8.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.52 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.24 -42.77 3.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.89 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.0 p -114.8 -29.91 6.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.08 19.71 7.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.466 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -89.98 179.09 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 71.9 t -134.89 136.08 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.09 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -136.85 143.66 43.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.8 p -107.11 -43.17 4.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.44 116.02 19.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.474 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -54.39 -41.35 69.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -65.15 -31.73 73.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -69.76 -49.95 47.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 310' ' ' HIS . 51.4 tp -65.07 -26.24 68.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -56.01 -40.21 73.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -79.15 -37.73 37.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' HIS . . . . . 0.471 ' HB3' HD12 ' A' ' 307' ' ' LEU . 86.4 t60 -55.62 -39.72 71.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -67.9 -30.79 70.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.01 -27.52 44.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.86 -53.01 7.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -53.47 -33.15 53.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.8 45.18 1.43 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 65.0 t -94.34 -34.43 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 111.079 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.6 HG23 ' H ' ' A' ' 319' ' ' LEU . 14.6 t -78.2 166.46 22.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 2.2 p -96.66 25.05 5.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.857 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.6 ' H ' HG23 ' A' ' 317' ' ' THR . 2.3 mp -145.88 -167.03 2.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 61.04 40.66 14.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 43.4 mt 52.62 49.09 21.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -75.25 -86.29 0.3 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -139.83 162.05 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.337 . . . . 0.0 110.957 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 9.0 mt 51.36 45.71 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.123 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -85.08 157.2 20.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 13.8 mt -119.48 69.07 11.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.604 0.716 . . . . 0.0 110.9 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 167.75 23.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.665 2.243 . . . . 0.0 112.3 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 167.74 23.53 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.695 2.263 . . . . 0.0 112.334 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 114.58 3.75 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.688 2.258 . . . . 0.0 112.363 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -98.61 94.15 6.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.2 tp 57.11 27.51 13.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.35 163.46 35.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.451 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -77.78 -32.18 52.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.828 0.346 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -80.78 153.3 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -76.55 -106.37 0.14 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.494 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.09 159.64 40.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.566 0.698 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 173.0 11.58 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.67 2.247 . . . . 0.0 112.361 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 49.5 mt -63.19 106.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.136 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.8 t -153.88 112.64 3.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -150.53 171.1 30.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 108.33 2.05 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.728 2.285 . . . . 0.0 112.32 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 79.1 p -101.34 84.12 2.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 27.1 m -161.55 155.87 22.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.526 179.978 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.0 t -133.14 150.93 52.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 0.0 110.86 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.3 m -74.1 86.24 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 156.04 -54.09 0.41 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.46 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.3 m -114.8 143.61 44.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.914 0.388 . . . . 0.0 110.829 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 48.5 t -67.25 154.02 42.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.837 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -135.61 115.32 1.34 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.5 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 19.5 mt -124.99 166.35 16.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.841 0.353 . . . . 0.0 110.912 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.79 153.87 42.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -157.03 121.8 4.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -154.87 171.96 18.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -77.3 -113.84 0.16 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.473 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.4 mm -59.84 136.72 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 111.105 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 31.0 mt -150.01 158.21 37.05 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.649 0.738 . . . . 0.0 110.937 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 148.55 65.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.654 2.236 . . . . 0.0 112.348 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.17 114.34 2.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.39 37.68 3.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.443 HD12 ' CD2' ' A' ' 314' ' ' HIS . 24.2 mt -124.32 -42.76 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.896 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 19.6 p -115.66 -26.49 7.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.12 20.28 7.61 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -89.67 179.11 6.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 68.3 t -135.59 135.41 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -134.06 124.85 26.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 26.7 p -90.67 -34.57 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -89.82 128.07 36.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -58.92 -58.59 7.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -52.91 -33.85 52.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 18.7 tpt85 -63.85 -44.01 94.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 53.8 tp -71.79 -27.17 62.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.13 -25.56 63.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -90.76 -35.05 15.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -71.04 -41.85 70.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 316' ' ' VAL . 39.1 mt-10 -63.04 -26.24 68.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.23 -34.0 72.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -62.33 -52.1 64.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' HIS . . . . . 0.443 ' CD2' HD12 ' A' ' 296' ' ' LEU . 61.3 m-70 -55.38 -31.1 61.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 107.35 40.62 1.75 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 311' ' ' GLU . 78.0 t -80.44 -59.16 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 111.17 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.7 p -122.07 150.4 42.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 16.1 p -106.32 31.94 4.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.839 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.2 pp -87.31 -29.47 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -59.73 120.93 10.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.91 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -58.14 156.26 9.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 100.39 162.33 28.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -76.35 153.13 36.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.371 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.99 170.13 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.111 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -144.69 150.71 37.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 26.5 tp 54.77 70.87 1.47 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.62 0.724 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 167.73 23.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.741 2.294 . . . . 0.0 112.329 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 167.81 23.45 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.657 2.238 . . . . 0.0 112.323 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 133.92 26.62 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.65 2.234 . . . . 0.0 112.319 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.67 64.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 13.0 tp -105.66 59.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -72.37 155.49 51.44 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.9 168.18 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.908 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -75.63 -33.98 60.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.551 ' O ' HD12 ' A' ' 336' ' ' LEU . . . -53.1 152.9 7.68 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.502 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 335' ' ' GLY . 0.5 OUTLIER 64.22 154.13 0.12 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.574 0.702 . . . . 0.0 110.899 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 173.88 10.31 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.719 2.279 . . . . 0.0 112.372 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.35 103.14 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 m -81.66 96.83 7.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.834 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -94.58 -74.77 1.26 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -22.62 31.63 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.68 2.253 . . . . 0.0 112.358 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 8.5 t -98.56 75.71 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 14.1 t -53.07 135.57 37.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.474 179.988 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.7 mm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.931 0.396 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.0 mt -150.0 158.25 37.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.616 0.722 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 144.72 54.9 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.717 2.278 . . . . 0.0 112.335 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 26.7 t -52.01 116.33 2.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.28 39.46 2.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.469 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 75.5 mt -130.07 -42.36 1.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 110.906 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 18.8 p -113.25 -30.39 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.97 19.46 7.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.474 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -86.48 164.99 16.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.54 133.93 67.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.415 ' CD1' HD13 ' A' ' 307' ' ' LEU . 61.9 m-85 -132.08 157.15 44.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 24.8 p -121.11 -33.23 3.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -93.99 120.79 34.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.828 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -53.63 -44.41 69.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.069 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.36 -37.86 88.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -66.98 -42.02 85.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.415 HD13 ' CD1' ' A' ' 301' ' ' PHE . 41.3 tp -71.63 -27.26 62.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -61.94 -35.39 78.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -75.88 -41.44 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -59.8 -39.75 86.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -55.36 -32.16 62.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.51 89.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.082 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -53.57 -40.79 65.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -79.38 -44.26 21.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 -179.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.87 0.367 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.4 mt -150.09 158.15 36.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.603 0.716 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 140.78 43.67 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 36.5 t -52.02 109.64 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -90.8 47.97 3.01 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.538 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 73.0 mt -134.23 -44.41 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.88 0.371 . . . . 0.0 110.931 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 13.8 p -116.46 -27.08 6.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.13 19.56 7.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.546 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -89.05 169.38 11.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.8 t -129.88 133.77 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -131.11 164.94 24.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.9 t -127.51 -38.09 1.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.88 117.04 25.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.22 32.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -80.31 -30.1 38.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -73.05 -47.65 42.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -28.92 69.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 41.6 ttp85 -59.21 -47.69 84.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -66.35 -29.95 70.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -72.07 -48.65 42.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -59.54 -29.04 67.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.74 -38.31 60.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -69.5 -34.75 74.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -69.63 -35.47 75.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.878 0.371 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.1 mt -150.02 158.27 36.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.64 0.733 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.445 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.74 144.17 53.3 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 46.8 t -52.8 115.09 1.65 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.36 43.03 2.54 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 64.7 mt -131.68 -40.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.859 0.361 . . . . 0.0 110.92 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 12.6 p -115.74 -30.05 6.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.98 20.68 7.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.495 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -89.61 179.29 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 293' ' ' PRO . 66.1 t -136.67 135.85 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -132.1 160.12 36.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 39.9 p -122.51 -35.06 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.136 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -91.44 116.48 28.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.81 -33.39 35.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -72.26 -37.94 68.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -67.3 -44.96 77.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 67.0 tp -67.37 -29.54 69.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -60.82 -40.92 94.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -76.91 -28.38 55.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.17 -40.31 82.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.39 -26.92 62.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.5 -30.44 60.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -77.89 -42.28 33.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -57.21 -37.01 71.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.9 mm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.85 0.357 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.8 mt -150.02 158.22 37.02 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.575 0.703 . . . . 0.0 110.958 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.28 47.53 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.38 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 30.0 t -52.52 114.44 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.84 32.97 5.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.444 HD12 ' CD2' ' A' ' 314' ' ' HIS . 32.0 mt -119.59 -41.02 2.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 12.6 p -116.13 -33.74 4.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.34 20.34 5.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.479 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -89.31 171.0 10.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 82.8 t -131.03 136.56 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.13 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.409 ' CD1' HD13 ' A' ' 307' ' ' LEU . 70.3 m-85 -135.41 161.51 35.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 70.8 p -121.54 -37.99 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.21 124.78 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.02 -51.91 62.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.043 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -56.79 -43.09 80.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -57.27 -52.75 64.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.409 HD13 ' CD1' ' A' ' 301' ' ' PHE . 59.0 tp -65.15 -29.55 70.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -54.51 -53.37 55.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -61.88 -38.59 88.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.09 -43.0 95.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -56.56 -41.29 76.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.23 -29.29 45.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.07 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -63.94 -44.77 91.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . 0.444 ' CD2' HD12 ' A' ' 296' ' ' LEU . 99.0 m-70 -72.36 -35.37 68.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.48 -179.976 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.892 0.377 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.0 mt -149.99 158.23 37.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.661 0.743 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.44 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.9 Cg_endo -69.8 146.65 60.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.711 2.274 . . . . 0.0 112.339 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 35.8 t -51.93 116.87 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.54 34.97 4.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 65.4 mt -123.48 -40.34 2.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 110.899 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 9.5 p -117.24 -28.36 6.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 109.72 20.32 7.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -86.63 169.07 13.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 293' ' ' PRO . 64.7 t -127.48 134.71 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.16 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.534 ' CD1' HD13 ' A' ' 307' ' ' LEU . 56.3 m-85 -131.38 173.6 10.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.822 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 43.4 p -134.42 -44.07 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.109 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.57 120.04 25.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.51 -44.97 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -65.71 -31.3 72.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -70.25 -49.9 45.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.534 HD13 ' CD1' ' A' ' 301' ' ' PHE . 35.1 tp -67.07 -29.15 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -57.05 -38.6 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -74.85 -34.96 62.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -65.03 -41.07 95.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -57.08 -29.91 63.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.27 -34.03 75.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -54.23 -51.9 63.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -70.5 -40.33 73.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.1 mt -150.05 158.12 37.04 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.624 0.726 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 139.62 40.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.64 2.227 . . . . 0.0 112.369 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 17.0 t -53.15 110.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.83 39.99 2.9 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 17.5 mt -126.02 -43.74 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.34 . . . . 0.0 110.921 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 23.8 p -115.44 -31.64 5.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.897 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.45 18.63 5.69 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.449 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -89.69 168.35 12.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.3 133.42 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -131.44 155.87 46.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.9 t -118.14 -28.92 5.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.119 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -100.03 123.06 43.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.76 71.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.105 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -55.41 -32.77 62.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -74.61 -45.13 47.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 63.5 tp -66.66 -26.42 67.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -57.54 -54.22 49.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -63.8 -31.39 72.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -69.94 -27.26 64.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -83.52 -26.43 30.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.88 -51.57 63.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.077 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -61.83 -32.3 72.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -67.89 -42.5 81.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.473 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.417 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.9 mm . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.07 158.19 36.94 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 0.0 110.916 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.539 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.75 149.14 66.54 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.69 2.26 . . . . 0.0 112.336 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 36.0 t -58.16 116.82 3.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.77 34.74 4.58 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.508 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.9 mt -122.56 -40.07 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.34 . . . . 0.0 110.923 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 14.9 p -116.36 -30.42 5.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.79 19.68 7.22 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -89.94 179.34 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.754 0.311 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 293' ' ' PRO . 67.2 t -136.58 138.69 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -138.08 145.28 41.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 4.0 p -108.7 -33.93 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.12 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.2 109.8 20.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.417 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -51.79 -30.82 24.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -72.45 -37.45 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -67.52 -48.11 68.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 32.0 tp -57.22 -33.88 67.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -52.56 -41.44 63.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.849 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -74.75 -26.58 59.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -70.25 -41.76 73.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -59.69 -29.22 67.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.27 -37.04 64.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -62.4 -53.59 52.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -65.44 -32.1 73.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.958 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.6 mt -150.02 158.25 36.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.572 0.701 . . . . 0.0 110.927 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 141.42 45.12 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.702 2.268 . . . . 0.0 112.33 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 32.3 t -53.46 110.87 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.42 46.59 2.58 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.454 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.1 mt -132.3 -49.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.346 . . . . 0.0 110.925 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 20.4 p -111.18 -26.96 8.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.05 20.97 6.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.473 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -89.79 167.19 13.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.748 0.309 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.3 133.81 67.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.139 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -132.4 140.32 48.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 7.1 p -106.52 -26.29 11.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -103.23 131.77 50.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.842 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.55 -49.05 76.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.089 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -56.25 -43.26 78.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -62.87 -46.95 85.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 51.2 tp -64.23 -26.0 68.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -52.06 -61.57 2.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.944 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -51.82 -48.38 63.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -53.25 -64.93 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -53.55 -40.05 65.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.81 -25.04 66.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -86.71 -32.29 20.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.898 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -57.45 -29.13 63.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.511 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.832 0.349 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.6 mt -150.03 158.16 37.04 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.598 0.713 . . . . 0.0 110.936 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 140.72 43.46 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.674 2.249 . . . . 0.0 112.325 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 49.8 t -56.18 107.84 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -91.24 45.7 2.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.456 HD12 ' CD2' ' A' ' 314' ' ' HIS . 13.2 mt -132.67 -44.42 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 21.5 p -114.72 -27.1 7.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.83 19.49 7.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.466 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -88.98 166.37 13.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.9 t -130.5 135.16 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -130.85 158.01 41.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.91 -43.65 2.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -84.54 139.6 32.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.42 84.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -65.79 -41.49 91.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 37.3 tpt85 -58.7 -49.16 78.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.531 HD12 ' HB3' ' A' ' 310' ' ' HIS . 59.8 tp -69.78 -26.03 64.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -55.93 -25.77 44.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -92.18 -34.32 14.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . 0.531 ' HB3' HD12 ' A' ' 307' ' ' LEU . 46.6 t60 -71.37 -33.67 69.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -71.16 -26.5 63.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.881 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -72.18 -37.95 69.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -58.01 -40.69 81.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . 0.456 ' CD2' HD12 ' A' ' 296' ' ' LEU . 68.1 m-70 -70.28 -41.87 72.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.483 -179.943 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.854 0.359 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 28.0 mt -150.01 158.2 37.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.636 0.731 . . . . 0.0 110.934 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 147.33 62.27 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.635 2.223 . . . . 0.0 112.338 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 37.4 t -52.7 117.59 3.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -95.18 32.77 5.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.48 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.571 HD12 ' CD2' ' A' ' 314' ' ' HIS . 18.3 mt -119.83 -40.89 2.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 0.0 110.974 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.4 p -116.86 -31.17 5.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 113.21 22.87 5.41 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -89.82 168.81 11.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.42 142.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.493 ' CD1' HD13 ' A' ' 307' ' ' LEU . 48.9 m-85 -141.61 160.97 39.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.1 p -127.86 -39.59 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.139 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.3 116.35 25.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.15 -45.43 65.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -65.68 -31.2 72.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -73.82 -45.31 52.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.493 HD13 ' CD1' ' A' ' 301' ' ' PHE . 34.6 tp -63.3 -26.61 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -55.13 -54.74 39.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -52.09 -49.76 62.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -56.77 -44.1 81.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -59.6 -31.81 69.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.93 70.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -61.93 -56.99 13.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . 0.571 ' CD2' HD12 ' A' ' 296' ' ' LEU . 95.5 m-70 -60.23 -44.52 95.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 -179.916 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.4 mm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.894 0.378 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.0 mt -150.05 158.18 36.99 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 145.54 57.64 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.666 2.244 . . . . 0.0 112.33 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 20.1 t -60.22 116.6 4.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -95.42 21.49 44.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 314' ' ' HIS . 41.2 mt -105.01 -40.32 5.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.353 . . . . 0.0 110.908 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.1 p -117.59 -29.14 5.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.67 20.48 7.28 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.51 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -89.79 178.75 6.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 80.4 t -135.22 135.07 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.118 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.553 ' CD1' HD13 ' A' ' 307' ' ' LEU . 41.6 m-85 -132.05 159.99 37.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.75 -31.8 4.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.162 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -98.78 127.65 44.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.31 88.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -67.51 -34.55 77.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -70.8 -45.35 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.553 HD13 ' CD1' ' A' ' 301' ' ' PHE . 62.2 tp -67.75 -27.64 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -54.63 -50.45 68.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -67.52 -36.51 81.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -60.5 -35.61 76.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -74.35 -32.74 62.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.44 -31.87 47.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -76.01 -36.4 59.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.971 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . 0.497 ' CD2' HD12 ' A' ' 296' ' ' LEU . 23.4 m-70 -65.29 -28.27 69.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.839 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.431 -179.977 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.871 0.367 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.8 mt -150.04 158.22 36.98 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.602 0.715 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 154.37 67.89 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.388 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.4 t -63.55 117.2 6.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.71 34.43 4.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 93.7 mt -121.82 -39.53 2.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.36 . . . . 0.0 110.921 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 13.7 p -117.78 -29.94 5.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.14 21.54 6.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -89.17 178.89 6.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.902 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.0 t -135.2 135.08 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -131.74 159.28 38.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.2 -32.67 4.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -99.45 132.04 45.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.61 -45.35 93.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -59.6 -39.35 83.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -66.95 -45.98 76.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.35 -27.25 67.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 8.1 ttm-85 -61.22 -53.98 50.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -61.07 -31.74 71.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -67.09 -42.64 84.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.26 -30.92 71.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.74 73.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.26 -33.72 75.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -70.47 -32.96 70.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.498 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.3 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.864 0.364 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.05 158.18 36.98 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.718 . . . . 0.0 110.968 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 145.53 57.2 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.346 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 20.7 t -56.34 114.95 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.77 30.87 7.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.469 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 21.1 mt -117.98 -40.81 2.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.892 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 20.8 p -115.71 -35.07 4.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 117.81 19.05 4.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.481 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -88.29 166.69 14.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.7 t -125.47 134.58 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.086 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -134.09 151.13 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.1 p -116.81 -46.69 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.62 128.09 33.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.51 -48.75 78.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -58.56 -35.19 71.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -65.12 -51.39 61.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.818 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 310' ' ' HIS . 51.3 tp -69.59 -26.34 64.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -56.19 -26.0 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -93.69 -34.29 13.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . 0.513 ' HB3' HD12 ' A' ' 307' ' ' LEU . 24.8 t60 -70.3 -33.59 71.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.816 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.21 -30.75 66.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.43 67.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -60.42 -60.34 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -53.72 -47.76 70.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.468 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.86 0.362 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.0 158.27 37.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 144.04 52.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.9 t -55.9 112.54 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.84 34.49 4.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 314' ' ' HIS . 92.5 mt -119.07 -45.7 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.373 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 26.3 p -113.1 -28.39 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.44 20.99 6.33 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.501 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -89.96 177.32 6.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 65.3 t -136.41 136.2 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -135.47 150.28 49.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 23.3 p -116.62 -45.32 2.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.095 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -78.47 118.1 20.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.71 -37.95 53.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -67.39 -37.98 83.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -63.08 -50.8 69.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.57 HD11 ' HG2' ' A' ' 311' ' ' GLU . 54.8 tp -65.6 -27.42 68.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -57.27 -26.16 60.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -93.31 -36.54 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -70.23 -59.83 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . 0.57 ' HG2' HD11 ' A' ' 307' ' ' LEU . 4.2 mm-40 -54.32 -29.76 48.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.21 -34.13 77.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -67.0 -47.26 72.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . 0.429 ' HB3' HD13 ' A' ' 296' ' ' LEU . 74.2 m-70 -55.53 -27.26 47.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.956 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.857 0.361 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.6 mt -150.09 158.13 36.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 145.53 57.36 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.637 2.225 . . . . 0.0 112.344 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 39.3 t -52.04 115.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.89 22.2 35.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.494 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.509 HD12 ' CD2' ' A' ' 314' ' ' HIS . 63.0 mt -105.32 -41.63 5.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.821 0.343 . . . . 0.0 110.902 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 26.7 p -118.96 -31.34 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 115.0 27.02 3.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.518 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -90.01 179.32 5.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.865 0.364 . . . . 0.0 110.884 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.7 t -136.05 139.82 45.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -138.72 167.22 22.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.0 p -118.71 -56.19 2.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.78 141.59 40.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.14 -60.45 3.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -53.51 -43.05 67.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -55.45 -48.99 73.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 29.3 tp -58.35 -38.28 76.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -38.12 81.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -52.31 -55.43 21.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.2 -50.84 72.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -52.46 -30.45 29.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.819 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 309' ' ' GLN . . . -54.9 -27.44 42.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.092 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -82.64 -44.17 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.956 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . 0.509 ' CD2' HD12 ' A' ' 296' ' ' LEU . 12.7 m-70 -52.91 -29.17 26.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.95 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 49.4 mm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.863 0.364 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.2 mt -150.05 158.26 36.93 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.599 0.714 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.576 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.79 161.23 46.74 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.715 2.276 . . . . 0.0 112.35 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.3 115.27 9.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.43 41.32 2.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.454 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 60.0 mt -127.94 -43.33 1.52 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 22.2 p -115.93 -27.55 6.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.7 19.59 7.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -89.85 177.64 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.576 HG22 ' HB3' ' A' ' 293' ' ' PRO . 63.8 t -136.82 138.65 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -135.0 145.47 48.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 17.4 p -106.62 -49.12 3.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -77.99 115.97 18.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.23 -29.62 23.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.058 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.9 -39.37 61.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -62.31 -39.56 93.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 310' ' ' HIS . 59.8 tp -74.6 -25.92 59.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -56.15 -25.89 48.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -92.69 -34.49 13.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . 0.495 ' HB3' HD12 ' A' ' 307' ' ' LEU . 83.1 t60 -69.17 -47.7 64.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -58.31 -26.36 62.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.16 -49.43 44.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -52.34 -36.28 53.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -67.6 -40.68 84.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.44 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.573 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.6 mm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.848 0.356 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.2 mt -150.09 158.21 36.88 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.619 0.723 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 138.64 38.22 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.245 . . . . 0.0 112.348 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 11.8 t -53.08 113.27 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.42 29.45 8.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 81.7 mt -115.93 -38.51 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 14.6 p -117.34 -33.37 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 114.7 18.88 6.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.421 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -90.08 170.53 10.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.809 0.337 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.23 138.34 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.128 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -139.7 156.5 46.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.66 -44.4 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.144 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -80.02 131.22 35.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -64.42 -38.71 91.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -65.65 -42.18 91.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -60.31 -50.51 73.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 56.2 tp -67.18 -26.33 66.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -56.66 -43.12 80.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -78.25 -32.3 49.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -67.97 -31.92 71.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.7 -36.76 57.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.57 -30.2 60.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.07 -51.81 49.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -56.44 -26.67 54.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 -179.943 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.876 0.369 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.7 mt -150.04 158.15 37.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.616 0.722 . . . . 0.0 110.94 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.543 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.78 146.99 61.76 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.654 2.236 . . . . 0.0 112.367 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 52.6 t -52.09 107.69 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -90.8 46.51 2.93 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.521 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 69.0 mt -131.39 -42.23 1.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.921 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 29.8 p -117.43 -28.49 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.47 23.66 4.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -90.04 178.49 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 293' ' ' PRO . 63.0 t -141.86 142.63 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -140.52 174.11 10.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.2 p -129.74 -39.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -88.34 127.67 35.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.77 84.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -73.07 -37.18 66.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -68.89 -46.25 68.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 26.0 tp -52.04 -38.44 57.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -58.33 -33.73 69.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . 0.44 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -51.86 -57.43 9.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -62.87 -48.9 76.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -54.89 -26.85 38.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 309' ' ' GLN . . . -55.8 -25.37 41.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -87.89 -43.87 11.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -52.02 -31.22 28.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.49 -179.955 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.9 mm . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.906 0.384 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 28.0 mt -150.03 158.22 37.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.571 0.7 . . . . 0.0 110.941 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 148.3 64.93 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.702 2.268 . . . . 0.0 112.325 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 25.8 t -58.87 113.98 2.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.75 29.26 8.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.52 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.24 -42.77 3.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.89 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.0 p -114.8 -29.91 6.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.08 19.71 7.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.466 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -89.98 179.09 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 71.9 t -134.89 136.08 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.09 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -136.85 143.66 43.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.8 p -107.11 -43.17 4.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.44 116.02 19.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.474 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -54.39 -41.35 69.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -65.15 -31.73 73.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -69.76 -49.95 47.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 310' ' ' HIS . 51.4 tp -65.07 -26.24 68.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -56.01 -40.21 73.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -79.15 -37.73 37.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . 0.471 ' HB3' HD12 ' A' ' 307' ' ' LEU . 86.4 t60 -55.62 -39.72 71.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -67.9 -30.79 70.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.01 -27.52 44.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.86 -53.01 7.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -53.47 -33.15 53.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.4 mm . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.868 0.366 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 31.0 mt -150.01 158.21 37.05 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.649 0.738 . . . . 0.0 110.937 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 148.55 65.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.654 2.236 . . . . 0.0 112.348 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.17 114.34 2.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.39 37.68 3.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.443 HD12 ' CD2' ' A' ' 314' ' ' HIS . 24.2 mt -124.32 -42.76 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.896 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 19.6 p -115.66 -26.49 7.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.12 20.28 7.61 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -89.67 179.11 6.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 68.3 t -135.59 135.41 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -134.06 124.85 26.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 26.7 p -90.67 -34.57 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -89.82 128.07 36.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -58.92 -58.59 7.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -52.91 -33.85 52.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 18.7 tpt85 -63.85 -44.01 94.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 53.8 tp -71.79 -27.17 62.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.13 -25.56 63.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -90.76 -35.05 15.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -71.04 -41.85 70.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.04 -26.24 68.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.23 -34.0 72.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -62.33 -52.1 64.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' HIS . . . . . 0.443 ' CD2' HD12 ' A' ' 296' ' ' LEU . 61.3 m-70 -55.38 -31.1 61.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 -179.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 46.8 p -165.06 151.65 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 0.0 110.891 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 39.8 m -76.29 174.38 10.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -161.05 -106.89 0.21 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.469 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 27.6 p -134.74 58.4 1.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.819 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.9 m -110.87 109.72 20.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.873 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 158.71 -140.15 6.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.07 172.1 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.868 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -77.2 82.88 3.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -105.33 91.93 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -86.41 -73.97 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 129.16 108.18 1.34 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.452 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.7 mm -84.32 135.05 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 0.0 111.088 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.0 mt -150.0 158.25 37.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.616 0.722 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 144.72 54.9 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.717 2.278 . . . . 0.0 112.335 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 26.7 t -52.01 116.33 2.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.28 39.46 2.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.469 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 75.5 mt -130.07 -42.36 1.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 110.906 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 18.8 p -113.25 -30.39 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.97 19.46 7.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.474 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -86.48 164.99 16.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.54 133.93 67.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.415 ' CD1' HD13 ' A' ' 307' ' ' LEU . 61.9 m-85 -132.08 157.15 44.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 24.8 p -121.11 -33.23 3.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -93.99 120.79 34.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.828 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -53.63 -44.41 69.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.069 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.36 -37.86 88.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -66.98 -42.02 85.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.415 HD13 ' CD1' ' A' ' 301' ' ' PHE . 41.3 tp -71.63 -27.26 62.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -61.94 -35.39 78.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -75.88 -41.44 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -59.8 -39.75 86.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -55.36 -32.16 62.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.933 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.51 89.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.082 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -53.57 -40.79 65.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -79.38 -44.26 21.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 110.1 38.96 1.6 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 81.9 t -62.61 100.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.958 0.409 . . . . 0.0 111.094 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.4 m 53.43 29.84 9.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 27.9 t -154.29 161.19 41.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.4 tt -119.79 90.14 3.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.964 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -82.28 114.65 20.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 321' ' ' LEU . 1.6 pt? -123.33 -176.75 3.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.93 -20.75 21.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -73.52 168.64 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.891 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 5.4 mp -95.28 132.06 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.116 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -148.01 134.95 20.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.827 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.68 70.97 17.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.633 0.73 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 167.73 23.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.671 2.247 . . . . 0.0 112.304 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 167.77 23.53 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.685 2.257 . . . . 0.0 112.341 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 152.61 69.07 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.664 2.243 . . . . 0.0 112.303 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.52 165.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 81.5 mt -108.11 95.85 5.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -156.7 168.23 33.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.526 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -150.91 172.39 15.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.883 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -159.52 159.45 33.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 111.63 59.39 0.46 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.14 159.62 71.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.622 0.725 . . . . 0.0 110.894 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -173.12 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.645 2.23 . . . . 0.0 112.367 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 45.2 mm -110.96 -28.39 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.147 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 73.8 m -96.94 -30.0 13.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 80.67 -176.47 54.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.478 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 143.98 52.83 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.67 2.247 . . . . 0.0 112.381 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 4.2 m -107.45 64.78 0.64 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.877 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.04 148.23 47.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.873 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 CA-C-O 119.168 -0.796 . . . . 0.0 112.483 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 82.6 p -146.78 155.47 42.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.854 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 5.6 p -115.66 -39.82 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 148.35 -157.23 27.23 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.478 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.7 m -142.88 152.54 42.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 80.8 p -121.69 63.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.897 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -109.88 164.54 12.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.27 168.61 15.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.951 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.24 155.3 15.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.839 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.64 119.34 9.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -117.36 65.49 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.112 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -135.16 -109.54 1.03 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.455 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.92 133.24 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 111.143 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.4 mt -150.09 158.15 36.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.603 0.716 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 140.78 43.67 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.657 2.238 . . . . 0.0 112.33 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 36.5 t -52.02 109.64 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -90.8 47.97 3.01 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.538 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 73.0 mt -134.23 -44.41 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.88 0.371 . . . . 0.0 110.931 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 13.8 p -116.46 -27.08 6.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.13 19.56 7.14 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.546 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -89.05 169.38 11.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.8 t -129.88 133.77 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.156 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -131.11 164.94 24.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.9 t -127.51 -38.09 1.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.88 117.04 25.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.22 32.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -80.31 -30.1 38.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -73.05 -47.65 42.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -28.92 69.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 41.6 ttp85 -59.21 -47.69 84.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -66.35 -29.95 70.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -72.07 -48.65 42.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.607 ' OE1' HG21 ' A' ' 316' ' ' VAL . 30.9 mm-40 -59.54 -29.04 67.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.74 -38.31 60.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -69.5 -34.75 74.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -69.63 -35.47 75.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.25 45.1 0.88 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.607 HG21 ' OE1' ' A' ' 311' ' ' GLU . 90.5 t -104.32 -52.23 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.934 0.397 . . . . 0.0 111.106 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.62 148.6 15.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.097 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 6.5 m -95.94 -34.15 11.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.0 mp -61.2 -49.44 77.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -82.11 160.18 23.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 321' ' ' LEU . 4.0 pp -59.04 130.82 48.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.934 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 179.71 -72.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.527 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -103.68 169.7 8.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.923 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 2.0 pp -61.92 178.01 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.129 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -134.29 154.41 51.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 65.6 mt 55.54 73.31 0.87 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.624 0.726 . . . . 0.0 110.923 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 167.75 23.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 167.74 23.6 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 103.62 1.18 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.735 2.29 . . . . 0.0 112.341 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -96.59 93.44 6.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.844 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.79 156.49 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 142.4 -118.34 1.26 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.473 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -135.51 132.16 36.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 0.0 110.922 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -163.33 116.57 1.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -155.54 143.93 10.41 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -109.23 159.18 32.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 110.909 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 99.54 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.688 2.259 . . . . 0.0 112.355 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 74.3 mt -113.99 91.36 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.4 m -164.03 169.2 18.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -174.93 68.86 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.458 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 108.47 2.09 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.681 2.254 . . . . 0.0 112.301 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 t -136.85 134.25 36.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 70.1 m -100.82 -44.26 5.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.159 -0.8 . . . . 0.0 112.469 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.2 p -157.39 122.6 4.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 110.854 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 37.1 t -110.8 131.49 55.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -74.79 96.54 0.95 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.5 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 72.7 p -76.36 164.46 25.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.856 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 18.1 t -111.1 105.03 13.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.27 40.3 2.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 11.5 mt -125.64 158.0 35.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.828 0.347 . . . . 0.0 110.899 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -167.25 152.27 7.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -119.92 90.32 3.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.47 144.72 25.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 96.37 -97.04 1.99 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.468 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.28 141.87 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 111.151 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.1 mt -150.02 158.27 36.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.64 0.733 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.445 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.74 144.17 53.3 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 46.8 t -52.8 115.09 1.65 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.36 43.03 2.54 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 64.7 mt -131.68 -40.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.859 0.361 . . . . 0.0 110.92 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 12.6 p -115.74 -30.05 6.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.98 20.68 7.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.495 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -89.61 179.29 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 293' ' ' PRO . 66.1 t -136.67 135.85 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -132.1 160.12 36.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 39.9 p -122.51 -35.06 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.136 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -91.44 116.48 28.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.81 -33.39 35.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -72.26 -37.94 68.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -67.3 -44.96 77.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 67.0 tp -67.37 -29.54 69.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -60.82 -40.92 94.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -76.91 -28.38 55.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -68.17 -40.31 82.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.39 -26.92 62.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.5 -30.44 60.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -77.89 -42.28 33.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -57.21 -37.01 71.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.83 20.71 6.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 86.6 t -67.26 143.37 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.928 0.394 . . . . 0.0 111.154 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.8 m -55.05 109.65 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 6.0 m -154.88 172.19 18.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.42 49.38 1.36 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -97.17 162.29 13.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 321' ' ' LEU . 2.3 pt? -119.09 169.63 9.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.959 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 156.8 -81.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.47 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -103.87 165.2 11.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.85 0.357 . . . . 0.0 110.902 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.85 144.87 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -124.3 164.18 20.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.56 159.65 51.96 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.64 0.733 . . . . 0.0 110.884 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.76 23.52 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.684 2.256 . . . . 0.0 112.325 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.74 23.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.677 2.251 . . . . 0.0 112.3 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 107.52 1.87 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.1 160.82 32.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.72 138.83 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 161.15 -56.18 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.477 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -112.02 113.9 26.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.85 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -144.07 178.83 7.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -74.64 -70.76 1.21 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.57 159.68 62.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.628 0.727 . . . . 0.0 110.887 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 174.84 8.93 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.65 2.233 . . . . 0.0 112.365 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 67.1 mt -88.38 135.11 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.13 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.6 t -73.95 137.96 43.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.832 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -88.92 -172.25 46.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.486 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 110.38 2.54 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 44.8 m -85.43 177.74 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.846 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 18.4 t -57.92 114.87 2.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.832 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 CA-C-O 119.148 -0.807 . . . . 0.0 112.45 -179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 11.0 t -169.04 110.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.883 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.5 p -147.18 174.07 11.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.867 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -148.58 -139.62 3.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.519 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 17.5 m -142.92 167.38 22.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.871 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.9 t -127.83 177.46 6.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 88.92 -115.32 4.43 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 53.61 49.12 20.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 0.0 110.942 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -111.0 28.85 8.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -98.79 117.32 33.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.22 67.95 3.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.088 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -166.1 -145.14 4.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.432 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.9 mm -64.07 138.21 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.85 0.357 . . . . 0.0 111.166 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.8 mt -150.02 158.22 37.02 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.575 0.703 . . . . 0.0 110.958 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 142.28 47.53 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.38 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 30.0 t -52.52 114.44 1.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.84 32.97 5.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.444 HD12 ' CD2' ' A' ' 314' ' ' HIS . 32.0 mt -119.59 -41.02 2.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 110.912 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 12.6 p -116.13 -33.74 4.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.34 20.34 5.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.479 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -89.31 171.0 10.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 110.922 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 82.8 t -131.03 136.56 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.13 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.409 ' CD1' HD13 ' A' ' 307' ' ' LEU . 70.3 m-85 -135.41 161.51 35.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 70.8 p -121.54 -37.99 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.21 124.78 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.02 -51.91 62.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.043 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -56.79 -43.09 80.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -57.27 -52.75 64.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.409 HD13 ' CD1' ' A' ' 301' ' ' PHE . 59.0 tp -65.15 -29.55 70.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -54.51 -53.37 55.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -61.88 -38.59 88.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.09 -43.0 95.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.849 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -56.56 -41.29 76.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.23 -29.29 45.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.07 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -63.94 -44.77 91.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . 0.444 ' CD2' HD12 ' A' ' 296' ' ' LEU . 99.0 m-70 -72.36 -35.37 68.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 109.09 31.44 3.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.48 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 67.9 t -57.4 135.94 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 111.174 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 2.7 p -59.99 103.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.6 m -159.57 165.57 32.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.5 mp -58.85 -38.46 78.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -53.31 109.78 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 39.4 mt -95.29 113.49 25.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.921 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -81.02 -100.81 0.34 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.478 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -128.19 -46.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 0.0 110.912 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 56.3 mt -146.75 130.06 9.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -82.11 102.91 11.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 20.3 mt -80.7 159.25 69.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.631 0.729 . . . . 0.0 110.919 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.69 23.73 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.713 2.275 . . . . 0.0 112.348 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 167.71 23.69 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.654 2.236 . . . . 0.0 112.332 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 171.77 13.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.666 2.244 . . . . 0.0 112.37 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -97.8 137.26 36.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 16.9 mt -129.18 172.81 11.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -163.83 -60.36 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.48 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -123.23 98.05 5.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -174.11 144.6 0.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.901 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -86.13 127.77 8.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.514 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -98.34 159.24 31.09 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.62 0.724 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 136.74 33.66 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.641 2.227 . . . . 0.0 112.338 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 62.5 mt -71.77 -68.51 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 6.1 m -75.99 170.62 15.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -132.26 -176.65 14.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.521 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 125.81 12.6 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.745 2.297 . . . . 0.0 112.325 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 7.0 t -67.73 116.45 8.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 4.5 m -97.58 -34.7 10.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.486 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 92.6 p -62.09 -27.25 68.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 110.889 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 28.5 t -127.01 148.76 50.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.845 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 150.21 68.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 30.5 t -99.88 149.19 23.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 0.0 110.874 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.0 p -130.7 131.92 45.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.856 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -136.2 104.03 0.47 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.517 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.7 mp -78.41 158.04 28.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -131.18 136.57 48.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -56.36 162.17 2.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -137.55 139.83 40.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -170.54 -126.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.522 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm -93.88 138.1 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.079 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.0 mt -149.99 158.23 37.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.661 0.743 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.44 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.9 Cg_endo -69.8 146.65 60.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.711 2.274 . . . . 0.0 112.339 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 35.8 t -51.93 116.87 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.54 34.97 4.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.49 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 65.4 mt -123.48 -40.34 2.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.887 0.375 . . . . 0.0 110.899 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 9.5 p -117.24 -28.36 6.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 109.72 20.32 7.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -86.63 169.07 13.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 293' ' ' PRO . 64.7 t -127.48 134.71 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.16 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.534 ' CD1' HD13 ' A' ' 307' ' ' LEU . 56.3 m-85 -131.38 173.6 10.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.822 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 43.4 p -134.42 -44.07 0.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.109 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.57 120.04 25.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.51 -44.97 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -65.71 -31.3 72.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -70.25 -49.9 45.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.534 HD13 ' CD1' ' A' ' 301' ' ' PHE . 35.1 tp -67.07 -29.15 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.878 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -57.05 -38.6 73.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.851 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -74.85 -34.96 62.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -65.03 -41.07 95.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -57.08 -29.91 63.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.27 -34.03 75.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -54.23 -51.9 63.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -70.5 -40.33 73.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 109.37 65.56 0.56 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 91.4 t -97.05 84.11 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.3 m 54.53 42.82 31.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 8.5 p -154.97 129.37 9.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 14.1 tp -94.85 91.43 6.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -61.47 158.64 14.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.979 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -112.43 88.63 2.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.954 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 135.08 47.9 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.512 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -100.84 -57.31 2.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.948 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.402 HG22 ' H ' ' A' ' 326' ' ' LEU . 56.5 mt -127.36 130.01 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -126.94 39.98 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . 0.402 ' H ' HG22 ' A' ' 324' ' ' ILE . 4.2 tt -154.01 73.3 6.39 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.632 0.729 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 167.77 23.48 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.666 2.244 . . . . 0.0 112.352 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 167.71 23.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.695 2.264 . . . . 0.0 112.337 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 175.04 8.66 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.647 2.232 . . . . 0.0 112.357 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.61 25.33 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 7.3 mt -73.55 106.38 5.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 98.55 64.94 0.86 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.516 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -133.31 138.71 46.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.904 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -108.29 -33.01 7.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -104.76 130.53 10.27 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.508 HD23 ' HD2' ' A' ' 337' ' ' PRO . 0.5 OUTLIER -92.84 160.24 34.41 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.695 0.759 . . . . 0.0 110.871 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.508 ' HD2' HD23 ' A' ' 336' ' ' LEU . 53.8 Cg_endo -69.73 145.01 56.05 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.723 2.282 . . . . 0.0 112.32 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 2.7 pp -60.55 165.11 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.101 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 8.2 t -107.13 -32.49 7.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.855 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 108.21 68.38 0.64 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.495 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 151.46 69.1 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.632 2.221 . . . . 0.0 112.361 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.5 t -101.03 146.33 27.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 12.2 p -62.91 -50.78 69.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.461 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.4 t -120.14 107.27 12.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 110.84 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 22.5 t -98.37 146.62 25.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 157.59 152.49 6.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.499 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 59.3 m -93.29 160.96 14.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.87 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.7 t -156.24 150.93 25.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.864 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 138.75 68.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.19 68.17 1.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.778 0.323 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 66.9 mmt-85 -116.29 -177.57 3.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -119.06 87.35 2.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -95.13 113.04 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.14 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -108.49 -30.53 3.78 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.495 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.1 mm -96.98 129.71 46.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.1 mt -150.05 158.12 37.04 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.624 0.726 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 139.62 40.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.64 2.227 . . . . 0.0 112.369 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 17.0 t -53.15 110.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.83 39.99 2.9 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.494 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 17.5 mt -126.02 -43.74 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.813 0.34 . . . . 0.0 110.921 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 23.8 p -115.44 -31.64 5.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.897 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.45 18.63 5.69 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.449 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -89.69 168.35 12.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.3 133.42 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -131.44 155.87 46.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.9 t -118.14 -28.92 5.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.119 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -100.03 123.06 43.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.76 71.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.105 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -55.41 -32.77 62.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -74.61 -45.13 47.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 63.5 tp -66.66 -26.42 67.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -57.54 -54.22 49.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -63.8 -31.39 72.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -69.94 -27.26 64.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -83.52 -26.43 30.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.88 -51.57 63.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.077 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -61.83 -32.3 72.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -67.89 -42.5 81.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.75 50.35 0.96 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.473 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 71.6 t -98.53 87.35 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.925 0.393 . . . . 0.0 111.143 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 6.1 p 46.15 36.14 3.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.13 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 15.8 m -118.64 146.4 44.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 13.6 mt -123.05 57.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.83 115.19 10.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.85 104.32 16.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -152.61 -84.03 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.496 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -91.3 164.51 13.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.839 0.352 . . . . 0.0 110.938 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 2.0 pp -56.31 151.33 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.161 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -164.72 127.66 2.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.77 159.67 64.04 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.69 23.67 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.694 2.263 . . . . 0.0 112.35 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 167.7 23.6 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.743 2.295 . . . . 0.0 112.367 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 127.01 13.98 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.7 2.267 . . . . 0.0 112.342 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -74.03 178.69 4.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.815 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 5.4 mp -75.29 176.99 6.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -99.39 150.67 19.23 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.73 142.2 28.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.348 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -91.05 -176.25 4.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -93.74 -91.38 1.6 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.482 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 337' ' ' PRO . 0.3 OUTLIER -78.2 160.65 72.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.665 0.745 . . . . 0.0 110.924 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.545 ' HD2' HD23 ' A' ' 336' ' ' LEU . 53.2 Cg_endo -69.79 98.59 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 0.0 112.33 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 72.3 mt -70.57 131.01 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.148 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 40.2 t -125.01 108.81 12.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -106.16 -173.46 23.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 98.85 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.699 2.266 . . . . 0.0 112.326 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.7 p -64.46 159.45 21.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.3 m -89.19 102.8 15.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.453 -179.974 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.8 m -118.4 174.89 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 110.837 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.5 m -83.15 141.64 31.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.45 171.63 38.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.467 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 34.4 p -175.03 114.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.39 . . . . 0.0 110.87 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 8.3 t -56.76 141.3 44.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 148.06 -21.91 1.42 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.57 76.02 1.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -96.93 36.7 1.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -148.73 174.5 12.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -81.88 159.35 23.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.094 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 147.97 -113.75 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.482 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.417 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.9 mm -72.76 138.06 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 0.0 111.101 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.07 158.19 36.94 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 0.0 110.916 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.539 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.75 149.14 66.54 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.69 2.26 . . . . 0.0 112.336 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 36.0 t -58.16 116.82 3.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.77 34.74 4.58 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.508 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 48.9 mt -122.56 -40.07 2.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.813 0.34 . . . . 0.0 110.923 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 14.9 p -116.36 -30.42 5.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.79 19.68 7.22 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.475 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -89.94 179.34 5.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.754 0.311 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 293' ' ' PRO . 67.2 t -136.58 138.69 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -138.08 145.28 41.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 4.0 p -108.7 -33.93 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.12 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.2 109.8 20.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.417 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -51.79 -30.82 24.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -72.45 -37.45 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -67.52 -48.11 68.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 32.0 tp -57.22 -33.88 67.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -52.56 -41.44 63.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.849 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -74.75 -26.58 59.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.947 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -70.25 -41.76 73.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -59.69 -29.22 67.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.872 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.27 -37.04 64.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -62.4 -53.59 52.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -65.44 -32.1 73.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 119.42 -83.86 0.36 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 63.8 t 59.1 79.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.7 m 51.84 35.64 16.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 2.6 p -130.71 145.0 51.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.848 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.34 63.89 3.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.945 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -122.34 165.88 15.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 28.3 mt -102.47 131.22 49.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -166.97 70.97 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.494 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -76.62 150.74 36.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.839 0.352 . . . . 0.0 110.937 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.07 126.5 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -128.72 149.26 50.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 3.0 mt 64.24 154.62 0.12 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.643 0.735 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.76 23.55 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.643 2.229 . . . . 0.0 112.323 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 167.76 23.55 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.642 2.228 . . . . 0.0 112.34 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 170.99 15.32 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.665 2.243 . . . . 0.0 112.329 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -81.44 106.23 13.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 51.3 tp -167.29 150.33 6.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 166.55 84.82 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.522 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -122.79 30.26 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.932 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -87.15 133.44 33.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -112.45 -106.63 2.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.78 159.68 33.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.701 . . . . 0.0 110.95 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 133.34 25.3 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.723 2.282 . . . . 0.0 112.323 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 31.0 mm -82.11 104.8 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.9 t -105.31 153.18 21.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -60.64 178.62 3.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 111.91 2.93 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.663 2.242 . . . . 0.0 112.38 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 51.8 p -71.85 117.22 13.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 83.9 p -91.57 -39.48 11.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.493 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.79 159.57 15.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.0 110.841 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 8.8 m -84.13 137.16 33.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.833 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -72.37 -65.39 2.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.454 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 39.8 p -165.19 177.94 7.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 0.0 110.883 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.8 p -150.0 133.86 16.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -153.54 131.76 3.38 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.446 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -71.35 -31.56 67.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.773 0.32 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -122.84 145.0 48.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.819 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -120.83 133.18 55.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -119.87 -69.02 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.095 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 150.12 -19.84 1.09 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.475 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm -82.9 140.26 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.6 mt -150.02 158.25 36.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.572 0.701 . . . . 0.0 110.927 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 141.42 45.12 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.702 2.268 . . . . 0.0 112.33 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 32.3 t -53.46 110.87 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.42 46.59 2.58 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.454 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.1 mt -132.3 -49.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.346 . . . . 0.0 110.925 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 20.4 p -111.18 -26.96 8.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.05 20.97 6.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.473 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -89.79 167.19 13.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.748 0.309 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.3 133.81 67.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.139 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -132.4 140.32 48.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 7.1 p -106.52 -26.29 11.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -103.23 131.77 50.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.842 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.55 -49.05 76.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.089 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -56.25 -43.26 78.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -62.87 -46.95 85.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 51.2 tp -64.23 -26.0 68.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -52.06 -61.57 2.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.944 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -51.82 -48.38 63.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -53.25 -64.93 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 316' ' ' VAL . 10.0 mt-10 -53.55 -40.05 65.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.608 ' N ' HE22 ' A' ' 320' ' ' GLN . . . -60.81 -25.04 66.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -86.71 -32.29 20.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.898 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -57.45 -29.13 63.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.74 20.76 6.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.511 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 311' ' ' GLU . 66.7 t -54.51 144.71 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.902 0.382 . . . . 0.0 111.141 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.77 165.43 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.153 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 5.8 t -66.03 91.67 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.41 ' O ' HD13 ' A' ' 319' ' ' LEU . 0.3 OUTLIER -137.35 -41.8 0.56 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.951 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.608 HE22 ' N ' ' A' ' 312' ' ' ALA . 27.3 mt-30 -55.33 163.0 1.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 12.5 mt -74.59 154.63 38.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.936 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 151.82 -158.61 27.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.49 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -128.45 28.06 5.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 110.95 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.13 45.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.082 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.35 38.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.862 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 4.0 tt -137.35 71.63 52.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.63 0.729 . . . . 0.0 110.902 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 167.77 23.46 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 167.73 23.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.677 2.252 . . . . 0.0 112.371 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 141.05 44.32 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.707 2.271 . . . . 0.0 112.328 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -161.14 140.92 10.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.92 111.92 9.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -92.79 -128.98 4.89 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -130.41 -176.77 4.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 110.891 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -103.97 41.99 1.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -92.82 -139.49 9.22 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.66 159.56 40.77 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.604 0.716 . . . . 0.0 110.942 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 114.7 3.78 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.0 112.38 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 1.2 pp -88.32 162.48 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 19.5 m -115.94 174.13 6.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -147.84 170.37 28.53 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.496 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 91.16 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.661 2.241 . . . . 0.0 112.343 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 52.2 p -152.8 150.04 28.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.809 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 57.7 m -84.81 121.17 27.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.177 -0.791 . . . . 0.0 112.473 179.996 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.3 m 54.58 30.59 13.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.919 0.39 . . . . 0.0 110.883 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 54.4 p -107.21 96.96 6.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.92 169.42 45.92 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.489 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 33.2 p -161.75 166.01 27.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 0.0 110.848 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 17.7 p -153.85 172.55 17.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 147.83 80.53 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.43 125.63 28.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.829 0.347 . . . . 0.0 110.871 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -156.98 168.42 27.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -81.54 150.41 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -58.7 132.85 55.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.059 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 155.74 -90.41 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.468 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm -72.26 135.41 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.349 . . . . 0.0 111.148 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.6 mt -150.03 158.16 37.04 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.598 0.713 . . . . 0.0 110.936 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 140.72 43.46 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.674 2.249 . . . . 0.0 112.325 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 49.8 t -56.18 107.84 0.41 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -91.24 45.7 2.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.456 HD12 ' CD2' ' A' ' 314' ' ' HIS . 13.2 mt -132.67 -44.42 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 21.5 p -114.72 -27.1 7.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.86 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.83 19.49 7.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.466 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -88.98 166.37 13.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.814 0.34 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.9 t -130.5 135.16 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -130.85 158.01 41.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.91 -43.65 2.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.099 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -84.54 139.6 32.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.42 84.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -65.79 -41.49 91.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 37.3 tpt85 -58.7 -49.16 78.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.531 HD12 ' HB3' ' A' ' 310' ' ' HIS . 59.8 tp -69.78 -26.03 64.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -55.93 -25.77 44.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -92.18 -34.32 14.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . 0.531 ' HB3' HD12 ' A' ' 307' ' ' LEU . 46.6 t60 -71.37 -33.67 69.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -71.16 -26.5 63.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.881 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -72.18 -37.95 69.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -58.01 -40.69 81.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . 0.456 ' CD2' HD12 ' A' ' 296' ' ' LEU . 68.1 m-70 -70.28 -41.87 72.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 108.73 38.22 1.93 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.483 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.55 -45.76 96.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.92 0.39 . . . . 0.0 111.126 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 15.0 t -131.98 170.55 14.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 61.6 p -79.57 60.97 3.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 53.7 mt -146.83 117.42 7.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.73 31.23 17.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.34 165.8 2.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -101.73 -102.31 2.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.478 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -109.65 27.21 9.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 110.936 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 4.9 mp -92.78 136.2 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 2.8 t0 63.34 43.02 6.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.38 73.41 2.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.61 0.719 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 167.69 23.7 Favored 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.712 2.275 . . . . 0.0 112.344 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 167.77 23.47 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.688 2.259 . . . . 0.0 112.318 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 164.7 33.6 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.256 . . . . 0.0 112.355 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -75.64 123.57 25.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 59.7 tp -77.58 115.02 17.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -100.19 -101.42 2.4 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -139.35 148.72 43.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.889 0.376 . . . . 0.0 110.897 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -88.22 151.42 22.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.856 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -82.1 -76.06 1.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.513 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.92 159.66 35.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.614 0.721 . . . . 0.0 110.881 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 148.01 63.96 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.71 2.273 . . . . 0.0 112.357 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 63.3 mt -84.98 128.0 39.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.4 t -95.74 -41.63 8.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -152.75 177.58 30.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.516 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 159.52 53.08 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.4 p -137.25 176.16 8.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.871 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 4.9 p -84.48 128.92 34.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-O 119.091 -0.838 . . . . 0.0 112.526 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 13.7 m -67.38 142.93 56.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 0.0 110.87 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.4 m -141.3 153.8 45.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.818 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.06 71.26 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.462 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 50.6 m -85.61 76.58 9.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.923 0.392 . . . . 0.0 110.825 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 18.6 p -79.44 114.95 18.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -108.34 79.2 0.25 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.511 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.95 81.29 2.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.344 . . . . 0.0 110.902 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 8.2 tpt85 -116.31 34.1 5.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -56.96 148.75 20.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -90.07 149.58 22.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.061 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -170.66 -149.29 6.36 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.485 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm -76.69 134.88 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 0.0 111.105 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 28.0 mt -150.01 158.2 37.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.636 0.731 . . . . 0.0 110.934 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 147.33 62.27 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.635 2.223 . . . . 0.0 112.338 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 37.4 t -52.7 117.59 3.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -95.18 32.77 5.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.48 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.571 HD12 ' CD2' ' A' ' 314' ' ' HIS . 18.3 mt -119.83 -40.89 2.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 0.0 110.974 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.4 p -116.86 -31.17 5.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 113.21 22.87 5.41 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -89.82 168.81 11.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.42 142.16 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.493 ' CD1' HD13 ' A' ' 307' ' ' LEU . 48.9 m-85 -141.61 160.97 39.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 21.1 p -127.86 -39.59 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.139 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.3 116.35 25.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.15 -45.43 65.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -65.68 -31.2 72.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.884 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -73.82 -45.31 52.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.493 HD13 ' CD1' ' A' ' 301' ' ' PHE . 34.6 tp -63.3 -26.61 68.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -55.13 -54.74 39.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -52.09 -49.76 62.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -56.77 -44.1 81.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -59.6 -31.81 69.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.44 -31.93 70.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -61.93 -56.99 13.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . 0.571 ' CD2' HD12 ' A' ' 296' ' ' LEU . 95.5 m-70 -60.23 -44.52 95.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 109.06 64.06 0.55 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 84.8 t -93.37 -57.89 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 0.0 111.151 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 33.2 p -114.84 31.35 6.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.158 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 35.2 t -173.47 155.72 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.77 66.45 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -87.26 163.71 16.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.899 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 5.3 tp -110.98 89.32 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -128.82 -72.15 0.14 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.488 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.87 160.25 3.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 2.0 pp -61.12 174.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -129.96 114.87 16.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.27 73.17 9.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.661 0.743 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 167.76 23.53 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 0.0 112.343 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 167.75 23.54 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.654 2.236 . . . . 0.0 112.365 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 133.29 25.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.711 2.274 . . . . 0.0 112.339 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.02 162.72 23.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 31.8 tp -153.62 145.68 23.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -66.25 143.02 43.83 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.84 137.0 38.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.932 0.396 . . . . 0.0 110.872 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -70.95 128.0 34.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -54.46 155.36 8.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -113.05 159.21 35.53 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.615 0.722 . . . . 0.0 110.942 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -174.19 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.706 2.271 . . . . 0.0 112.359 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 1.2 pp -126.64 174.15 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 30.8 t -114.34 163.47 15.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -142.71 -179.26 19.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 146.19 59.44 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.653 2.235 . . . . 0.0 112.342 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.1 t -117.66 178.31 4.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 12.1 m -120.58 164.65 16.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 CA-C-O 119.187 -0.785 . . . . 0.0 112.52 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.6 t -122.56 -41.0 2.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 110.822 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 4.9 p -126.24 88.61 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.85 141.45 4.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.503 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 5.5 t -166.62 143.38 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.871 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -102.21 104.61 15.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -150.1 -75.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 5.9 mp -118.49 98.9 6.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.69 -34.96 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -97.43 -16.8 20.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . 60.07 28.51 18.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -153.97 -96.77 0.13 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.477 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.4 mm -56.57 141.91 12.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 0.0 111.141 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.0 mt -150.05 158.18 36.99 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 145.54 57.64 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.666 2.244 . . . . 0.0 112.33 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 20.1 t -60.22 116.6 4.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -95.42 21.49 44.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.499 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 314' ' ' HIS . 41.2 mt -105.01 -40.32 5.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.353 . . . . 0.0 110.908 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.1 p -117.59 -29.14 5.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.67 20.48 7.28 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.51 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -89.79 178.75 6.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 80.4 t -135.22 135.07 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.118 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.553 ' CD1' HD13 ' A' ' 307' ' ' LEU . 41.6 m-85 -132.05 159.99 37.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.75 -31.8 4.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.162 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -98.78 127.65 44.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.16 -38.31 88.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -67.51 -34.55 77.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -70.8 -45.35 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.553 HD13 ' CD1' ' A' ' 301' ' ' PHE . 62.2 tp -67.75 -27.64 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -54.63 -50.45 68.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -67.52 -36.51 81.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -60.5 -35.61 76.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -74.35 -32.74 62.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.44 -31.87 47.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -76.01 -36.4 59.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.971 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . 0.497 ' CD2' HD12 ' A' ' 296' ' ' LEU . 23.4 m-70 -65.29 -28.27 69.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.839 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 107.75 27.38 5.2 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.431 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 82.5 t -81.62 138.23 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 111.119 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 2.2 t -56.39 110.51 0.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 24.0 p -159.59 163.36 35.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.88 61.43 1.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.952 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -39.06 40.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 5.5 tp -87.38 128.38 35.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -80.64 79.24 1.78 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.51 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -86.1 -28.91 23.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.893 0.377 . . . . 0.0 110.956 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 45.2 mm -94.01 146.01 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -99.4 135.64 40.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 9.4 tp -158.53 71.42 3.81 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 167.75 23.47 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.263 . . . . 0.0 112.342 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 167.77 23.49 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.658 2.239 . . . . 0.0 112.335 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 174.3 9.76 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.624 2.216 . . . . 0.0 112.349 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -56.31 158.45 4.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.836 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 18.4 tp -52.23 113.69 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 169.51 40.67 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.494 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -146.43 150.97 36.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.911 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -106.79 157.55 17.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 155.15 -108.44 0.36 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.463 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.25 159.65 71.06 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.646 0.736 . . . . 0.0 110.928 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 176.21 7.07 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.698 2.265 . . . . 0.0 112.356 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 338' ' ' ILE . 1.2 pp -126.61 162.72 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.14 172.82 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 134.41 71.62 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.455 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 172.15 13.23 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.355 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 94.3 p -117.96 -178.5 3.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.4 m -110.98 81.03 1.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 CA-C-O 119.122 -0.821 . . . . 0.0 112.466 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.1 t -141.97 118.24 10.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.828 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.1 t -146.5 147.69 31.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 132.78 158.88 9.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.484 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.6 p -150.58 111.46 4.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.875 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 56.9 p -68.55 87.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 169.41 46.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.515 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 19.7 mt -102.21 31.73 3.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.65 129.35 19.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.905 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -167.49 145.36 4.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.15 91.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -173.8 -112.67 0.29 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.7 mm -66.49 137.8 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.113 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.8 mt -150.04 158.22 36.98 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.602 0.715 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 154.37 67.89 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.388 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.4 t -63.55 117.2 6.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.71 34.43 4.76 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 93.7 mt -121.82 -39.53 2.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.857 0.36 . . . . 0.0 110.921 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 13.7 p -117.78 -29.94 5.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.14 21.54 6.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -89.17 178.89 6.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.902 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.0 t -135.2 135.08 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -131.74 159.28 38.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.2 -32.67 4.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -99.45 132.04 45.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -62.61 -45.35 93.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -59.6 -39.35 83.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -66.95 -45.98 76.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.35 -27.25 67.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 8.1 ttm-85 -61.22 -53.98 50.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -61.07 -31.74 71.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -67.09 -42.64 84.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.26 -30.92 71.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -59.06 -35.74 73.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.26 -33.72 75.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -70.47 -32.96 70.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.5 27.92 3.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.498 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 63.6 t -74.33 -42.19 50.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.123 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.4 t -126.02 137.74 53.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 51.0 m -103.43 -35.45 8.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.0 pp -54.93 -30.67 59.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -56.45 125.47 22.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.34 149.33 16.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -90.37 -163.7 39.25 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.501 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.11 130.7 14.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 0.0 110.854 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 324' ' ' ILE . 8.9 mt 51.34 45.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -59.51 143.06 51.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 3.7 tt -119.93 70.2 14.23 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.57 0.7 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 167.75 23.61 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.63 2.22 . . . . 0.0 112.353 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 167.75 23.56 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.644 2.229 . . . . 0.0 112.346 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 99.62 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.662 2.241 . . . . 0.0 112.385 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 45.3 mmm-85 -93.2 -18.08 22.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 11.6 tp -95.19 70.79 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -111.44 65.73 0.25 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.48 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -132.36 108.92 9.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 110.933 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 30.6 t30 57.42 27.96 14.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -146.82 132.93 4.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.506 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -86.56 159.2 53.22 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.627 0.727 . . . . 0.0 110.929 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 148.71 66.05 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.732 2.288 . . . . 0.0 112.328 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.09 100.47 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.118 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 20.1 m -67.42 157.98 32.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -157.84 71.53 0.25 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.447 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 175.86 7.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.701 2.267 . . . . 0.0 112.32 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 33.0 t -108.47 118.05 35.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 2.5 t -109.27 177.17 4.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.855 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.48 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 55.5 m -149.46 143.66 25.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 0.0 110.91 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.8 t -159.72 172.47 17.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 147.62 56.64 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.463 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 14.6 m -115.27 145.39 42.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.867 0.365 . . . . 0.0 110.887 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 35.9 m -105.74 99.12 8.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.9 -115.71 3.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.51 125.33 54.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 0.0 110.889 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -64.66 -66.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -91.66 113.97 26.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -86.28 105.42 16.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.102 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -93.5 -100.93 1.55 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.496 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.3 mm -57.23 135.35 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 111.106 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.05 158.18 36.98 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.718 . . . . 0.0 110.968 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 145.53 57.2 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 0.0 112.346 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 20.7 t -56.34 114.95 2.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.77 30.87 7.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.469 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 21.1 mt -117.98 -40.81 2.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.348 . . . . 0.0 110.892 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 20.8 p -115.71 -35.07 4.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 117.81 19.05 4.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.481 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -88.29 166.69 14.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 64.7 t -125.47 134.58 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.086 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -134.09 151.13 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.1 p -116.81 -46.69 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -78.62 128.09 33.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.51 -48.75 78.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -58.56 -35.19 71.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -65.12 -51.39 61.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.818 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 310' ' ' HIS . 51.3 tp -69.59 -26.34 64.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -56.19 -26.0 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -93.69 -34.29 13.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . 0.513 ' HB3' HD12 ' A' ' 307' ' ' LEU . 24.8 t60 -70.3 -33.59 71.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.816 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.21 -30.75 66.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.78 -30.43 67.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.119 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -60.42 -60.34 3.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -53.72 -47.76 70.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 129.66 35.61 0.44 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.468 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 67.5 t -74.89 144.39 12.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 0.0 111.136 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 5.0 t -52.55 124.26 13.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 9.9 p -173.84 166.99 4.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.411 ' C ' HD12 ' A' ' 319' ' ' LEU . 4.3 pp -75.85 -27.6 57.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.95 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -55.1 101.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -53.37 155.53 2.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -139.81 135.62 7.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.515 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -98.9 -28.36 13.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 0.0 110.926 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 3.6 mp -59.62 138.51 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.165 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -55.99 160.6 2.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.78 154.96 78.3 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.617 0.722 . . . . 0.0 110.944 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 167.71 23.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.721 2.281 . . . . 0.0 112.302 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.74 23.57 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.704 2.269 . . . . 0.0 112.351 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 175.53 7.98 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.704 2.269 . . . . 0.0 112.308 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -111.66 94.72 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 15.6 mt -93.9 57.13 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -67.11 167.21 39.72 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.474 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -96.45 96.59 8.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.379 . . . . 0.0 110.893 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -66.76 112.34 4.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -56.52 123.2 30.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.504 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 20.3 mt -98.46 159.24 31.03 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.661 0.744 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 178.15 4.89 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.666 2.244 . . . . 0.0 112.353 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 72.7 mt -73.63 97.77 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 10.2 p -69.15 179.06 2.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 107.4 174.37 22.47 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -175.01 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.645 2.23 . . . . 0.0 112.374 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 10.7 t -156.86 150.82 24.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.3 t -100.07 99.63 10.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.834 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 119.155 -0.803 . . . . 0.0 112.493 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.0 m -53.93 138.9 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.8 t -65.38 -57.4 8.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.5 53.95 3.26 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.2 p -67.81 179.22 1.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 0.0 110.842 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 3.7 m -107.35 -31.58 8.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.839 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 76.98 -68.54 2.57 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.452 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.68 HD12 ' HB3' ' A' ' 289' ' ' ALA . 0.4 OUTLIER -150.55 149.87 30.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.775 0.322 . . . . 0.0 110.926 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -121.62 -55.9 1.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -91.08 77.22 6.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.68 ' HB3' HD12 ' A' ' 286' ' ' LEU . . . -142.09 125.53 16.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.051 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -88.02 -26.07 29.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.529 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.0 mm -84.12 137.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.5 mt -150.0 158.27 37.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.607 0.718 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 144.04 52.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.307 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.9 t -55.9 112.54 1.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.84 34.49 4.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.468 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 314' ' ' HIS . 92.5 mt -119.07 -45.7 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.884 0.373 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 26.3 p -113.1 -28.39 7.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.44 20.99 6.33 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.501 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -89.96 177.32 6.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.889 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 65.3 t -136.41 136.2 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -135.47 150.28 49.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 23.3 p -116.62 -45.32 2.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.095 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -78.47 118.1 20.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -51.71 -37.95 53.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.142 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -67.39 -37.98 83.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -63.08 -50.8 69.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.57 HD11 ' HG2' ' A' ' 311' ' ' GLU . 54.8 tp -65.6 -27.42 68.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.927 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -57.27 -26.16 60.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -93.31 -36.54 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -70.23 -59.83 2.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.57 ' HG2' HD11 ' A' ' 307' ' ' LEU . 4.2 mm-40 -54.32 -29.76 48.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.21 -34.13 77.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -67.0 -47.26 72.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . 0.429 ' HB3' HD13 ' A' ' 296' ' ' LEU . 74.2 m-70 -55.53 -27.26 47.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 112.28 24.77 4.96 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.54 HG21 ' CD ' ' A' ' 311' ' ' GLU . 66.6 t -78.06 144.21 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.956 0.408 . . . . 0.0 111.106 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 44.1 m -52.58 116.27 2.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.076 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 14.7 t -160.98 171.96 17.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 12.3 mt -62.87 -36.85 84.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -64.44 133.67 52.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.11 166.11 18.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -177.49 59.3 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.502 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -50.22 -36.73 32.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 110.961 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 54.6 mt -150.66 133.92 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.151 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -132.82 147.83 52.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.838 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 6.6 tp -165.66 72.33 1.32 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.607 0.718 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 167.75 23.5 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.348 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 167.76 23.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.661 2.24 . . . . 0.0 112.3 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 136.39 32.83 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.647 2.231 . . . . 0.0 112.34 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.62 147.99 29.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 7.7 tp -133.11 118.0 18.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.966 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 170.55 76.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -107.21 89.18 2.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.875 0.369 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -159.53 -179.6 8.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.606 ' C ' HD23 ' A' ' 336' ' ' LEU . . . -78.86 -149.33 4.61 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.468 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.606 HD23 ' C ' ' A' ' 335' ' ' GLY . 0.1 OUTLIER -157.17 159.63 30.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.552 0.691 . . . . 0.0 110.889 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 165.35 31.2 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.691 2.261 . . . . 0.0 112.374 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 68.4 mt -95.49 99.66 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.5 p -96.63 134.48 39.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.869 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -171.44 73.59 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.52 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -43.66 2.56 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.692 2.261 . . . . 0.0 112.392 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 55.56 35.63 25.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 7.4 p -147.16 119.94 8.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-O 119.148 -0.807 . . . . 0.0 112.485 -179.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.1 m -58.74 113.23 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.347 . . . . 0.0 110.902 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 8.1 t -161.56 133.95 5.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.839 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -71.57 -118.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.462 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 28.7 t -153.95 153.42 31.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 110.833 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 74.7 p -112.24 104.86 13.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.841 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -106.14 103.17 2.04 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.53 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.7 mp -107.28 131.37 54.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.94 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -117.26 -41.14 3.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.03 139.84 58.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -97.26 -177.3 3.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 110.03 -87.45 0.47 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.46 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 44.7 mm -67.29 129.85 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.361 . . . . 0.0 111.148 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.6 mt -150.09 158.13 36.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 145.53 57.36 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.637 2.225 . . . . 0.0 112.344 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 39.3 t -52.04 115.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -92.89 22.2 35.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.494 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.509 HD12 ' CD2' ' A' ' 314' ' ' HIS . 63.0 mt -105.32 -41.63 5.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.821 0.343 . . . . 0.0 110.902 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 26.7 p -118.96 -31.34 4.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 115.0 27.02 3.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.518 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -90.01 179.32 5.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.865 0.364 . . . . 0.0 110.884 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.7 t -136.05 139.82 45.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.163 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -138.72 167.22 22.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 3.0 p -118.71 -56.19 2.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.78 141.59 40.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -61.14 -60.45 3.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -53.51 -43.05 67.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -55.45 -48.99 73.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 29.3 tp -58.35 -38.28 76.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -38.12 81.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -52.31 -55.43 21.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.2 -50.84 72.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.722 ' OE1' HG21 ' A' ' 316' ' ' VAL . 12.0 mm-40 -52.46 -30.45 29.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.819 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 309' ' ' GLN . . . -54.9 -27.44 42.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.092 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -82.64 -44.17 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.956 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . 0.509 ' CD2' HD12 ' A' ' 296' ' ' LEU . 12.7 m-70 -52.91 -29.17 26.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 119.03 19.9 4.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.722 HG21 ' OE1' ' A' ' 311' ' ' GLU . 91.2 t -84.75 134.85 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 111.116 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 2.2 p -60.17 127.07 30.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 7.1 p -162.27 163.28 28.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 6.0 mp -81.39 57.98 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.67 123.11 29.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.53 113.71 8.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.19 98.71 1.35 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.501 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -58.59 162.0 4.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.899 0.38 . . . . 0.0 110.872 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 324' ' ' ILE . 4.7 mp -88.68 128.28 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.122 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -116.0 143.37 45.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 4.0 tt 58.23 71.52 1.01 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.569 0.699 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 167.73 23.56 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.685 2.257 . . . . 0.0 112.352 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.76 23.51 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.654 2.236 . . . . 0.0 112.368 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 178.47 4.56 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.28 151.69 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 88.0 mt -115.44 -33.93 5.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 93.42 -80.93 1.04 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.519 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -139.37 105.41 5.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -124.04 101.81 7.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 140.49 159.76 8.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.473 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.85 82.54 43.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.614 0.721 . . . . 0.0 110.913 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 91.97 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.666 2.244 . . . . 0.0 112.371 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 68.8 mt -122.09 97.35 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.114 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.69 157.51 34.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 174.74 -71.74 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 100.71 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.716 2.278 . . . . 0.0 112.328 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 2.8 m -123.83 153.57 40.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 48.4 t 52.87 55.2 9.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.849 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 CA-C-O 119.123 -0.821 . . . . 0.0 112.454 -179.974 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.8 p -64.39 144.74 56.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 0.0 110.839 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 7.9 t 60.84 54.22 3.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.87 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -137.19 46.07 1.03 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.51 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 3.8 m -131.99 -50.19 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.88 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 43.6 t -56.74 110.82 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -179.67 -173.95 45.21 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.55 59.74 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.785 0.326 . . . . 0.0 110.919 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -116.08 85.21 2.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -111.13 28.63 8.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . 56.55 25.04 9.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 65.69 -92.5 0.16 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.51 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 49.4 mm -93.81 140.81 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.364 . . . . 0.0 111.09 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.2 mt -150.05 158.26 36.93 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.599 0.714 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.576 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.79 161.23 46.74 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.715 2.276 . . . . 0.0 112.35 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.3 115.27 9.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.43 41.32 2.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.454 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 60.0 mt -127.94 -43.33 1.52 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 22.2 p -115.93 -27.55 6.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 111.7 19.59 7.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -89.85 177.64 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.576 HG22 ' HB3' ' A' ' 293' ' ' PRO . 63.8 t -136.82 138.65 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.111 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -135.0 145.47 48.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 17.4 p -106.62 -49.12 3.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -77.99 115.97 18.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.23 -29.62 23.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.058 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.9 -39.37 61.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -62.31 -39.56 93.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 310' ' ' HIS . 59.8 tp -74.6 -25.92 59.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -56.15 -25.89 48.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -92.69 -34.49 13.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . 0.495 ' HB3' HD12 ' A' ' 307' ' ' LEU . 83.1 t60 -69.17 -47.7 64.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 316' ' ' VAL . 20.3 mt-10 -58.31 -26.36 62.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.16 -49.43 44.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.105 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -52.34 -36.28 53.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -67.6 -40.68 84.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 111.92 42.68 1.0 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.44 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.577 HG12 HG23 ' A' ' 317' ' ' THR . 82.5 t -78.32 -71.8 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 111.13 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.577 HG23 HG12 ' A' ' 316' ' ' VAL . 50.6 p -113.2 35.11 4.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.154 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 78.7 p -165.48 176.26 8.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.32 32.68 5.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -53.37 151.93 5.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -105.65 170.46 7.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 164.67 -80.91 0.12 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.504 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -131.04 31.68 4.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.902 0.382 . . . . 0.0 110.929 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 41.3 mm -94.09 140.72 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 18.3 p30 -67.96 156.18 37.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.836 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.76 159.28 84.75 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.613 0.721 . . . . 0.0 110.888 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 167.72 23.59 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.746 2.297 . . . . 0.0 112.301 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 167.7 23.65 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.717 2.278 . . . . 0.0 112.319 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 95.63 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.267 . . . . 0.0 112.317 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -136.57 137.89 40.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 17.1 tp -62.53 125.77 25.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 172.95 129.18 1.12 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.521 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -77.47 96.94 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -80.95 -38.16 28.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 146.85 70.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.514 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 2.8 mt 64.2 154.66 0.12 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.636 0.731 . . . . 0.0 110.928 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 104.4 1.32 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.665 2.243 . . . . 0.0 112.324 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 2.5 pp -78.81 151.97 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 87.6 p -159.29 145.9 16.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -134.81 179.23 17.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 176.88 6.16 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.731 2.287 . . . . 0.0 112.318 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 27.6 m -103.31 124.3 48.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 46.3 t -148.68 158.21 43.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 CA-C-O 119.185 -0.786 . . . . 0.0 112.518 -179.956 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 12.0 p -150.73 156.16 40.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.854 0.359 . . . . 0.0 110.859 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 45.8 t -105.42 123.48 47.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -97.69 47.43 1.55 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.486 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 18.8 p -95.8 144.24 26.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 0.0 110.867 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 87.1 p -141.74 145.21 34.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.872 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -151.32 -164.52 12.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -151.33 168.9 23.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.912 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -100.22 166.16 11.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -107.29 -16.81 14.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -79.05 -66.12 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 100.44 19.89 16.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.5 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.573 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.6 mm -97.77 134.58 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.156 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.2 mt -150.09 158.21 36.88 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.619 0.723 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 138.64 38.22 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.245 . . . . 0.0 112.348 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 11.8 t -53.08 113.27 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.42 29.45 8.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.521 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 81.7 mt -115.93 -38.51 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 14.6 p -117.34 -33.37 4.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 114.7 18.88 6.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.421 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -90.08 170.53 10.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.809 0.337 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 62.2 t -129.23 138.34 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.128 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -139.7 156.5 46.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.66 -44.4 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.144 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -80.02 131.22 35.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -64.42 -38.71 91.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -65.65 -42.18 91.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -60.31 -50.51 73.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 56.2 tp -67.18 -26.33 66.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 15.6 ttt85 -56.66 -43.12 80.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -78.25 -32.3 49.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -67.97 -31.92 71.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.7 -36.76 57.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.4 ' HB2' ' OE1' ' A' ' 320' ' ' GLN . . . -55.57 -30.2 60.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.07 -51.81 49.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -56.44 -26.67 54.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 110.79 29.1 3.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 74.2 t -79.83 137.36 21.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 111.125 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.8 p -73.49 77.49 1.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.105 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 53.1 p -112.97 34.97 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.07 46.15 4.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.909 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.4 ' OE1' ' HB2' ' A' ' 312' ' ' ALA . 20.9 mt-30 -136.79 136.55 38.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.944 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 4.5 pp -105.1 172.54 6.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -169.46 -68.23 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.496 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -109.45 169.54 8.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.862 0.363 . . . . 0.0 110.936 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 5.4 mp -87.28 134.07 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -74.65 150.38 39.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -155.82 154.8 28.53 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.591 0.71 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 167.75 23.51 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.355 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 167.71 23.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 175.07 8.57 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.264 . . . . 0.0 112.331 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -77.39 132.92 38.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.35 -27.76 27.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 163.47 -148.96 15.88 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.464 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.83 127.43 52.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.825 0.345 . . . . 0.0 110.909 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -105.15 139.37 39.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.936 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -169.31 -179.3 41.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.21 81.39 67.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.615 0.721 . . . . 0.0 110.907 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 160.43 49.72 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.723 2.282 . . . . 0.0 112.33 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 73.9 mt -116.0 95.86 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 10.3 p -98.29 -59.58 1.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 140.45 72.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.474 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 147.0 61.62 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.724 2.282 . . . . 0.0 112.313 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.8 m -58.36 160.14 5.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 67.4 m -141.18 164.01 31.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 CA-C-O 119.121 -0.822 . . . . 0.0 112.452 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.1 m -128.83 72.76 1.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.915 0.388 . . . . 0.0 110.897 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 9.4 p -99.8 147.22 25.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -148.48 -168.92 14.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.543 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 63.9 p -112.36 161.83 16.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 110.828 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 32.9 p -136.42 105.28 5.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.817 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 138.66 109.88 0.9 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.5 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 76.7 mt -113.64 130.55 56.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.809 0.338 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.05 110.37 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -145.89 150.61 36.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -116.76 106.36 13.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.073 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -149.56 129.36 2.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.47 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 43.4 mm -61.12 131.74 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.876 0.369 . . . . 0.0 111.18 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 30.7 mt -150.04 158.15 37.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.616 0.722 . . . . 0.0 110.94 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.543 ' HB3' HG22 ' A' ' 300' ' ' VAL . 53.8 Cg_endo -69.78 146.99 61.76 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.654 2.236 . . . . 0.0 112.367 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 52.6 t -52.09 107.69 0.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -90.8 46.51 2.93 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.521 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 69.0 mt -131.39 -42.23 1.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 110.921 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 29.8 p -117.43 -28.49 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.831 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 116.47 23.66 4.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -90.04 178.49 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 293' ' ' PRO . 63.0 t -141.86 142.63 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -140.52 174.11 10.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.2 p -129.74 -39.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -88.34 127.67 35.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.77 84.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -73.07 -37.18 66.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -68.89 -46.25 68.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 26.0 tp -52.04 -38.44 57.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.931 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -58.33 -33.73 69.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . 0.44 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.0 OUTLIER -51.86 -57.43 9.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -62.87 -48.9 76.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.743 ' OE1' HG21 ' A' ' 316' ' ' VAL . 6.6 mm-40 -54.89 -26.85 38.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 309' ' ' GLN . . . -55.8 -25.37 41.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -87.89 -43.87 11.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -52.02 -31.22 28.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 110.24 19.37 8.05 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.49 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.743 HG21 ' OE1' ' A' ' 311' ' ' GLU . 91.6 t -73.81 -52.4 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 111.172 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 14.0 p -65.7 139.36 58.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 71.0 m -113.33 -30.64 6.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 19.2 mt -97.63 26.48 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -113.55 73.55 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.943 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.08 106.26 13.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 167.95 52.11 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -86.64 -42.74 13.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.846 0.355 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 57.4 mt -133.26 139.47 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.134 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.14 120.8 37.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 2.9 tt 61.01 73.36 0.61 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.648 0.737 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.74 23.56 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.72 2.28 . . . . 0.0 112.349 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 167.75 23.57 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.683 2.255 . . . . 0.0 112.371 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 154.93 67.14 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.72 2.28 . . . . 0.0 112.329 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -142.64 118.63 10.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.845 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -52.82 143.12 17.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 97.17 -24.07 32.99 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.494 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -68.58 101.2 1.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 0.0 110.873 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -110.42 174.48 5.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -177.53 -143.74 5.1 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.2 82.93 61.49 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.615 0.722 . . . . 0.0 110.872 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 141.63 45.33 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.639 2.226 . . . . 0.0 112.325 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 338' ' ' ILE . 1.2 pp -126.83 169.74 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 5.0 t -76.5 156.93 32.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -163.6 177.72 39.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.479 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 108.17 2.03 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.665 2.243 . . . . 0.0 112.348 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 4.0 m -63.63 129.89 42.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 14.5 m -110.42 -46.01 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.519 -179.976 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.8 t 56.38 42.15 28.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.94 0.4 . . . . 0.0 110.873 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 10.5 p -102.01 135.23 43.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.866 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.15 20.08 59.72 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.459 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 55.3 p -102.91 105.99 16.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 0.0 110.847 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.1 p -171.96 110.47 0.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.866 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -97.09 138.3 13.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.473 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.73 111.36 6.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 110.91 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 19.4 ptt85 -106.05 43.42 1.14 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -111.34 31.6 5.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -99.33 163.44 12.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.104 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -81.96 -30.92 33.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.484 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.9 mm -98.0 139.87 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 111.107 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 28.0 mt -150.03 158.22 37.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.571 0.7 . . . . 0.0 110.941 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 148.3 64.93 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.702 2.268 . . . . 0.0 112.325 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 25.8 t -58.87 113.98 2.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -93.75 29.26 8.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.52 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.24 -42.77 3.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.89 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 17.0 p -114.8 -29.91 6.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 112.08 19.71 7.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.466 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -89.98 179.09 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 71.9 t -134.89 136.08 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.09 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -136.85 143.66 43.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 1.8 p -107.11 -43.17 4.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.44 116.02 19.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.474 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -54.39 -41.35 69.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -65.15 -31.73 73.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -69.76 -49.95 47.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 310' ' ' HIS . 51.4 tp -65.07 -26.24 68.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -56.01 -40.21 73.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -79.15 -37.73 37.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . 0.471 ' HB3' HD12 ' A' ' 307' ' ' LEU . 86.4 t60 -55.62 -39.72 71.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -67.9 -30.79 70.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.01 -27.52 44.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.86 -53.01 7.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -53.47 -33.15 53.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 104.8 45.18 1.43 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 65.0 t -94.34 -34.43 5.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.879 0.371 . . . . 0.0 111.079 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.6 HG23 ' H ' ' A' ' 319' ' ' LEU . 14.6 t -78.2 166.46 22.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.153 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 2.2 p -96.66 25.05 5.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.857 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.6 ' H ' HG23 ' A' ' 317' ' ' THR . 2.3 mp -145.88 -167.03 2.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 61.04 40.66 14.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 43.4 mt 52.62 49.09 21.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -75.25 -86.29 0.3 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -139.83 162.05 36.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.337 . . . . 0.0 110.957 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 9.0 mt 51.36 45.71 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.123 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -85.08 157.2 20.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 13.8 mt -119.48 69.07 11.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.604 0.716 . . . . 0.0 110.9 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 167.75 23.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.665 2.243 . . . . 0.0 112.3 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 167.74 23.53 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.695 2.263 . . . . 0.0 112.334 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 114.58 3.75 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.688 2.258 . . . . 0.0 112.363 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -98.61 94.15 6.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.2 tp 57.11 27.51 13.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 94.35 163.46 35.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.451 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -77.78 -32.18 52.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.828 0.346 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -80.78 153.3 27.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . -76.55 -106.37 0.14 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.494 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.09 159.64 40.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.566 0.698 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 173.0 11.58 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.67 2.247 . . . . 0.0 112.361 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 49.5 mt -63.19 106.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.136 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.8 t -153.88 112.64 3.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -150.53 171.1 30.4 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 108.33 2.05 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.728 2.285 . . . . 0.0 112.32 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 79.1 p -101.34 84.12 2.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 27.1 m -161.55 155.87 22.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.526 179.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 26.0 t -133.14 150.93 52.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 0.0 110.86 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.3 m -74.1 86.24 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 156.04 -54.09 0.41 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.46 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 16.3 m -114.8 143.61 44.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.914 0.388 . . . . 0.0 110.829 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 48.5 t -67.25 154.02 42.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.837 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -135.61 115.32 1.34 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.5 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 19.5 mt -124.99 166.35 16.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.841 0.353 . . . . 0.0 110.912 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.79 153.87 42.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -157.03 121.8 4.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -154.87 171.96 18.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.106 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -77.3 -113.84 0.16 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.473 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 304' ' ' ALA . 43.4 mm -59.84 136.72 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 111.105 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 31.0 mt -150.01 158.21 37.05 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.649 0.738 . . . . 0.0 110.937 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 148.55 65.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.654 2.236 . . . . 0.0 112.348 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.17 114.34 2.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -94.39 37.68 3.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.443 HD12 ' CD2' ' A' ' 314' ' ' HIS . 24.2 mt -124.32 -42.76 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.896 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' CYS . . . . . . . . . . . . . 19.6 p -115.66 -26.49 7.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.12 20.28 7.61 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -89.67 179.11 6.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 0.0 110.884 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 68.3 t -135.59 135.41 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -134.06 124.85 26.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 26.7 p -90.67 -34.57 15.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -89.82 128.07 36.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.864 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' A' ' 291' ' ' ILE . . . -58.92 -58.59 7.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -52.91 -33.85 52.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' ARG . . . . . . . . . . . . . 18.7 tpt85 -63.85 -44.01 94.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . . . . . . . . . 53.8 tp -71.79 -27.17 62.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -59.13 -25.56 63.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -90.76 -35.05 15.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -71.04 -41.85 70.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 316' ' ' VAL . 39.1 mt-10 -63.04 -26.24 68.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.23 -34.0 72.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -62.33 -52.1 64.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . 0.443 ' CD2' HD12 ' A' ' 296' ' ' LEU . 61.3 m-70 -55.38 -31.1 61.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 107.35 40.62 1.75 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 311' ' ' GLU . 78.0 t -80.44 -59.16 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 111.17 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.7 p -122.07 150.4 42.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 16.1 p -106.32 31.94 4.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.839 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.2 pp -87.31 -29.47 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -59.73 120.93 10.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.91 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -58.14 156.26 9.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 100.39 162.33 28.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -76.35 153.13 36.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.88 0.371 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.99 170.13 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.111 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -144.69 150.71 37.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' LEU . . . . . . . . . . . . . 26.5 tp 54.77 70.87 1.47 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.62 0.724 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 167.73 23.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.741 2.294 . . . . 0.0 112.329 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 167.81 23.45 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.657 2.238 . . . . 0.0 112.323 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 133.92 26.62 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.65 2.234 . . . . 0.0 112.319 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.67 64.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 13.0 tp -105.66 59.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -72.37 155.49 51.44 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.527 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.9 168.18 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.351 . . . . 0.0 110.908 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -75.63 -33.98 60.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.551 ' O ' HD12 ' A' ' 336' ' ' LEU . . . -53.1 152.9 7.68 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.502 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 335' ' ' GLY . 0.5 OUTLIER 64.22 154.13 0.12 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.574 0.702 . . . . 0.0 110.899 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 173.88 10.31 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.719 2.279 . . . . 0.0 112.372 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 5.3 mp -105.35 103.14 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 m -81.66 96.83 7.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.834 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -94.58 -74.77 1.26 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.486 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -22.62 31.63 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.68 2.253 . . . . 0.0 112.358 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 8.5 t -98.56 75.71 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 14.1 t -53.07 135.57 37.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.474 179.988 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_